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1 General Introduction 
Visual impairment and blindness can be caused by various diseases and may affect people of 
every age and social class. The leading causes of blindness worldwide are, for example, 
cataract, glaucoma, age-related macular degeneration and diabetic retinopathy (Thylefors et al. 
1995). Every disease has its own possible risk factors. Among them are environmental factors, 
aging, smoking and genetic predispositions. Dysregulation of signaling pathways which are 
critical for development and homeostasis of the ocular environment may also cause 
malfunctions which can then lead to blindness.  
 
1.1 TGF-β signaling 
During development and adulthood, TGF-β signaling modulates essential processes e.g.cell 
growth and differentiation, tissue maintenance and apoptosis (Massagué 2012, Heldin et al. 
1997). However, TGF-β has divers functions which are discussed controversially, as the effects 
of TGF-β depend on the affected cell type and the cellular environment (Massagué 2012). To 
date, three different isoforms of the cytokine TGF-β are known in mammals (TGF-β1-3) 
(Massagué 1992, Kingsley 1994). These ligands have the ability to bind TGF-β receptor type II 
(Tgfbr2, TβRII) which is essential for TGF-β signaling. TGF-β receptor type I recognizes this 
process, joins the complex and is phosphorylated by receptor type II (Wrana et al. 1992, Wrana 
et al. 1994). TGF-β receptor type II as well as type I are transmembrane serine/threonine 
kinases. Phosphorylation correlates with their kinase activity (Massagué et al. 1994, Wrana et al. 
1994). Upon complex formation, the activated type I receptor phosphorylates the receptor-
regulated (R-) Smads, Smad2 and 3, which form a complex with the co-mediator Smad, Smad4. 
This complex translocates into the nucleus to regulate the expression of target genes (Figure 1) 
(Visser and Themmen 1998, Massagué 1998). 
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Figure 1: TGF-β signaling pathway.  Binding of TGF-β to Tgfbr2 leads to recruitment and 
phosphorylation of Tgfbr1 which posphorylates and thereby activates the R-Smads. The R-Smads form a 
complex with the Co-Smad Smad4. This complex translocates into the nucleus and regulates the 
expression of target genes. 
 
1.2 Cre loxP system 
To understand the function of a specific gene in vivo, a common experimental approach is to 
analyze its function by generating animal models that harbor an inactivation or mutation of the 
gene (Rajewsky et al. 1996). However, when working with genes that have important functions 
during cell development or maintenance, researchers are frequently confronted with the problem 
of embryonic lethality (Branda and Dymecki 2004, Maddison and Clarke 2005). The 
establishment of the Cre loxP system in mouse models greatly enhanced the opportunities in 
this context. When using a Cre that is expressed in mice carrying a loxP targeted gene, the gene 
modification can be restricted to certain cell types or developmental stages depending on the 
use of specific promotors. 
In general, two specific components, both derived from the bacteriophage P1, are necessary to 
achieve recombination using this system, namely a Cre recombinase and loxP sites: Cre stands 
for causes recombination and denotes a 38 kDa protein that recognizes and recombines loxP 
flanked DNA sequences. LoxP is an abbreviation for locus of crossover (x) in P1 bacteriophage 
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and describes a 34 bp asymmetric DNA sequence (Kuhn and Torres 2002, Sternberg and 
Hamilton 1981).  
Tamoxifen inducible Cre recombinases are known as a special variant of the Cre loxP system 
(Figure 2). These allow recombination of the target gene at any desired time point. A tamoxifen-
inducible Cre recombinase is characterized by its fusion with a mutated form of an estrogen 
receptor binding domain (ERTM). This mutation prevents the binding of endogenous 17β-
estradiol but makes the ERTM domain susceptible to tamoxifen. Furthermore, this fusion leads to 
a sequestration of the Cre in the cytoplasm by interaction with Hsp90, thus preventing the Cre’s 
access to the nucleus and therefore recombination. The binding of tamoxifen causes a 
disruption of this complex. Thus, the Cre is able to translocate into the nucleus to initiate 
recombination (Hayashi and McMahon 2002). 
 
Figure 2: Tamoxifen-inducible Cre–loxP system.  The Cre recombinase is fused to a modified estrogen 
receptor (ER) and controlled by a specific promoter. In the inactivated state, heat shock protein 90 
(Hsp90) binds to the ER, retaining it in the cytosol. Upon tamoxifen treatment, tamoxifen binds the ER, the 
Hsp90 protein is released, and the Cre–ER fusion protein can translocate in the nucleus to initiate 
recombination. Slightly modified from (Gunschmann et al. 2014).  
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1.3 The ocular vasculature 
The oxygenation of the retina during initial development is ensured by two different and 
independent circulatory systems: the choroidal vessels and the hyaloid system. The mature and 
fully developed retina has the highest oxygen consumption per unit weight of any human tissue 
and thus needs a perfect system for oxygen supply (Saint-Geniez and D'amore 2004). 
Therefore, during ocular development and maturation, the embryonic, hyaloid vascular system is 
replaced by the mature retinal vasculature which consists of three vascular plexus, namely the 
superior, intermediate and deep plexus (Stahl et al. 2010).  
The inner wall of capillaries consists of a single layer of endothelial cells (ECs). These cells are 
densely coated with either several layers of vascular smooth muscle cells (in larger arteries) or a 
single layer of non-overlapping pericytes (in smaller arteries and arterioles) (Saint-Geniez and 
D'amore 2004). Together, the endothelial cells and the pericytes form the vascular basement 
membrane (Figure 3) (Mandarino et al. 1993). In general, pericytes have long cytoplasmatic 
processes which they use for contacting neighbouring endothelial cells and therefore can 
intgrate signals along the vessel length (Bergers and Song 2005). Furthermore, they show 
various characteristics correlating with muscle-cell activity and have the ability to produce 
vasoconstriction and vasodilation to regulate capillary blood flow (Rucker et al. 2000).  
 
Figure 3: Composition of capillaries.  Endothelial cells (EC, green) form the inner wall of capillaries, 
surrounded by the basement membrane in which pericytes (PC, red) or,vascular smooth muscle cells are 
embedded. Drawing taken from (Bergers and Song 2005) 
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1.3.1 Development of the retinal vasculature 
There are two mechanisms responsible for the formation of new blood vessels, namely 
vasculogenesis and angiogenesis. The term vasculogenesis stands for the de novo formation of 
blood vessels which begins with the formation of clusters consisting of primitive vascular cells or 
hemangioblasts (Doetschman et al. 1987). These clusters form tube-like structures that fuse to 
form a vascular network (Vokes 2004). Angiogenesis, however, refers to the formation of 
vessels by the sprouting of capillaries from already existing vessels (Risau et al. 1988). In the 
human retina, both processes occur during vascularization, whereas in mice, retinal 
vascularization appears to be mediated only via angiogenesis (Hughes et al. 2000, Jiang et al. 
1995, Fruttiger 2007, Ashton 1970).  
During early stages of retinal development, oxygen supply is provided by the hyaloid 
vasculature. The hyaloid artery enters the optic cup through the optic nerve and forms an arterial 
network in the vitreous (Fruttiger 2007, Anand-Apte and Hollyfield 2010). In the more developed 
retina, the hyaloid vascular system regresses and is replaced by the retinal vasculature. This 
phenomenon occurs in humans around mid-gestation, in mice regression starts around birth and 
is finished at approx. P7 (Fruttiger 2007, Lang and Bishop 1993). The regression of the hyaloid 
arteries starts with an atrophy of the capillaries a process that is mediated via macrophage 
activity and WNT signaling (Fruttiger 2007, Diez-Roux and Lang 1997, Lobov et al. 2005). 
Herein, the occlusion of the capillaries by macrophages seems to be a critical step to induce 
their atrophy. (Anand-Apte and Hollyfield 2010).  
Simultaneously with the regression of the hyaloid system, the development of the retinal 
vasculature starts. Endothelial cells migrate from the optic nerve head over the inner surface of 
the retina toward the periphery of the retina and form the superficial plexus (Figure 4A). This 
migration is guided by a gradient of angiogenic factors, e.g. VEGF (vascular endothelial growth 
factor), expressed from a preexisting astrocytic template (Figure 4E) (Dorrell et al. 2002, Hughes 
et al. 2000, Ling et al. 1989). The endothelial cells follow the VEGF gradient of the astrocytic 
network (Stone et al. 1995). Endothelial cells at the vascular front possess filopodia and are 
called “tip cells” (Figure 4D). Astrocytes guide these tip cells to the remaining avascular areas 
(Siemerink et al. 2013).  
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Figure 4: Development of the retinal vasculature in the mouse.  A. Growth of the retinal vasculature 
starts at the optic nerve head and extends to the periphery to build the superficial plexus. B. Secondary 
branches grow into the retina and reach the outer plexiform layer to develop the deep vascular plexus. C. 
From the deep plexus, vessels extend to the inner plexiform layer, where the intermediate plexus is 
located. D. Endothelial cell at the vascular front shows long filopodia (arrows). E. Astrocytes (red) guide 
endothelial cells (green) to form the superficial plexus. INL, inner nuclear layer; ONL, outer nuclear layer; 
GCL, ganglion cell layer; NBL, neuroblast layer. Pictures taken from (Ye et al. 2010), slightly modified.  
 
In mice, the vessels of the superficial plexus reach the periphery of the retina on postnatal day 9 
(P9). Subsequently, the vessels from the already existing plexus are growing toward the outer 
plexiform layer to form the deep vascular plexus (Figure 4B). Just a few days later, the 
intermediate plexus begins to develop from vertical sprouting of the deep plexus upwards to the 
inner plexiform layer (Figure 4C) (Stahl et al. 2010). Studies assume that the intermediate and 
deep vascular plexus are built independently of astrocyte guidance (Fruttiger 2007). There are 
some differences in the development of the retinal vasculature between humans and mice: In 
mice the development of the retinal vasculature is completed at P21 and in humans already at 
birth. Also, the chronology of plexus formation in humans is different compared to mice: After the 
development of the superficial plexus, the intermediate plexus is formed, and finally the deep 
vascular plexus (Gariano 2003). 
 
1.3.2 Blood retinal barrier 
The blood retinal barrier (BRB) plays an essential role in the microenvironment of the retina and 
retinal neurons, as it regulates ion, protein and water in- and outflow of the retina (Cunha-Vaz et 
al. 2011). This barrier allows the neural retina to develop and maintain specific substrate and ion 
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concentrations which are substantial for proper neuronal function (Cunha-Vaz et al. 2011). 
Furthermore, it regulates infiltration of immune competent cells, toxins and various other factors 
that could have negative effects on the neurons e.g. impede with their function (Cunha-Vaz 
2009, Phillips et al. 2007). The blood supply for the retina is secured by two vascular systems, 
one at the level of the retinal vasculature, and the other at the interface of the choroid and RPE 
retinal pigment epithelial. Both systems have a BRB which is consequently, subdivided into two 
major components: the inner blood retinal barrier (iBRB) which comprises the endothelium of the 
retinal vessels and an interaction with glial cells and perivascular cells like pericytes, and the 
outer blood retinal barrier (aBRB) which is formed by the retinal pigment epithelium (RPE) 
(Phillips et al. 2007, Cunha-Vaz 1976, Chen et al. 2008, Klaassen et al. 2013).  
The iBRB is formed by tight junctions between the neighboring endothelial cells of the retinal 
vessels. These junctions make the endothelial cells impermeable to any molecules that are 
larger than approximately 30 kDA. Small molecules, like glucose and ascorbate, are transported 
via facilitated diffusion (Chen et al. 2008). The continuous endothelial layer at the inside of the 
vessel’s basal lamina, comprises the main structure of the inner blood retinal barrier. However, 
at the outside, the.basal lamina is covered by pericytes, which together with endothelial cells 
form the basal lamina, processes of astrocytes and Müller glia cells (Bergers and Song 2005). It 
is of interest to note that the pericytes do not form a continuous layer (Jordan and Ruiz-Moreno 
2013). However, morphological studies could show that pericytes may act as supressors of 
endothelial cell growth and contact between these two cell types is necessary for the activation 
of latent TGFβ-1 (Antonelli-Orlidge et al. 1989) Activation of TGFβ-1 inhibits proliferation and 
migration of endothelial cells (Orlidge 1987). Furthermore, TGFβ-1 is an important player during 
vessel formation, as it induces differentiation of mesenchymal stem cells and neuro crest cells 
into pericytes (Chen and Lechleider 2004, Ding et al. 2004, Bergers and Song 2005) 
Astrocytes, pericytes and Müller glia cells influence the activity of retinal endothelial cells and the 
iBRB by transmitting regulatory signals to ECs (Chen et al. 2008, Bergers and Song 2005). In 
humans, a loss of pericytes, a phenomenon called “pericyte-dropout” in patients suffering from 
diabetic retinopathy, results in a weakening of the vascular walls and can result in the 
development of microaneurysms (Wilkinson-Berka et al. 2004, Hammes et al. 2002). However, 
in mice, lacking >50% of pericytes, retinal microaneurysms are not a prominent finding (Enge 
2002, Hammes et al. 2002, Hammes 2005). In general, a breakdown of the inner blood retinal 
barrier is associated with diseases like diabetic retinopathy (Cunha-Vaz 2009, Cunha-Vaz 1976, 
Chen et al. 2008) 
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The outer blood retinal barrier is formed by tight junctions (zonulae occludentes) between the 
neighboring cells of the retinal pigment epithelium (Peyman and Bok 1972, Strauss 2005). The 
RPE consists of a single layer of pigmented cells and disconnects the neural retina from the 
underlying fenestrated endothelium of the choriocapillaris and therefore plays an essential role in 
extracting nutrients from the blood and making them accessible to the photoreceptors. 
Furthermore, the RPE eliminates debris and maintains retinal adhesion. The relationship 
between the retinal pigment epithelium and the photoreceptor layer is essential for maintaining  
visual function (Cunha-Vaz 2009, Strauss 2005). Alterations in the tightness of the outer blood 
retinal barrier may result in diseases like age-related macular degeneration (AMD) (Cunha-Vaz 
1976, Cunha-Vaz 2009).  
 
1.4 Pathologies of the ocular vasculature 
1.4.1 Diabetic retinopathy 
Diabetic retinopathy (DR) is the leading cause of blindness in the developed world (Cai and 
McGinnis 2016). This disease can be divided into two stages: nonproliferative DR and 
proliferative DR (Engerman 1989). An early sign of nonproliferative diabetic retinopathy is the 
appearance of multiple microaneurysms (Speiser et al. 1968). These microaneurysms are 
presumed to be the result of loss of pericytes, a phenomenon that is called “pericyte dropout” 
(Wilkinson-Berka et al. 2004, Hammes et al. 2002). The loss of pericytes initiates the death of 
ECs and therefore leads to a weakening of the vascular walls. When microaneurysms rupture, 
microhemorrhages (Figure 5) can be observed throughout the retina (Wilkinson-Berka et al. 
2004, Bandello et al. 2014). Further symptoms for nonproliferative diabetic retinopathy are a 
thickening of the basement membrane, development of hard exudates, cotton wool spots (Figure 
5) and occlusion of retinal vessels (Cai and McGinnis 2016, 2016, Bandello et al., Cai and 
Boulton 2002, Engerman 1989). When diabetic retinopathy changes toward a proliferative 
phenotype, neovascularizations can be observed. Neovascularizations towards the vitreous can 
in the following lead to vitreous contraction, hemorrhage and tractional retinal detachment (Cai 
and McGinnis 2016, Cheung et al. 2010, Antonetti et al. 2012).  
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Figure 5: Diabetic retinopathy.  A. Drawing of a healthy eye and an eye with diabetic retinopathy. 
Pathological changes like hemorrhages, abnormal growth of blood vessels, aneurysms, cotton wool spots 
and hard exudates can be seen in the eye with diabetic retinopathy. B. Funduscopy of an healthy eye (left 
panel, macula is marked by black circle) and an eye with severe diabetic retinopathy chracterized by 
several widespread hemorrhages inside and outside the major vascular arcades, cotton wool spots ( black 
arrows ) A. Slightly modified from www.shutterstock.com. B. Slightly modified from (Jager et al. 2008, 
Bandello et al. 2014).  
 
The pathological changes which occur during diabetic retinopathy are well described, albeit the 
underlying molecular mechanisms remain still unclear. Undoubtedly, diabetes represents the 
greatest risk for developing DR. Furthermore, type I diabetes is more likely to result in vision loss 
than type II. Along with  diabetes, further important risk factors for developing DR are race, 
smoking, hyperglycemia and hyperlipidemia (Das et al. 2015). A key element in the development 
of diabetic retinopathy is VEGF (vascular endothelial growth factor) which is clearly elevated in 
diabetic retinal tissue without overt retinopathy. It is presumed to be the initiator of increased 
©Tefi/Shutterstock.com 
A 
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permeability of the retinal vasculature in diabetes (Amin et al. 1997, Sone et al. 1997, Clermont 
et al. 1997). Increased VEGF levels lead to a decreased tight junction protein expression which 
is strongly associated with a breakdown of the inner blood retinal barrier (Antonetti et al. 1998). 
Another growth factor that may contribute to the pathogenesis of diabetic retinopathy is TGF-β. 
Several studies have shown that levels of TGFβ-2 were elevated in the vitreous of patients with 
diabetic retinopathy, especially in those who suffer from a proliferative form of the disease (Kita 
et al. 2006, Hirase et al. 1998). These findings suggest that TGF-β signaling may be involved in 
the molecular pathogenesis of diabetic retinopathy.  
 
1.4.2 Age-related macular degeneration 
In people of 50 years and older, age-related macular degeneration (AMD) supersedes diabetic 
retinopathy as the leading cause of severe vision loss in the developed world (Pascolini et al. 
2004, Congdon et al. 2004). In general, two forms (wet and dry) of AMD can be distinguished 
(Bowes Rickman et al. 2013). In the early stage, the disease develops slowly and remains 
mostly asymptotic for years (Coleman et al. 2008, Hogg and Chakravarthy 2006). The late 
stage, however, is characterized by severe vision loss (de Jong, Paulus T V M 2006, Sarks et al. 
1999). Typically, focal deposition of acellular debris between the retinal pigment epithelium and 
the Bruch`s membrane occur during aging (Bird et al. 1995). These deposits are called drusen 
and are usually the first clinical finding of dry age-related macular degeneration (Figure 6A) (Bird 
et al. 1995). They can be observed in the macula as well as in the peripheral retina. Drusen can 
be classified in three different stages by their diameter. There are small (< 63µm), medium 
(between 63µm and 124µm) and large drusen (  124µm) (Bird et al. 1995). Furthermore, drusen 
can be characterized as soft or hard, based on the appearance of their margins. While hard 
drusen show discrete margins, soft drusen are characterized by indistinct edges (Bird et al. 
1995). Excessive formation of drusen can subsequently lead to a damage of the retinal pigment 
epithelium. This effect together with a chronic inflammatory response can result in areas of 
retinal atrophy, also known as “geographic atrophy” (Figure 6B) (de Jong, Paulus T V M 2006, 
Maguire and Vine 1986, Sunness et al. 1999). In the following, an induction of angiogenic 
cytokines like VEGF can occur, leading to the formation of choroidal neovascularization (CNV) 
which is accompanied by increased vascular permeability (Figure 6C). These newly formed 
vessels grow from the choriocapillaris through the Bruch`s membrane toward and into the 
subretinal space (Pauleikhoff 2005, van Lookeren Campagne et al. 2014). The development of 
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these neovascularization is directly related to serious hemorrhages and detachment of the RPE 
(de Jong, Paulus T V M 2006, Jager et al. 2008).  
 
Figure 6: Funduscopy – age-related macular degeneration.  A. Funduscopy of an eye with 
intermediate age-related macular degeneration showing large drusen. B. Geographic atrophy involving the 
centre of the fovea, with sharply demarcated loss of normal retinal pigment epithelial cells and evidence of 
deeper larger choroidal vessels. C. Neovascular age-related macular degeneration, with retinal 
haemorrhage, lipids, or retinal hard exudate and subretinal fluid. Slightly modified from (Coleman et al. 
2008).  
 
The strongest risk factor for developing age-related macular degeneration is age (Mitchell et al. 
1995, Klein et al. 1999, Klein et al. 1992, Friedman et al. 1999). Other than that, smoking as well 
as genetic factors may be involved in causing AMD (Evans et al. 2005, Thornton et al. 2005, 
Scholl et al. 2007, Haddad et al. 2006). A recent study could demonstrate that high temperature 
requirement factor A1 (HTRA1) influences the risk of AMD (Yang et al. 2010).  
Recently it was shown, that HTRA1 can interact with members of the TGF-β signaling pathway 
and plays a critical role in the regulation of angiogenesis via TGF-β signaling (Friedrich et al. 
2015). Growth differentiation factor 6 (GDF6), which is a member of the TGF-β family is involved 
in ectoderm patterning and eye development. Furthermore, GDF6 could be identified as a novel 
disease gene for AMD (Zhang et al. 2012). In summary, these findings implicate a potential role 
of TGF-beta signaling in the molecular pathogenesis of age related macular degeneration. 
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1.5 Aim of the study 
The systemic knockout of TGF-β is embryonically lethal, because of haematopoietic and 
vascular defects in the yolk sack (Dickson et al. 1995). Therefore, scientists are confronted with 
serious problems when investigating the role of TGF-β signaling in vivo during development and 
in adulthood. The Cre loxP system allows to circumvent embryonic lethality, using Cre 
recombinases that are time-dependent or tissue specific.  
To date, there is no Cre recombinase available with an ubiquitous expression of Cre that is 
restricted to all cells of the eye. Therefore our group established a method to obtain efficient Cre 
mediated recombination in the entire eye. In previous studies we could show that tamoxifen eye 
drops successfully achieve the activation of Cre when applied to the eyes of 4 days old mouse 
pups carrying an tamoxifen dependent cre recombinase which is under control of an ubiquitously 
expressed chicken β actin promotor (CAGG-Cre ERTM) (Hayashi and McMahon 2002). When 
crossing heterozygous CAGG-Cre ERTM mice with mice carrying loxP sites flanking exon 2 of 
Tgfbr2 (Chytil et al. 2002), the administration of tamoxifen led to a deletion of Tgfbr2 in all ocular 
tissue. The downregulation of TGF-β signaling resulted in marked morphological changes of the 
retinal vasculature. Most strikingly, Tgfbr2 deficient mice (Tgfbr2Δeye) developed multiple 
microaneurysms, similar to those that can be seen in patients suffering from diabetic retinopathy. 
Furthermore, the expression levels of Vegf-a and Hif1-α were significantly increased in the 
retinae of 4 week-old mice. At the age of 6 weeks the mice additionally developed choroidal 
neovascularization (CNV) which are a hallmark for the wet form of age related macular 
degeneration.  
The overal goal of my thesis was to characterize the newly established system of tamoxifen 
administration and to investigate the phenotype of Tgfbr2 deficient mice with an early and late 
induced deletion of the TGF-β signaling pathway. In particular following aims were pursued:  
 What is the effect of an early-induced deletion of the TGF-β signaling pathway on the 
pericytes? Is the formation of microaneurysms in the Tgfbr2Δeye animal model a result of 
pericyte loss, a scenario that is called “pericyte-dropout” in diabetic retinopathy? Are 
there further similarities to diabetic retinopathy in humans? 
 
 Are the choroidal neovascularization in the early-induced Tgfbr2Δeye animal model, a 
primary effect caused by the deletion of ocular TGF-β signaling or are they a result of 
the irregularly developed retinal vasculature and the herein resulting hypoxia?  
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 To discriminate these two possibilities I inhibited the TGFβ-signaling pathway after the 
retinal vasculature had been developed. The late-induced Tgfbr2Δeye animal model was 
analyzed using a broad range of histological and molecular techniques.  
 
 Which cell type is responsible for the formation of the choroidal neovascularization? To 
answer this question, I will delete Tgfbr2 specifically in the retinal pigment epithelium or 
in the endothelial cells using appropriate inducible Cre mouse lines.  
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Tamoxifen-Containing Eye Drops Successfully Trigger Cre-
Mediated Recombination in the Entire Eye 
 
(adapted from: Anja Schlecht*, Sarah V. Leimbeck*, Ernst R. Tamm, Barbara M. Braunger 
Tamoxifen-Containing Eye Drops Successfully Trigger Cre-Mediated Recombination in 
the Entire Eye. Adv Exp Med Biol. 2016;854:495-500) 
*contributed equally to the study 
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2 Tamoxifen-Containing Eye Drops Successfully Trigger Cre-Mediated 
Recombination in the Entire Eye 
 
2.1 Abstract  
Embryonic lethality in mice with targeted gene deletion is a major issue that can be 
circumvented by using Cre-loxP-based animal models. Various inducible Cre systems are 
available, e.g. such that are activated following tamoxifen treatment, and allow deletion of a 
specific target gene at any desired time point during the life span of the animal. In this study, we 
describe the efficiency of topical tamoxifen administration by eye drops using a Cre- reporter 
mouse strain (R26R). We report that tamoxifen-responsive CAGG Cre-ERTM mice show a robust 
Cre-mediated recombination throughout the entire eye. 
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2.2 Introduction 
When working with genes associated with germline null alleles that are required for major 
developmental or cell maintenance pathways, scientists frequently face the problem of 
embryonic lethality after constitutional targeted deletion of their gene of interest (Branda and 
Dymecki 2004, Maddison and Clarke 2005). The use of Cre loxP- based animal models has 
greatly expanded the possibilities for scientists to delete essential genes in the mouse and thus 
circumvent the embryonic lethality, as this approach allows the generation of tissue- or cell-
specific conditional deletions (Kühn and Torres 2002). Moreover, different inducible Cre systems 
are available, like such that are tamoxifen-responsive, and allow gene deletion at any desired 
time point. In this study, we used CAGG Cre-ERTM mice (Hayashi and McMahon 2002) that 
carry the Cre-ERTM fusion protein, which is comprised of the Cre-recombinase fused to a mutant 
form of the mouse estrogen receptor (Hayashi and McMahon 2002). The fusion protein is 
restricted to the cytoplasm and Cre- ERTM will only access the nucleus after exposure to 
tamoxifen. Thus, exposure to tamoxifen in a spatially-defined manner allows tissue-specific 
targeted gene deletion. In this article, we describe a protocol that efficiently causes Cre-
mediated recombination following topical tamoxifen treatment by applying tamoxifen-containing 
eye drops. Using a Cre- reporter mouse strain (R26R), we show a robust Cre-mediated 
recombination throughout the entire eye. 
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2.3 Material and Methods 
2.3.1 Mice  
All procedures conformed to the tenets of the National Institutes of Health Guidelines on the 
Care and Use of Animals in Research, the EU Directive 2010/63/E, and institutional guidelines. 
Mice that were heterozygous for CAGG Cre-ERTM were crossed with homozygous Cre-reporter 
(R26R) (Soriano 1999) mice. R26R mice carry a loxP-flanked DNA segment that prevents the 
expression of the downstream lacZ gene. However, when R26R mice are crossed with a Cre 
transgenic strain, the Cre expression results in the removal of the loxP-flanked DNA segment 
and lacZ is expressed in all cells or tissues where Cre is expressed. In this study, CAGG Cre-
ERTM/R26R mice were used as experimental mice, and R26R littermates as control mice. 
Genetic backgrounds were 129SV (R26R) or C57Bl6 (CAGG Cre-ERTM). 
 
2.3.2 Tamoxifen Treatment 
To induce the nuclear trans-localization of the Cre recombinase and its activation, CAGG Cre-
ERTM/R26R mice and R26R littermates were treated with tamoxifen-containing eye drops. To 
this end, tamoxifen (Sigma) was diluted in corn oil (Sigma) to a final concentration of 5 mg/ml 
and the solution was pipetted as eye drops (10 μl/ drop) onto the closed eyelids of mouse pups 
three times per day in 4 h intervals. Our treatment started at p8 and lasted to p12, which 
obviously can be adjusted for other time points depending on the gene and molecular processes 
of interest. 
 
2.3.3 PCR Analysis 
Genotypes were screened by isolating genomic DNA from tail biopsies and testing for transgenic 
sequences by PCR as described previously (Braunger et al. 2013b). The following PCR primers 
were used: Cre genotyping (5′-CAC CCT GTT ACG TAT AGC-3′ and 5′-CTA ATC GCC ATC 
TTC CAG-3′) and LacZ genotyping (5′- ATC CTC TGC ATG GTC AGG TC-3′ and 5′-CGT GGC 
CTG ATT CAT TCC-3′). The thermal cycle profile was denaturation at 96 °C for 30 s, annealing 
at 57 °C (Cre), or 60 °C (LacZ) for 30 s, and extension at 72 °C for 1 min for 35 cycles. 
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2.3.4 β-galactosidase Staining 
Lac-Z-staining was performed in mixed CAGG Cre-ERTM/R26R and R26R mice following a 
previously published protocol (Baulmann et al. 2002). Briefly, after enucleation, eyes were fixed 
in LacZ fixative solution (2 mM MgCl2, 5 mM EGTA (pH 7.3), 0.2 % glutaraldehyde in 0.1 M 
phosphate buffer (pH 7.3) at 4 °C for 30 min. After three 10 min rinses in LacZ wash buffer (0.01 
% sodium deoxycholate, 0.02 % NP-40, 2 mM MgCl2 in 0.1 M phosphate buffer (pH 7.3)), β-
galactosidase activity was visualized in X-Gal staining solution (500 mM K4 Fe(CN)6 × 3 H20, 
500 mM K3Fe(CN)6, 1 mg/ml X-gal in LacZ wash buffer). The eyes were stained in X-Gal 
solution at 37 °C for 24 h, rinsed in LacZ wash buffer (3 × 10 min) followed by one 10 min rinse 
in phosphate buffer and then processed to paraffin embedding. Paraffin sections (6 μm thick) 
were analyzed as mentioned previously (Braunger et al. 2013a). 
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2.4 Results - Localization of Cre-mediated Recombination in Ocular Tissues 
After topical tamoxifen treatment with eye drops, we used β-galactosidase staining to localize 
Cre-mediated recombination in the eye. Eyes of CAGG Cre-ERTM/R26R mice (Figure 7b) 
showed an intense β-galactosidase reaction throughout the entire organ while control eyes 
(R26R) were essentially negative (Figure 7a and Figure 8a, c, e, and g).  
 
 
Figure 7. Localization and activation of Cre recombinase in the eye following tamoxifen containing 
eye drops.  An intense β-galactosidase staining throughout the entire eye in 14 days old CAGG Cre 
ER
TM
/R26R mouse (b) indicates a successful activation of the Cre recombinase in ocular tissue following 
treatment with tamoxifen eye drops. Control littermates (R26R) (a) did not show a positive reaction. 
Experiment performed by Anja Schlecht and Sarah V. Leimbeck. 
 
The detailed analysis of CAGG Cre-ERTM/R26R eyes showed an intense β-galactosidase 
reaction in the anterior eye segment. We observed in particular a strong β-galactosidase 
staining in the structures of the chamber angle outflow pathway, in the ciliary body (Figure 8b) 
and in the cornea, as well as in the epithelium of the lens (Figure 8d). In the posterior eye 
segment of CAGG Cre-ERTM/R26R eyes, the sensory retina, the retinal pigment epithelium 
(RPE) and the choroid (Figure 8f) stained positive for β-galactosidase indicating a successful 
Cre-mediated recombination in basically every ocular cell type. In addition, in sections where the 
optic nerve was cut, we observed positive staining along the sheaths surrounding the nerve 
indicating that tamoxifen had been distributed outside the eye (Figure 8h).  
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Figure 8. Detailed localization and activation of Cre recombinase in the eye.  Detailed magnification 
of the β-galactosidase staining in the structures of the chamber angle outflow pathway (b), the cornea and 
the lens epithelium (d), the retina and choroid (f) and the optic nerve (h) of a 14 days old CAGG Cre-
ER
TM
/R26R mouse. The control littermate did not show a positive reaction for β-galactosidase (a, c, e and 
g). RGC retinal ganglion cells, INL inner nuclear layer, ONL outer nuclear layer, RPE retinal pigment 
epithelium, C choroid, ON optic nerve, CB ciliary body, CO cornea, TM Trabecular meshwork, SC 
Schlemm’s canal, LE lens. Experiment performed by Anja Schlecht and Sarah V. Leimbeck. 
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2.5 Discussion 
Our results show that induction of Cre recombinase by using tamoxifen-containing eye drops is a 
suitable method to induce a tamoxifen-dependent Cre-mediated recombination in ocular tissues. 
The topical application of tamoxifen-containing eye drops provides several advantages. As a 
non-invasive method it greatly reduces or even avoids the potential risk of infections, which 
might eventually result from intra-peritoneal injections (Leenaars et al. 1998, Leenaars and 
Hendriksen 2005), which is a common method to administer tamoxifen. Intravitreal tamoxifen 
injections harbor the same risks of infection. Furthermore this route might influence the 
expression level of potential genes of interests because intravitreal injection of the vehicle alone 
already results in the activation of microglia and/or an elevated expression of neuroprotective 
molecules (Braunger 2014, Seitz and Tamm 2014). In our study, we noticed staining along the 
optic nerve outside the eye, a finding that appears to indicate that tamoxifen is distributed to 
tissues outside the eye. One could avoid this and achieve even greater spatial control of Cre 
expression by reducing the duration of tamoxifen treatment, e.g. from 5 days, to 3 days or 
maybe even less. Of course, this approach could in turn result in a Cre-mediated recombination 
gradient in the eye itself. This scenario might be of great interest for scientist focusing on the 
anterior segment of the eye like the cornea or the chamber angle outflow pathway. Here, a 
reduced exposure time might reduce the tamoxifen- induced Cre- mediated recombination in 
other parts of the eye or the body to an even greater extend. As a side note, our system also 
allows the usage of strong promoters like CMV or β- actin that would drive Cre- expression in 
every cell. The expression of Cre, however, can be spatially controlled, as the tamoxifen is 
applied topical. Finally, considering tamoxifen induced toxicity, which may influence cell viability 
or even promote cell death (Kim et al. 2014), the topical administration of tamoxifen using eye 
drops could obviously reduce this risk, too. In summary, our approach may be of great interest 
for scientists in the field of experimental eye research. 
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Deletion of ocular TGF-β signaling mimics essential 
characteristics of diabetic retinopathy 
 
(adapted from: Barbara M. Braunger, Sarah V. Leimbeck, Anja Schlecht, Cornelia Volz, Herbert 
Jägle and Ernst R. Tamm. Deletion of ocular TGF-β signaling mimics essential 
characteristics of diabetic retinopathy. Am J Pathol. 2015 Jun;185(6):1749-68) 
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3 Deletion of ocular TGF-β signaling mimics essential characteristics 
of diabetic retinopathy 
3.1 Abstract 
Diabetic retinopathy, a major cause of blindness, is characterized by a distinct phenotype. The 
molecular causes of the phenotype are not sufficiently clear. Here we report that deletion of 
TGF-β signaling in the retinal microenvironment of newborn mice induces changes that largely 
mimic the phenotype of non-proliferative and proliferative diabetic retinopathy in humans. Lack 
of TGF-β signaling leads to the formation of abundant microaneurysms, leaky capillaries, and 
retinal hemorrhages. Retinal capillaries are not covered by differentiated pericytes, but by a coat 
of vascular smooth muscle-like cells and a thickened basal lamina. Reactive microglia is found in 
close association with retinal capillaries. In older animals, loss of endothelial cells and the 
formation of ghost vessels are observed, findings that correlate with the induction of angiogenic 
molecules and the accumulation of retinal HIF-1α indicating hypoxia. Consequently, retinal and 
vitreal neovascularization occurs, a scenario that leads to retinal detachment, vitreal 
hemorrhages, neuronal apoptosis and impairment of sensory function. We conclude that TGF-β 
signaling is required for the differentiation of retinal pericytes during vascular development of the 
retina. Lack of differentiated pericytes initiates a scenario of structural and functional changes in 
the retina that mimics those of diabetic retinopathy strongly indicating a common mechanism.  
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3.2 Introduction 
 
Diabetic retinopathy is a leading cause of visual impairment and blindness in the developed 
world (Sivaprasad et al. 2012, Congdon et al. 2003). Clinically, diabetic retinopathy begins with 
typical microvascular signs in the retina of an individual with diabetes mellitus. The earliest 
clinical signs of diabetic retinopathy include the formation of microaneurysms, small 
outpouchings from retinal capillaries, and of dot intraretinal hemorrhages (Frank 2004). Number 
and sizes of hemorrhages increase as the disease progresses. In addition, the barrier of retinal 
capillaries becomes impaired which may lead to retinal edema, to the deposition of plasma lipid 
and lipoprotein contents, and the formation of hard exudates. In parallel to the increase in 
vascular permeability, occlusion and loss of retinal vessels is observed, a scenario that is 
thought to cause the formation of ischemic infarcts of the nerve fiber layer (cotton-wool spots). 
Because of the high metabolic requirements of retinal neurons, capillary damage in the retina 
causes hypoxia and the release of potent angiogenic factors such as vascular endothelium 
growth factor (VEGF). As a result, diabetic retinopathy progresses from a non-proliferative stage 
to a fibrotic, proliferative stage that is characterized by the growth of new capillaries in retina and 
vitreous. Diabetic neovascularization leads to preretinal or vitreous hemorrhages, and to 
tractional retinal detachment caused by proliferative vitreoretinopathy (Cheung et al. 2010, 
Antonetti et al. 2012).  
The characteristic histopathological lesion that occurs early in diabetic retinopathy, is the relative 
selective loss of pericytes from retinal capillaries (Kuwabara 1963). The loss of pericytes is 
followed by the loss of capillary endothelial cells and apoptosis is thought to be the mechanism 
that is largely responsible for the loss of both cell types (Mizutani et al. 1996, Barber et al. 2011). 
Similarly, pericyte dropout and acellular occluded capillaries were observed in numerous 
diabetic animal models (Hammes 2005). Pericyte loss appears to be causatively involved in 
capillary occlusion as genetically modified mice with specific deficiency of platelet-derived 
growth factor-β (PDGF- β) in endothelial cells show a varying degree of pericyte loss in parallel 
with occlusions of retinal capillaries (Hammes 2005). Comparable findings were observed in 
heterozygous PDGF-β-deficient diabetic mice (Hammes et al. 2002). Still, other characteristics 
of diabetic retinopathy such as sprouting of retinal capillaries and the formation of 
microaneurysms are not commonly observed in mice with pericyte dropout (Hammes et al. 
2002). Accordingly, besides pericyte dropout, other mechanisms appear to contribute to the 
structural changes in diabetic retinopathy and immunological processes are likely candidates 
(Adamis and Berman 2008, Kern 2007).  
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Evidence suggests that transforming growth factor (TGF)-β signaling plays an important role in 
the proliferation and the differentiation of both pericytes and endothelial cells during 
development (Armulik et al. 2011). The specific action of TGF-β signaling in this context appears 
to depend on the respective concentrations of the TGF-β isoforms and the availability of 
appropriate receptors, and may inhibit or promote proliferation and differentiation of the vascular 
cell types (Gaengel et al. 2009). In the retina, constitutive TGF-β signaling appears to be 
important for maintaining the structure and function of retinal capillaries. Accordingly, the 
inhibition of TGF-β signaling by systemic expression of soluble endoglin results in the apoptosis 
of vascular cells, the formation of leaky capillaries and the impairment of retinal perfusion 
(Walshe et al. 2009). Moreover, TGF-β signaling is thought to serve an important 
immunosuppressive role in the retina (Chytil et al. 2002). Still, the role of TGF-β signaling for the 
formation and maintenance of the retinal vasculature has only been incompletely studied, since 
the deletion of most of the different TGF-β signaling pathway genes results in embryonic lethality 
during midgestation (Armulik et al. 2011, Gaengel et al. 2009). Here we report on the phenotype 
of mice with a conditional deletion of the essential TGF-β type II receptor (TβRII) in ocular 
tissues. We provide evidence that impairment of TGF-β signaling in the retinal microenvironment 
promotes the development of structural changes in the retina that largely mimic the phenotype of 
non-proliferative and proliferative diabetic retinopathy. Our results point towards an important 
role of TGF-β signaling in the pathogenesis of diabetic retinopathy. 
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3.3 Materials and Methods 
3.3.1 Mice 
Mice with two floxed alleles of Tgfbr2 (Chytil et al. 2002) were crossed with Tgfbr2flox/flox;CAGG 
Cre-ERTM animals that were heterozygous for transgenic CAGG Cre-ERTM. Resulting 
Tgfbr2flox/flox;CAGG Cre-ERTM animals were used as experimental mice, and littermates with two 
unrecombined Tgfbr2fl/fl alleles are referred to as control mice. Genetic backgrounds were 
129SV (Tgfbr2) or C57Bl6 (CAGG Cre-ERTM). All mice were reared in 12 h light–12 h dark 
cycles (lights on at 7 am). Genotypes were screened by isolating genomic DNA from tail 
biopsies and testing for transgenic sequences by PCR. For Cre-PCR analysis primers were: 5'- 
ATGCTTCTGTCCGTT TGCCG-3' (sense) and 5'-CCTGTTTTGCACGTTCACCG-3' (antisense). 
The thermal cycle profile was denaturation at 96°C for 30 s, annealing at 57°C for 30 s, and 1 
min extension at 72°C for 35 cycles. For genotyping of TGF-β-R2flox/flox animals, primers were 5’-
GCAGGCATCAGGACCCAGTTTGATCC-3’ (sense) and 5’-AGAGTGAAGCCGTGGTAGGT 
GAGCTTG-3’ (antisense). The thermal cycle profile was denaturation at 96°C for 30 s, annealing 
at 61°C for 30 s, and 1 min extension at 72°C for 35 cycles. To induce Cre recombinase, mice 
were treated with tamoxifen (Sigma) eye drops. Tamoxifen was diluted in corn oil to a final 
concentration of 5 mg/ml. From P4 to P8, eye drops at a volume of 10 µl were pipetted onto the 
closed eyelids of mouse pups three times a day. All procedures conformed to the tenets of the 
National Institutes of Health Guidelines on the Care and Use of Laboratory Animals (National 
Research Council (U.S.) and Institute for Laboratory Animal Research (U.S.) 2011), the EU 
Directive 2010/63/E, and institutional guidelines, and were approved by the local authority 
(Regierung der Oberpfalz, Bavaria, Germany, 54-2532.1-44/12). 
 
3.3.2 Western blot analysis 
Retinal proteins were isolated following the manufacturer’s instructions (Invitrogen) for TRIzol 
protein isolation. Proteins were separated by SDS-PAGE (6%, 8% or 10% gels, depending on 
the molecular weight of the protein of interest) and transferred by semidry blotting onto a 
polyvinyl difluoride membrane (PVDF, Milipore). PVDF membranes were incubated with TBS 
containing 0.1% Tween 20 (TBST; pH 7.2) and blocking reagent (Table 1) overnight. Antibodies 
were used as described in Table 1. After washing with TBS-T, secondary antibodies (1:2000) 
were added. Chemiluminescence was detected on a LAS 3000 imaging workstation. For 
normalization, blots were labeled with antibodies against glyceraldehyde 3-phosphate 
dehydrogenase (GAPDH, 1:10,000, HRP-conjugated, Cell Signaling) or α-tubulin (1:5000, 
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Rockland). Western blots were evaluated by relative densitometry using the Aida Image 
Analyzer v.4.06 software (Raytest). 
 
Table 1. Antibodies used for Western Blot analysis 
Primary antibody Blocking Secondary antibody 
TβRII c16 (Santa Cruz) 
1:200 
5% non-fat dry milk chicken anti-rabbit coupled to 
horseradish peroxidase (Santa Cruz) 
pSmad3 (Cell Signaling) 
1:200 
5% bovine serum albumin chicken anti-rabbit coupled to 
horseradish peroxidase (Santa Cruz) 
FGF-2 sc79 (Santa Cruz) 
1:200 
5% bovine serum albumin chicken anti-rabbit coupled to 
horseradish peroxidase (Santa Cruz) 
HIF1- α (Cayman Chemical) 
1:200 
5% bovine serum albumin chicken anti-rabbit coupled to 
horseradish peroxidase (Santa Cruz) 
Collagen IV (Rockland) 
1:500 
5% bovine serum albumin goat anti-rabbit coupled to alkaline 
phosphatase (Santa Cruz) 
Smooth muscle α-actin 
(Genetex) 1:500 
5% bovine serum albumin goat anti-rabbit coupled to alkaline 
phosphatase (Santa Cruz) 
NG2 (Merck Millipore) 
1:1000 
5% bovine serum albumin chicken anti-rabbit coupled to 
horseradish peroxidase (Santa Cruz) 
GAPDH (Cell Signaling) 
1:10000 
5% non-fat dry milk directly horseradish peroxidase coupled 
α-tubulin (Rockland) 1:5000 5% bovine serum albumin goat anti-rabbit coupled to alkaline 
phosphatase (Santa Cruz) 
 
3.3.3 Microscopy and morphometry 
Mice were deeply anesthetized with ketamine (120 mg/kg body weight, i.m.) and xylazine (8 
mg/kg body weight), and perfused with 1 ml of modified Karnowsky’s fixative (Karnovsky 1965) 
through the left ventricle of the heart. Eyes and optic nerves were isolated, postfixed for 24 h in 
the same fixative and embedded in Epon (Serva) as described elsewhere (Kritzenberger et al. 
2011). Semi-thin sagittal sections (1.0 µm thick) were cut through the eyes and stained after 
Richardson (Richardson et al. 2009). Transmission electron microscopy was performed 
according to protocols published previously (Braunger et al. 2013a). Semi-thin sections of 
retinae and cross semi-thin sections through the optic nerve were stained with 
paraphenylenediamine (PPD) as described previously (Kroeber et al. 2010) to visualize lipid 
deposits or myelinated axons, respectively. For quantification of optic nerve axons, the number 
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of PPD-labeled axons in optic nerve cross sections was counted using ImageJ Cell counter as 
described previously (Braunger et al. 2013b). Thickness of the outer nuclear layer (ONL) was 
measured on semi-thin sections along the mid-horizontal (nasal-temporal) plane. The distance 
between ora serrata (OS) and optic nerve head (ONH) was divided into tenths and measured 
between each tenth (Braunger et al. 2013b). Fluorescence-labeled retinal whole mounts or 
sagittal sections were investigated on an Axiovision fluorescent microscope (Carl Zeiss) using 
appropriate Axiovision software 4.8 (Carl Zeiss, Jena, Germany). Analysis of retinal whole 
mounts by confocal microscopy was performed on a Zeiss Axiovert 200M inverted microscope 
combined with a LSM 510 laser-scanning device. FITC-dextran was excited using an Ar-laser at 
488 nm, CyTM-3 was excited using a HeNe laser at 543nm. The software used for image 
acquisition and processing was AIM 4.2 (Zeiss). 
 
3.3.4 LacZ staining 
Lac-Z-staining was performed in mixed CAGG CreERTM/Rosa-LacZ (Cre-reporter) or 
Tgfbr2Δeye/TOP-Gal (WNT-reporter) mice (The Jackson Laboratory) as described previously 
(Braunger et al. 2013a, Baulmann et al. 2002). Paraffin sections (6.0 µm) were cut, placed on 
glass slides (SuperFrost/Plus; Menzel) and analyzed by light microscopy (Carl Zeiss). 
 
3.3.5 Immunohistochemistry 
Prior to TβRII, pSmad3, glial fibrillary acid protein (GFAP), collagen IV and CD31 staining, eyes 
were fixed for 4 h in 4% paraformaldehyde (PFA), washed extensively in phosphate buffer (PP, 
0.1M) and embedded in paraffin according to standard protocols. Paraffin sections (6 µm) were 
deparaffinized and washed in H2O. For detection of TβRII and pSmad3, sections were treated 
with boiling citrate buffer (1 x 10 min, ph 6), washed again in H2O and incubated in 0.1M PP. For 
detection of collagen IV and CD31, sections were pretreated with 0.05 M Tris-HCL (5 min) and 
covered with Proteinase K (100 µl of Proteinase K in 57 ml Tris-HCl (0.05 M), 5 min), washed in 
H2O, incubated in 2 N HCl (20 min), and washed again in H2O. Sections were incubated in PP 
for 5 min. IBA-1, F4/80 and α-smooth muscle-actin (α-SMA) immunohistochemistry was 
performed on frozen sections. For Iba-1 and α-SMA staining, eyes were fixed for 4 h in 10% 
glacial acetic acid, 60% methanol, and 30% chloroform, transferred to 50% and 25% methanol 
30 min each, washed in phosphate buffered saline (PBS), incubated in 10%, 20%, 30% 
sucrose/PBS overnight at 4°C and shock frozen in tissue mounting medium (DiaTec). For F4/80 
staining, eyes were fixed for 4 h in 4% PFA and washed extensively in phosphate buffer (PP, 
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0.1M). For immunohistochemistry, sections were washed three times in TBS (pSmad3) or PP 
(others) for 5 min each and blocked with 2% BSA in PP/TBS 45 min (F4/80: 1% dry milk, 0.01% 
Tween in PBS) at room temperature. Primary antibodies (Table 2) were diluted in a 1:10 dilution 
of blocking solution in PP/TBS (F4/80: 2% BSA, 0.02% NaN3, 0.01% Triton in PBS) and 
incubated at 4°C overnight. After three washes in PP/TBS (5 min each), biotinylated antibodies 
were applied for 1 h diluted in a 1:10 dilution of the blocking solution as an additional step, then 
anti-biotin or appropriate secondary antibodies (Table 2), diluted in a 1:10 dilution of the blocking 
solution, were applied for 1 h. Sections were washed again three times and cell nuclei were 
counterstained with DAPI (Vectashield, Vector Laboratories) 1:10 diluted in fluorescent mounting 
medium (Serva).  
 
Table 2. Antibodies used for immunohistochemistry 
Primary antibody Fixation Secondary antibody 
TβRII- L21 (Santa Cruz) 
1:20 
4% paraformaldehyde 
(PFA) 
anti-rabbit, biotinylated (Vector) 1:500, 
Streptavidin Alexa 488 (Invitrogen) 1:1000 
pSmad3 (Cell Signaling) 
1:20 
4% PFA anti-rabbit, biotinylated (Vector) 1:500, 
Streptavidin Alexa 488 (Invitrogen) 1:1000 
Iba-1 (Wako) 1:1000 methyl-Carnoy anti-rabbit Cy
TM
-3 conjugated (Jackson 
Immuno Research Lab) 1:2000 
Collagen IV (Chemicon) 
1:100 
4% PFA anti-rabbit, biotinylated (Vector) 1:500, 
Streptavidin Alexa 546 (Invitrogen) 1:1000 
α-smooth muscle-actin 
(Genetex) 1:50 
methyl-Carnoy (section)  
methanol (whole mount) 
anti-rabbit Cy
TM
-3 conjugated (Jackson 
Immuno Research Lab) 1:2000 
NG2 (Merck Milipore) 1:50 methanol anti-rabbit Cy
TM
-3 conjugated (Jackson 
Immuno Research Lab) 1:2000 
CD31 (RD Systems) 1:100 4% PFA anti-goat  Cy
TM
-3 conjugated (Jackson 
Immuno Research Lab) 1:2000 
Collagen IV (Abcam) 1:100 4% PFA anti-rabbit Alexa 488 (Invitrogen) 1:1000 
F4/80 (Acris Antibodies) 
1:600 
4% PFA anti-rat Cy
TM
-3 conjugated (Jackson 
Immuno Research Lab) 1:2000 in PBS 
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3.3.6 Dextran perfusion and retinal whole mounts 
Mice were deeply anesthetized with ketamine (120 mg/kg body weight, i.m.) and xylazine (8 
mg/kg body weight) and perfused through the left ventricle with 1 ml of phosphate buffered 
saline (PBS) containing 50 mg high molecular weight (MW = 2,000,000) FITC-dextran (TdB 
Consultancy). The eyes were enucleated and placed in 4% paraformaldehyde for 2 h. Retinae 
were dissected and flat mounted using fluorescent mounting medium (Serva). If sagittal sections 
of FITC-dextran-perfused retinae were used, the perfused eyes were fixed for 4 h in 10% glacial 
acetic acid, 60% methanol, and 30% chloroform, transferred to 50% and 25% methanol 30 min 
each, washed in phosphate-buffered saline (PBS), incubated in 10%, 20%, 30% sucrose/PBS 
overnight at 4°C and shock frozen in tissue mounting medium (DiaTec). Following sectioning, 
nuclei were counterstained with DAPI (Vectashield, Vector Laboratories) 1:10 diluted in 
fluorescent mounting medium (Serva). If immunhistochemical  labelling was performed using 
retinal whole mounts, fixation was modified (Tab. 2), and antibodies were applied according to 
Tab. 2 and as described in the immunhistochemistry section. 
 
3.3.7 Apoptosis 
Apoptotic cell death was analyzed by terminal deoxynucleotidyl transferase-mediated dUTP nick 
end labeling using the Apoptosis Detection System (DeadEnd Fluorometric TUNEL, Promega). 
Paraffin sections were treated following manufacturers’ instructions and protocols reported 
previously (Braunger et al. 2013b). For quantitative analysis, the number of TUNEL-positive 
nuclei in sagittal sections throughout the entire retina was counted.  
 
3.3.8 Trypsin digest 
Eyes were fixed for 48 h in 4% PFA. Retinae were washed in H2O for 75 min, transferred to 
glass slides and incubated for 90 min with 3% trypsin 0.2 M Tris-HCl at 37°C. Retinae were 
transferred on a new glass slide, again incubated for 120 min in 3% trypsin 0.2 M Tris-HCl at 
37°C and stained with periodic acid–Schiff (PAS). 
 
GFAP (DAKO) 1:1000 4% PFA anti-rabbit Alexa 488 (Invitrogen) 1:1000 
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3.3.9 Electroretinography 
Mice were dark adapted for at least 12 h before experiments and anesthetized by s.c. injection 
of ketamine (65 mg/kg) and xylazine (13 mg/kg). Pupils were dilated with tropicamide eyedrops 
(Mydriaticum Stulln; Pharma Stulln). Silver needle electrodes served as reference (forehead) 
and ground (tail), and gold wire ring electrodes as active electrodes. Corneregel (Bausch & 
Lomb) was applied to keep the eye hydrated and to maintain good electrical contact. ERGs were 
recorded using a Ganzfeld bowl (Ganzfeld QC450 SCX, Roland Consult) and an amplifier & 
recording unit (RETI-Port, Roland Consult). ERGs were recorded from both eyes 
simultaneously, band-pass filtered (1 to 300 Hz) and averaged. Single flash scotopic (dark 
adapted) responses to a series of ten LED-flash intensities ranging from -3.5 to 1.0 log cd.s/m2 
with an inter stimulus interval of 2 up to 20 seconds for the highest intensity were recorded. All 
analysis and plotting was carried out with R 2.15.2 (The R Foundation for Statistical Computing) 
and ggplot2 0.9.3 (Wickham 2009).  
 
3.3.10 Fundus imaging and angiography 
Retinal imaging was performed with a commercially available imaging system (Micron III; 
Phoenix Research Laboratories, Inc.). Light source path and imaging path filters (low pass and 
high pass at 500 nm) were used for fluorescein angiography (FLA). Mice were anesthetized by 
s.c. injection of ketamine (65 mg/kg) and xylazine (13 mg/kg), and their pupils were dilated with 
tropicamide eyedrops before image acquisition. FLA was performed using a s.c. injection of 75 
mg/kg body weight fluorescein-Na (Alcon). 
 
3.3.11 RNA analysis 
Total RNA from neural retinae was extracted using TRIzol and first strand cDNA synthesis was 
performed using iScript cDNA Synthesis Kit (Bio-Rad) according to manufacturer’s instructions. 
Quantitative real-time RT-PCR analyses were performed using the Bio-Rad iQ5 Real-Time PCR 
Detection System. The temperature profile was denaturation at 95°C for 10 seconds and 
annealing and extension at 60°C for 40 seconds for 40 cycles. All primer pairs were purchased 
from Invitrogen and extended over exon–intron boundaries, except for GAPDH. Sequences of 
primer pairs, melting temperatures and PCR product sizes are shown in Table 3. RNA that was 
not reverse transcribed served as negative control for real-time RT-PCR. Prior to relative 
quantification, mRNAs from three different potential housekeeping genes were tested: 
glyceraldehyde 3-phosphate dehydrogenase (Gapdh), guanine nucleotide binding protein 
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(Gnb2l), and ribosomal protein L32 (Rpl32). After statistical evaluation, Rpl32 was used for 
relative quantification. Quantification was performed using BioRad iQ5 Standard-Edition (Version 
2.1) software (BioRad). 
 
Table 3. Primers used for quantitative real-time PCR amplification 
Gene Sequence forward Sequence reverse  
GAPDH 5’-TGTCCGTCGTGGATCTGAC-3’ 
 
5’-CCTGCTTCACCACCTTCTTG-3’ 
GNB2L 5’-TCTGCAAGTACACGGTCCAG-3’ 
 
5’-ACGATGATAGGGTTGCTGCT-3’ 
RPL32 
 
5’-GCTGCCATCTGTTTTACGG-3’ 
 
5’-TGACTGGTGCCTGATGAACT-3’ 
Tgfbr2 5’-AGAAGCCGCATGAAGTCTG-3’ 
 
5’-GGCAAACCGTCTCCAGAGTA-3’ 
Tgfbr1 5’-AATGTTACGCCATGAAAATATCC-3’ 
 
5’-CGTCCATGTCCCATTGTCTT-3’ 
Smad2 5’-AGGACGGTTAGATGAGCTTGAG-3’ 
 
5’-GTCCCCAAATTTCAGAGCAA-3’ 
Smad3 5’-TCAAGAAGACGGGGCAGTT-3’ 
 
5’-CCGACCATCCAGTGACCT-3’ 
Smad6 5’-GTTGCAACCCCTACCACTTC-3’ 
 
5’-GGAGGAGACAGCCGAGAATA-3’ 
Smad7  5’-ACCCCCATCACCTTAGTCG-3’ 
 
5’-GAAAATCCATTGGGTATCTGGA-3’ 
Ndp 5’-CCCACTGTACAAATGTAGCTCAA-3’ 
 
5’-AGGACACCAAGGGCTCAGA-3’ 
Ng2 5’-CTTGGCCTTGTTGGTCAGAT-3’ 
 
5’-CACCTCCAGGTGGTTCTCC-3’ 
Rgs-5 5’-GCTTTGACTTGGCCCAGAAA-3’ 
 
5’-CCTGACCAGATGACTACTTGATTAGCT-3’ 
Pdgf-Rβ 5’-ACCTCAAAAGGTGTCCACGA-3’ 
 
5’-GTGTGCTCACCACCTCGTAT-3’ 
α-Sma 5’-CAACCGGGAGAAAATGACC-3’ 
 
5’-CAGTTGTACGTCCAGAGGCATA-3’ 
Vegf-R1 5’-TACCTCACCGTGCAAGGAAC-3’ 
 
5’-AAGGAGCCAAAAGAGGGTCG-3’ 
Vegf-R2 5’-CAGTGGTACTGGCAGCTAGAAG-3’ 5’-ACAAGCATACGGGCTTGTTT-3’ 
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Pdgfb 5’-TCGAGTTGGAAAGCTCATCTC-3’ 
 
5’-GTCTTGCACTCGGCGATTA-3’ 
Vegf-a-120 5’-GGAGAGATGAGCTTCCTACAGCA-3’ 
 
5’-CTGAACAAGGCTCACAGTCATTTT-3’ 
Vegf-a-164 5’-GGAGAGATGAGCTTCCTACAGCA-3’ 
 
5’-CCTTGGCTTGTCACATTTTTCT-3’ 
Ang-2 5’-CACACTGACCTTCCCCAACT-3’ 
 
5’-CCCACGTCCATGTCACAGTA-3’ 
Igf-1 5’-CAAAAGCAGCCCGCTCTA-3’ 
 
5’-TCGATAGGGACGGGGACT-3’ 
Fgf2 5’-GGCTCTACTGCAAGAACG-3’ 
 
5’-TGCTTGGAGTTGTAGTTTGACG-3’ 
Ccl2 5’-CATCCACGTGTTGGCTCA-3’ 
 
5’-GATCATCTTGCTGGTGAATGAGT-3’ 
Cd68 5’-CTCTCTAAGGCTACAGGCTGCT-3’ 
 
5’-TCACGGTTGCAAGAGAAACA-3’ 
Egr1 5’-CCTATGAGCACCTGACCACA-3’ 
 
5’-TCGTTTGGCTGGGATAACTC-3’ 
Il6 5’-GCTACCAAACTGGATATAATCAGGA-3’ 
 
5’-CCAGGTAGCTATGGTACTCCAGAA-3’ 
iNos 5’-GGGCTGTCACGGAGATCA-3’ 
 
5’-CCATGATGGTCACATTCTGC-3’ 
Tnf-α 5’-TCTTCTCATTCCTGCTTGTGG-3’ 
 
5’-GGTCTGGGCCATAGAACTGA-3’ 
Casp8 5’-TTGAACAATGAGATCCCCAAA-3’ 
 
5’-CCATTTCTACAAAAATTTCAAGCAG-3’ 
Col IV a1 5’-TTAAAGGACTCCAGGGACCAC-3’ 
 
5’-CCCACTGAGCCTGTCACAC-3’ 
Col III a1 5’-TCCCCTGGAATCTGTGAATC-3’ 
 
5’-TGAGTCGAATTGGGGAGAAT-3’ 
 
3.3.12 Statistical analysis 
All results are expressed as mean ± s.e.m. Comparisons between the mean variables of  two 
groups were made by a two-tailed Student’s t-test. P values ≤ 0.05 were considered to be 
statistically significant.   
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3.4 Results 
3.4.1 Conditional deletion of TβRII in the eye following local tamoxifen treatment 
In order to test if local tamoxifen treatment of newborn CAGG Cre-ERTM mouse pups would 
induce the expression of Cre to levels that are high enough to cause recombination, we crossed 
the animals with mice carrying the Rosa26 reporter (R26R) allele. At two weeks of age, the 
tamoxifen-treated eyes were stained for β-galactosidase. An intense positive staining was seen 
throughout the entire eye of CAGG Cre-ERTM; R26R mice, while ocular tissues of R26R 
littermates, which did not carry the CAGG Cre-ERTM transgene, were completely unstained 
(Figure 9A). We now generated Tgfbr2fl/fl; CAGG Cre-ERTM mice that were equally treated with 
tamoxifen. For simplicity, we will refer to Tgfbr2fl/fl; CAGG Cre-ERTM mice as Tgfbr2Δeye mice; 
however, littermates with two unrecombined Tgfbr2fl/fl alleles are referred to as controls. Using 
immunohistochemistry, a distinct immunoreactivity for TβRII was seen in the ganglion cell layer 
of the control inner retina, but was barely detectable in the outer retina (Figure 9B). In contrast, 
in retinae of Tgfbr2eye littermates immunoreactivity for TβRII was almost absent. We next 
performed western blot analyses for TβRII (70 kDa) in protein extracts from the tissues of the 
anterior eye or the retinae of four-week-old control and conditional TβRII-deficient Tgfbr2Δeye 
littermates (Figure 9C). By relative densitometry, the western blot band was found to be 
significantly less intense in both anterior eye (0.36 ± 0.16 versus 1 ± 0.09, P = 0.03) and retinae 
(0.37 ± 0.10 versus 1 ± 0.16, P = 0.02) of TβRII-deficient mice when compared to controls. To 
analyze the activity of TGF-β signaling, western blot analyses of retinal proteins detected 
pSmad3 (54 kDa) in retinal proteins of two-week-old mice (Figure 9D) and relative densitometry 
confirmed the band as being significantly less intense in Tgfbr2Δeye mice compared to controls 
(0.30 ± 0.04 versus 1 ± 0.17, P = 0.04). Using immunohistochemistry, retinal immunoreactivity 
for pSmad3 was observed preferentially in the nuclei of the ganglion cell layer in control mice 
(Figure 9E). In contrast, nuclear immunoreactivity for pSmad3 was essentially absent in retinae 
of Tgfbr2Δeye littermates (Figure 9E). Finally we investigated the expression of Tgfbr2 and Smad3 
mRNA by real-time RT-PCR and observed significant lower amounts in RNA from Tgfbr2Δeye 
mice than in control littermates (Figure 9F). No changes were observed in the expression of 
mRNA for other molecules associated with TGF-β signaling such as Tgfbr1, Smad2, Smad6, 
Smad7 and Ndp. 
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Figure 9. TβRII deletion and inhibition of TGF-β signaling in Tgfbr2
Δeye
 eyes.  A. β-galactosidase 
staining is seen in the entire retina of 14-day-old double transgenic CAGG Cre-ER
TM
 mice, but not in 
R26R control littermates. B. Immunoreactivity for TβRII (green) in the retina at 4 weeks of age. TβRII is 
detectable in the ganglion cell layer (arrows) and the inner retina in controls, but absent in the Tgfbr2
Δeye
 
littermate. Antibody control section indicates specific staining. C. Western blot and densitometric analyses 
for TβRII in proteins from anterior eye segment or retinae of 4-week-old animals. GAPDH was used as 
loading control. D. Western blot and densitometric analyses for pSmad3 (retina, 2-week-old). GAPDH was 
used as loading control. E. Immunoreactivity for pSmad3 (green) in the retina at 4 weeks of age. The 
control animal shows immunoreactivity for pSmad3 in the nuclei of the inner retina (arrows), which is 
considerably weaker in the Tgfbr2
Δeye
 littermate. F. Real-time RT-PCR in 2-week-old control and 
Tgfbr2
Δeye
 retinae. Nuclei are DAPI-stained (blue). Data are expressed as mean ± SEM. Western blot 
analysis (C): TβRII (anterior eye segment): control: n = 3, Tgfbr2
Δeye
: n = 5; TβRII (retina): control: n = 4, 
Tgfbr2
Δeye
: n = 4; pSmad3 (retina): control: n = 3, Tgfbr2
Δeye
: n = 4; Real-time RT-PCR: control: n ≥ 4, 
Tgfbr2
Δeye
: n ≥ 7. (F, Tgfbr2
Δeye
). *P ≤ 0.05, ***P ≤ 0.001. AU, arbitrary unit; GAPDH, glyceraldehyde 3-
phosphate dehydrogenase; GCL, ganglion cell layer; INL, Inner nuclear layer; ONL, Outer nuclear layer; 
RPE, Retinal pigment epithelium; R26R, Rosa26 reporter; TGF, transforming growth factor; TβRII, TGF-β 
type II receptor. Experiments performed by Barbara M. Braunger and Sarah V. Leimbeck.  
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3.4.2 Conditional deletion of TGF-β signaling results in leaky retinal capillaries that form 
microaneurysms 
Eyes of Tgfbr2Δeye mice were investigated by funduscopy at four weeks of age and no obvious 
differences compared to controls were observed (Figure 10A). Still, a marked dilation of retinal 
vessels was observed in the eyes of Tgfbr2Δeye mice by fluorescein angiography. The vessels 
were tortuous and appeared blurry indicating massive vascular leakage (Figure 10A). In 
contrast, retinal vessels of control littermates looked essentially normal (Figure 10A). At eight 
weeks of age, funduscopic exams of Tgfbr2Δeye mice identified numerous white areas on the 
retina, which formed fluffy white patches or were rather dot-like. The white areas were quite 
reminiscent of hard exudates and cotton wool spots in human patients with diabetic retinopathy, 
and were not seen in control retinae (Figure 10B). By fluorescein angiography, numerous round 
spots similar to capillary microaneurysms were visible in close association with retinal capillaries 
throughout the entire retina (Figure 10B). We next examined whole-mounted retinae of four-
week-old animals after perfusion with FITC-labeled dextran and observed abundant FITC-
labeled capillary microaneurysms throughout the entire retina of Tgfbr2Δeye mice (Figure 10C). 
Again, retinal capillaries of control littermates looked essentially normal (Figure 10C). At higher 
magnifications, microaneurysms were seen to originate laterally from capillaries or to be 
localized rather at the blind-ending tips of capillaries (Figure 10D). Moreover, numerous 
capillaries were observed from which FITC-labeled dextran had leaked corroborating the 
findings obtained by angiography (Figure 10D). In retinal sections, the microaneurysms were 
seen to have a wide lumen that was frequently filled with erythrocytes (Figure 10E). When 
trypsin-digested retinal capillaries were investigated, microaneurysms were found to be 
frequently covered by cells in which nuclear chromatin had been condensed to chromosomes 
indicating mitosis (Figure 10E). Retinal sections or whole mounts were studied following FITC-
dextran perfusions and microaneurysms were found in capillaries from all three (superficial, 
intermediate and deep) vascular plexus of the retina (Figure 11A). Quite intriguingly, the capillary 
network of the intermediate and deep plexus was considerably denser in control animals than in 
Tgfbr2Δeye mice (Figure 11A). 
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Figure 10. Retinal vasculature after TβRII deletion and inhibition of TGF-β signaling in Tgfbr2
Δeye
 
eyes.   Retinal vasculature after TβRII deletion and inhibition of TGF-β signaling in Tgfbr2
Δeye
 eyes. In vivo 
fundoscopy and fluorescein angiography at 4 weeks (A) and 8 weeks (B) of age. A. Retinal vessels in 
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Tgfbr2
Δeye
 eyes are dilated, tortuous and blurry, indicating fluorescein leakage (green). B. Multiple 
microaneurysms (angiography) and white patches (funduscopy) are visible in Tgfbr2
Δeye
 animals. C: FITC-
dextran-perfused retinal whole mounts of 4-week-old mice. White arrows indicate multiple 
microaneurysms in the Tgfbr2
Δeye
 mouse. D. Higher magnification of FITC-dextran (green)-perfused retinal 
vessels in a 4-week-old Tgfbr2
Δeye
 mouse. FITC-dextran leaks (arrowheads) from microaneurysms 
(arrows) and vessels. E. Richardson’s-stained semi-thin section (1 µm thick) of a 4-week-old Tgfbr2
Δeye
 
mouse. The white arrows point toward a microaneurysm filled with erythrocytes. Trypsin digest of retinal 
vessels with magnification of a microaneurysm at 4 weeks of age. Arrows in the bottom panel point toward 
nuclei with condensed chromosomes, indicating mitosis. FITC, fluorescein isothiocyanate; TGF, 
transforming growth factor; TβRII, TGF-β type II receptor. Experiments performed by (A,B) Sarah V. 
Leimbeck, Herbert Jägle and Cornelia Volz; (C,D) Anja Schlecht; (E,F) Barbara M. Braunger and Sarah V. 
Leimbeck.  
 
 
3.4.3 Lack of pericyte differentiation upon absence of retinal TGF-β signaling 
To investigate pericyte covering of retinal capillaries in Tgfbr2Δeye mice, we perfused animals with 
FITC-dextran and immunolabeled retinal whole mounts with antibodies against NG2, a marker 
for differentiated pericytes in the retina (Armulik et al. 2011). Retinal capillaries of control mice 
were densely covered by NG2-positive cells (Figure 11A). In contrast, NG2-positive cells were 
only rarely observed in retinal capillaries of Tgfbr2Δeye littermates (Figure 11A) and were not 
found covering capillary microaneurysms (Figure 11A). We next stained retinal whole-mounts 
and sections with antibodies against α-smooth muscle-actin (α-SMA) which stains vascular 
smooth muscle cells, but not quiescent and differentiated pericytes (Armulik et al. 2011). In 
control animals, staining for α-SMA actin was strictly confined to retinal arteries and arterioles 
(Figure 11B). In contrast, inTgfbr2Δeye littermates the staining extended to retinal capillaries 
(Figure 11B) and α-SMA positive cells densely covered all FITC-dextran-filled retinal capillaries 
of Tgfbr2Δeye mice (Figure 11C). Moreover, numerous α-SMA-labeled capillaries were observed 
that were not filled with FITC-dextran, a finding that suggested the presence of non-perfused or 
ghost vessels (Figure 11C). The covering of α-SMA positive cells was also seen along the 
surface of many microaneurysms (Figure 11C).  
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Figure 11. Lack of pericyte differentiation in Tgfbr2
Δeye
 mice.  A. Meridional sections and whole 
mounts of 4-week-old FITC-dextran (green)-perfused retinae. Tgfbr2
Δeye
 mice show dilated vessels and 
multiple microaneurysms in all (superficial, intermediate and deep) vascular plexus. The capillary network 
in the intermediate and deep vascular plexus of Tgfbr2
Δeye
 mice is less dense compared to controls. FITC-
dextran-perfused (green) and NG2 (red)-labeled retinal whole mounts at 4 weeks of age. White arrows 
point towards NG2-positive pericytes that are markedly reduced in number in the Tgfbr2
Δeye
 retina. B. 
Retinal whole mounts of 4-week-old mice stained for α-SMA. In the control, staining is confined to retinal 
arteries and arterioles (white arrows), whereas it extends to capillaries in the Tgfbr2
Δeye
 mouse. Red 
arrowheads mark the persistent α-SMA negative hyaloid capillaries. C. α-SMA staining in arterioles and 
arteries of a 4-week-old control mouse does not extend (arrows) to FITC-dextran (green)-labeled 
capillaries. In the Tgfbr2
Δeye
 mouse, retinal capillaries are covered by α-SMA-positive cells. Perfused 
FITC-dextran does not enter all α-SMA-positive capillaries (arrows). Meridional sections of α-SMA (red) 
and FITC-dextran (green)-labeled retinae (3-week-old). In controls, immunoreactivity for α-SMA (red) is 
restricted to the vessels of the superior vascular plexus. In Tgfbr2
Δeye
 animals, intraretinal vessels and 
microaneurysms are covered by α-SMA positive cells (white arrows). Nuclei are DAPI-stained (blue). 
FITC, fluorescein isothiocyanate; GCL. ganglion cell layer; INL. inner nuclear layer; ONL. outer nuclear 
layer; α-SMA, α-smooth muscle actin.  Experiments performed by (A, upper and middle panel) Sarah V. 
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Leimbeck; (A, lower panel) Anja Schlecht; (B, C upper panel) Anja Schlecht; (C, lower panel) Barbara M. 
Braunger and Sarah V. Leimbeck.  
Western blot analyses confirmed the results seen by immunohistochemistry (Figure 12A, B). By 
relative densitometry, we detected a decrease in the amounts of retinal NG2 inTgfbr2Δeye mice 
when compared to control littermates (0.37 ± 0.098 versus 1.0 ± 0.25, P = 0.042) together with 
an increase in the amounts of retinal α-SMA (4.70 ± 0.99 versus 1 ± 0.12, P = 0.0029). The 
results correlated with those obtained by real-time RT-PCR, as the amounts of retinal mRNA for 
Ng2 were decreased inTgfbr2Δeye mice (2 weeks: P = 0.0023; 6 weeks: P = 0.045), while those 
of α-Sma mRNA were increased (2 weeks: P = 0.0056; 4 weeks: P = 0.012) (Figure 12C). The 
amounts of retinal mRNA for Pdgf-Rβ, a gene expressed in both pericytes and vascular smooth 
muscle cells were lower in 2-week-oldTgfbr2Δeye mice than in controls (P = 0.021), while no 
differences were detected at 4 weeks of age. The levels of mRNA for Rgs-5 which is an 
angiogenic pericyte marker that is upregulated during physiological angiogenesis and vascular 
remodeling were significantly (P = 0.020) increased in four-week-old Tgfbr2Δeye mice (Figure 
12C). 
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Figure 12. Lack of pericyte differentiation in Tgfbr2
Δeye
 mice.  A and B. Western blot analysis and 
densitometry for NG2 (A) and α-SMA (B) in retinal proteins of 4-week-old mice. GAPDH and α-tubulin 
were used as loading control.C. Quantitative real-time RT-PCR in RNA from 2- and 4-week-old (6 weeks 
for Ng2, respectively) retinae. Data are expressed as means ± SEM, n ≥ 6 (A and B); n ≥ 4 (C, control at 2 
weeks); n ≥ 6 (C, Tgfbr2
Δeye
 2 and 4 weeks and control at 6 weeks); n = 9 (C, Ng2, Tgfbr2
Δeye
 at 6 weeks); 
n = 11 (C, Ng2 control at 6 weeks). *P ≤ 0.05, **P ≤ 0.01. AU, arbitrary unit; GAPDH, glyceraldehyde 3-
phosphate dehydrogenase; α-SMA, α-smooth muscle actin. Experiments performed by Anja Schlecht and 
Barbara M. Braunger.  
 
We next investigated retinal capillaries by transmission electron microscopy. In sections of 
control capillaries, individual pericytes were regularly observed that shared the basal lamina with 
endothelial cells (Figure 13A). In contrast, retinal capillaries of four-week-old Tgfbr2Δeye mice 
were surrounded by 1-2 complete layers of perivascular cells that contained numerous 5-6 nm 
actin microfilaments and showed the essential ultrastructural characteristics of vascular smooth 
muscle cells (Figure 13A). The cells were completely surrounded by a basal lamina which was at 
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least double as thick as that covering pericytes in control sections. In addition, immunostaining 
with antibodies against collagen type IV was more pronounced around capillaries of Tgfbr2Δeye 
mice than around control capillaries corroborating the findings observed by transmission electron 
microscopy (Figure 13B).  Staining for collagen IV showed a thicker basal lamina around 
capillaries of Tgfbr2Δeye animals and was more intense in the internal limiting membrane than in 
control eyes (Figure 13B). Western blot analyses confirmed the higher levels of collagen type IV 
(1 ± 0.20 versus 4.18 ± 1.03, P = 0.017) in retinae of Tgfbr2Δeye mice (Figure 13C). Finally, we 
investigated by real-time RT-PCR the expression of mRNA for the collagen subunits Col4A1 and 
Col3A1. We observed no difference in the expression of both subunits in two-week-old animals. 
Still, at four weeks of age, the time when the vascular basal lamina was observed to be thicker in 
Tgfbr2Δeye mice, the expression of Col4A1 and Col3A1 was higher (P = 0.0012 or P = 0.032) in 
Tgfbr2Δeye mice than in controls (Figure 13D). 
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Figure 13. Extracellular matrix accumulation in Tgfbr2
Δeye
 mice.  A. Electron micrographs of retinal 
capillaries in 4-week-old mice. In control eyes, pericytes share the basal lamina (arrows) with endothelial 
cells. Retinal capillaries of Tgfbr2
Δeye
 mice are surrounded by one to two complete layers of smooth 
muscle-like cells that are completely surrounded by a basal lamina (arrows) that is thicker than in controls. 
B. Immunoreactivity for collagen IV (red) in the retina at 4 weeks of age. Distinct immunoreactivity for 
collagen IV is detectable surrounding the retinal vessels (arrows) of the control mouse, but is even more 
intense around the vessels of the Tgfbr2
Δeye
 littermate. Nuclei are stained with DAPI (blue). C. Western 
blot analysis and corresponding relative densitometric analysis for collagen IV in 4-week-old retinae. 
GAPDH was used as loading control. D. Quantitative real-time RT-PCR for mRNA of Col4a1 and Col3a1 
in 2 and 4 weeks old control and Tgfbr2
Δeye
 retinae. Data are expressed as mean ± SEM. n = 6 (C, control, 
and D, control and Tgfbr2
Δeye
 at 4 weeks); n = 7 (C, Tgfbr2
Δeye 
and D, Tgfbr2
Δeye
 at 2 weeks); n = 5 (D, 
control at 2 weeks). *P ≤ 0.05, ** P ≤ 0.01. AU, arbitrary unit; GAPDH, glyceraldehyde 3-phosphate 
dehydrogenase; GCL, ganglion cell layer; INL, inner nuclear layer; ONL, outer nuclear layer; TEM, 
transmission electron microscopy. Experiments performed by (A,C) Anja Schlecht and Barbara M. 
Braunger; (B) Sarah V. Leimbeck.  
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3.4.4 Hemorrhages and vessel loss in TGF-β-deficient retinae 
Another characteristic finding concerning the ultrastructure of Tgfbr2Δeye vessels in four-week-old 
mice was the presence of numerous caveolae along the luminal cell membrane of their 
endothelial cells (Figure 14A). Next to the vessels, we regularly observed accumulations of 
erythrocytes between perikarya of retinal neurons indicating intraretinal hemorrhage (Figure 
14C). Regional hemorrhages were also observed between photoreceptor outer segments and 
cells of the retinal pigment epithelium. Cells with the typical ultrastructural characteristics of 
phagocytosing macrophages, such as the presence of numerous cytoplasmic phagolysosomes, 
were frequently associated with the hemorrhages (Figure 14C). Moreover, we regularly 
observed cells in close association with retinal vessels, which contained round cytoplasmic 
inclusions that were typically 2-2.5 μm in diameter (Figure 14D). The inclusions stained intensely 
with PPD and were osmiophilic strongly indicating their lipid content (Figure 14D). Finally, we 
observed many capillaries in the outer plexiform layer of Tgfbr2Δeye mice in which the lumen was 
markedly narrowed or absent (Figure 14B). This finding was especially evident when retinae 
fixed by intracardial perfusion were investigated. While in control mice capillaries had an open 
lumen that was surrounded by vascular endothelial cells and pericytes, the opposing vascular 
walls of Tgfbr2Δeye capillaries were often in contact with each other (Figure 14B). In addition, 
completely occluded capillaries were identified which showed no lumen, but were still 
surrounded by a complete basal lamina (Figure 14B). To clarify, if endothelial cell loss was 
associated with the occlusion of retinal capillaries, we performed double immunohistochemistry 
with antibodies against both CD31 and type IV collagen. Collagen IV staining in control retinae 
identified a vascular basal lamina that surrounded CD31-positive cells (Figure 14E, F). In 
contrast in Tgfbr2Δeye mice, type IV collagen staining identified numerous vascular basal laminae, 
in which CD31-staining was essentially absent indicating endothelial cell loss (Figure 14E, F).  
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Figure 14. Intraretinal hemorrhages and vessel loss in Tgfbr2
Δeye
 mice.  A. Electron micrographs of 4-
week-old Tgfbr2
Δeye
 mice. Endothelial cells of intraretinal vessel show numerous caveolae (arrows). Boxed 
area is shown at high magnification on the right. B. Electron micrographs show intraretinal vessels in the 
OPL of an 8 week-old control (left) and Tgfbr2
Δeye
 (middle) mouse. In Tgfbr2
Δeye
 mice, the lumen of the 
capillaries is narrow (middle) or absent (right). C, Left: Extravascular erythrocytes (arrows) in the retina. 
Right: Phagocytosing macrophage (arrows) containing numerous cytoplasmic phagolysosomes. D, Left: 
PPD-stained semithin section of a 4-week-old Tgfbr2
Δeye
 mouse. Arrows point toward PPD-positive, lipid-
rich, cytoplasmatic inclusions. Right: Electron micrograph of the cytoplasmatic inclusions (arrows). E. 
Immunoreactivity for collagen IV (green) and CD31 (red) in the retina at 4 weeks of age. The control 
mouse shows intense immunoreactivity for collagen IV and CD31 (arrows). In the Tgfbr2
Δeye
 littermate, 
immunoreactivity for CD31 is considerably weaker (arrows). Nuclei are DAPI-stained (blue). Antibody 
control sections indicate specific staining. F. Immunoreactivity for collagen IV (green) and CD31 (red) in 
the retina at 4 weeks of age with focus on the OPL. In control the mouse, collagen IV-positive vascular 
basal laminae (arrows) surround CD31
+
 endothelial cells. In Tgfbr2
Δeye
 mice, numerous vascular basal 
laminae are collagen IV-positive (arrows), whereas CD31 staining is absent. Er, Erythrocyte; GCL, 
ganglion cell layer; INL, inner nuclear layer; ONL, outer nuclear layer; OPL, outer plexiforme layer; PPD 
paraphenylenediamine; TEM, transmission electron microscopy. Experiments performed by Anja Schlecht 
and Barbara M. Braunger.  
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3.4.5 Lack of ocular TGF-β signaling leads to hyaloid vasculature persistence 
Impairment of ocular TGF-β signaling not only affects the retinal vasculature, but also the 
second vascular tree in the eye, the hyaloid vasculature which is transiently present during eye 
development. While hyaloid vessels had completely disappeared in the normal mouse eye at 
around P16, they were still detectable by fluorescence angiography in eight-week-old Tgfbr2Δeye 
mice (Figure 15A). The hyaloid vessels originated from the optic nerve head and formed a 
typical tunica vasculosa lentis around the lens (Figure 15B). There is evidence that regression of 
the hyaloid vasculature requires macrophages to initiate a cell death program in target cells by 
activating the canonical Wnt pathway via WNT7b as a short-range paracrine signal (Lobov et al. 
2005). We therefore utilized immunohistochemistry with antibodies against IBA-1 or F4/80 to 
visualize macrophages. Around the persistent hyaloid vasculature of three-week-old Tgfbr2Δeye 
mice, we detected numerous macrophages that were IBA-1- or F4/80-immunoreactive (Figure 
15C and D). Next we crossed Tgfbr2Δeye mice with TOP-Gal Wnt pathway reporter mice. We 
observed an intense staining for β-galactosidase around the hyaloid vessels and in the epithelial 
layers of lens and ciliary body of P10 Tgfbr2Δeye/Top Gal mice (Figure 15E). In contrast, Top Gal 
mice crossed with control littermates of Tgfbr2Δeye mice showed only a week signal around the 
few hyaloid vessels that were still present at that age (Figure 15E). Overall, our findings strongly 
indicate that TGF-β signaling is required for the regression of the hyaloid vasculature and that 
the activity of canonical Wnt signaling is rather increased than decreased when ocular TGF-β 
signaling is absent. 
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Figure 15. Persistence of the hyaloid vasculature in Tgfbr2
Δeye
 mice.  A. In vivo fluorescence 
angiography of an 8-week-old Tgfbr2
Δeye
 mouse shows the hyaloid artery and the retinal vasculature 
(white arrow points at the retinal vessels). B. Richardson’s- stained semithin section of a 4-week-old 
control and Tgfbr2
Δeye
 eye. In the Tgfbr2
Δeye
 mouse, the hyaloid artery persists (arrows) throughout the 
vitreous. FITC- dextran-perfused retinal whole mount of a 4-week-old Tgfbr2
Δeye
 mouse with hyaloid 
vessels located on the retinal surface (white arrows). C. Immunoreactivity for IBA-1(red) and FITC-dextran 
(green) at the hyaloid artery of a Tgfbr2
Δeye
 mouse at 3 weeks of age. Nuclei are DAPI-stained (blue). D. 
Immunoreactivity for F4/80 (red) and FITC-dextran (green) at the hyaloid artery of a Tgfbr2
Δeye
 mouse at 2 
weeks of age. Nuclei are DAPI-stained (blue). E. β-galactosidase staining in 10-day-old double transgenic 
control/TOP-Gal and Tgfbr2
Δeye
/ TOP-Gal mice. In the Tgfbr2
Δeye
/TOP-Gal mouse, an intense staining is 
present throughout the hyaloid artery. CB. Ciliary body; FITC, fluorescein isothiocyanate; Le: lens. 
Experiments performed by (A) Anja Schlecht, Herbert Jägle, Cornelia Volz; (B,C) Barbara M. Braunger 
and Sarah V. Leimbeck; (D) Anja Schlecht and Barbara M. Braunger; (E) Sarah V. Leimbeck.  
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3.4.6 Absence of TGF-β signaling induces microglia reactivity in the retina 
The presence of numerous macrophages in the vitreous of Tgfbr2Δeye mice prompted us to 
search for evidence of microglia/macrophage reactivity in the retinae. In two-week old Tgfbr2Δeye 
mice, real-time RT-PCR showed a significant increase in the expression of mRNA for markers of 
reactive microglia such as Cd68, Tnf-α and Ccl-2 (Figure 16A). At four weeks of age, the 
expression of iNos, Il6, and Egr-1 was also significantly increased compared to control 
littermates (Figure 16A). By immunohistochemistry of control eyes, IBA-1-positive cells were 
seen in their typical localization such as the retinal surface, and the inner and outer plexiform 
layers in which the cells had the characteristic shape of ramified microglia (Figure 16B). IBA-1-
immunoreactive cells were not obviously associated with retinal capillaries. In contrast, in 
Tgfbr2Δeye retinae, IBA-1-positive cells formed a distinct and almost complete layer around the 
enlarged retinal capillaries (Figure 16B). Moreover, IBA-1 immunoreactive cells had changed 
their shape from that of ramified microglia to reactive microglia (Figure 16B). 
Immunohistochemistry for F4/80, a marker for macrophages and reactive microglia cells further 
validated this observation by showing multiple F4/80 positive cells in close association with 
FITC-dextran perfused capillaries of the inner retina. In contrast, in control eyes F4/80 positive 
cells were absent in the retina, but were observed in the choroid (Figure 16C). Finally, we 
labeled for GFAP to a analyze reactivity of Müller cell glia. In control eyes, GFAP labeling was 
restricted to cells on the inner retinal surface and very likely indicated the presence of GFAP in 
astrocytes and/or Müller cell end-feet. In Tgfbr2Δeye retinae, radial GFAP staining was seen 
throughout the retina reflecting reactivity and the typical gliosis reaction of Müller cell glia (Figure 
16D). In addition, GFAP staining in the inner retina was more prominent than in controls (Figure 
16D). GFAP staining did not overlap with that of IBA-1 or F4/80. 
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Figure 16. Microglia reactivity in retinae of Tgfbr2
Δeye
 mice.  A. Real-time RT-PCR for mRNA of Cd68, 
Il6, Tnf-α, iNOS, Egr-1 and Ccl-2 in 2- and 4-week-old retinae. B. Immunoreactivity for IBA-1 (red) in the 
retina at 8 weeks of age. Distinct immunoreactivity for IBA-1 (arrows) is detectable in the plexiform layers 
of the control mouse. In the Tgfbr2
Δeye
 littermate microglia labeling is more intense, primarily localized 
around retinal vessels (arrows) and indicates a switch to a reactive, non-ramified phenotype (arrowhead). 
Nuclei are DAPI-stained (blue). C. Immunoreactivity for F4/80 (red) in the retina at 3 weeks of age. No 
immunoreactivity for F4/80 is detectable in the retina of the control mouse , whereas a distinct 
immunoreactivity is detectable in the choroid (arrow). In contrast, in the Tgfbr2
Δeye
 littermate F4/80 labeling 
is more intense and primarily localized around retinal vessels (arrows). Nuclei are DAPI-stained (blue). D. 
Immunoreactivity for GFAP (green) in the retina at 4 weeks of age. Distinct immunoreactivity for GFAP 
(arrowhead) is detectable at the inner retinal surface of the control mouse. In the Tgfbr2
Δeye
 littermate 
GFAP labeling on the retinal surface is more intense. In addition, radial staining is seen throughout the 
retina (arrows), indicating reactivity of Müller glia. Nuclei are DAPI-stained (blue). Data are expressed as 
m eans ± SEM. Sample size (A): 2 weeks: control: n ≥ 5, Tgfbr2
Δeye
: n ≥ 10, Il6: hardly detectable, n ≥ 4; 4 
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weeks: control: n ≥ 9, Tgfbr2
Δeye
: n ≥ 8; Il6: hardly detectable, n ≥ 3. *P ≤ 0.05; **P ≤ 0.01;***P ≤ 0.001. 
AU, arbitrary unit; FITC, fluorescein isothiocyanate; GCL, ganglion cell layer; GFAP, glial fibrillary acid 
protein; INL, inner nuclear layer; ONL, outer nuclear layer; RPE, retinal pigment epithelium. Experiments 
performed by (A) Barbara M. Braunger; (B,D) Sarah V. Leimbeck; (C) Anja Schlecht and Barbara M. 
Braunger.  
 
 
3.4.7 Continuous lack of retinal TGF-β signaling leads to proliferative retinopathy 
At around six weeks of age, we frequently observed capillaries that penetrated the inner limiting 
membrane of Tgfbr2Δeye retinae and grew into the vitreous body to cause proliferative retinopathy 
(Figure 17A). To identify stimuli for the proliferation, we assessed by real-time RT-PCR the 
amounts of mRNA for various angiogenic growth factors. At two weeks of age, the expression of 
mRNA for Vegf-a-120, Vegf-a-164, Pdgf-b, Ang2, Igf1 and Fgf2 was not significantly different 
when RNA from Tgfbr2Δeye retinae was compared with that of controls (Figure 17B, C). In 
contrast in four-week-old animals, the expression of mRNA for Vegf-a-120, Vegf-a-164, Pdgf-b, 
Ang2, Igf1 and Fgf2 was significantly higher in the retinae of Tgfbr2Δeye mice (Figure 17B, C). As 
the mRNA levels for Fgf2 showed the highest (approx. 10.5-fold) increase (Figure 17C), we 
additionally investigated the amounts of FGF2 and observed a significant and approx. 4-10-fold 
increase in the amounts of the FGF2 isoforms (18 kDa, 21 kDa, and 24 kDa) when compared to 
controls (Figure 17D). As retinal hypoxemia might contribute to the observed effects, we 
investigated the amounts of HIF-1α and detected retinal levels of HIF-1α that were almost 
double as high as those in controls (Figure 17E).  
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Figure 17. Tgfbr2
Δeye
 mice develop proliferative retinopathy.  A. Meridional section of a 6-week-old 
FITC-dextran (green)-perfused Tgfbr2
Δeye
 retina shows neovascularization into the vitreous (white arrows). 
B. Real-time RT-PCR for mRNA of Vegf-a-120, Vegf-a-164, Pdgf-b, Ang-2 and Igf-1 in 2- and 4-week-old 
retinae. C. Real-time RT-PCR for Fgf2 mRNA in 2- and 4-week old retinae. Data are expressed as means 
± SEM (same samples as in B). D and E. Western blot and relative densitometric analyses for FGF2 (D) 
and HIF1-α in the retina of 4 week old animals. GAPDH was used as loading control. Data are expressed 
as mean ± SEM. Sample size: (B) 2 weeks: control: n ≥ 4, Tgfbr2
Δeye
: n ≥ 5; 4 weeks: n ≥ 7; (D and E) 
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FGF2: n = 4, HIF1-α: n ≥ 7; *P ≤ 0.05;**P ≤ 0.01; ***P ≤ 0.001. AU, arbitrary unit; FITC, fluorescein 
isothiocyanate; Fgf2, basic fibroblast growth factor; GAPDH, glyceraldehyde 3-phosphate dehydrogenase 
GCL, ganglion cell layer; HIF, hypoxia-inducible factor; INL, inner nuclear layer; ONL, outer nuclear layer. 
Experiments performed by (A) Sarah V. Leimbeck; (B,C,D,E) Barbara M. Braunger.  
 
 
Proliferative retinopathy resulted in the formation of epiretinal vascular membranes on the 
surface of Tgfbr2Δeye retinae (Figure 18A) that were not observed in controls (Figure 18A). In 
four-month-old animals, we frequently observed detachment of the sensory retina which 
remained in contact with the underlying RPE by thin strands of presumably glial tissue (Figure 
18A). Proliferative retinopathy and retinal detachment correlated with pronounced changes in the 
sensory retina that lost its layered structure (Figure 18A). The structural differences occurred in 
parallel to a loss of retinal neurons. In support of this, we observed a significant reduction in the 
amounts of PPD-labeled optic nerve axons that were counted in optic nerve cross sections 
(Figure 18B) as a measure of retinal ganglion cell number. Moreover, the thickness of the ONL 
was significantly reduced, again indicating neuronal loss (Figure 18C). The structural changes 
caused marked functional changes in the retinae of Tgfbr2Δeye mice including a reduction in b/a-
amplitude ratio indicating a more pronounced inner retinal function loss (Figure 18D). As likely 
reason for the neuronal loss, we identified an increase in neuronal apoptotic cell death. 
Accordingly, the number of retinal TUNEL-positive nuclei was significantly higher in four-week-
old Tgfbr2Δeye retinae (Figure 18E and G) as was the expression of Casp8 mRNA at two and four 
weeks of age (Figure 18F). 
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Figure 18. Tgfbr2
Δeye
 mice develop functional and structural deficits.  A. Richardson’s-stained semi-
thin section of a 2-month-old control (left) and 3- and 4-month-old Tgfbr2
Δeye
 retina. Tgfbr2
Δeye
 mice 
develop intravitreal membranes (middle, 3-month-old), resulting in traction retinal detachment (right, 4 
months old). B. Number of optic axons in 8 to 12-week-old mice. C. ONL thickness in 8-week-old mice. D. 
Dark adapted ERGs show similar waveforms (upper left panel) but significantly lower a- and b-wave 
amplitudes (upper right panel) for Tgfbr2
Δeye
 compared with control. In addition, slightly lower b/w-wave 
amplitude ratios (lower right panel) point toward a predominant inner retinal function loss. Implicit times 
are similar for both groups (lower left panel). E. Number of TUNEL-positive cells/meridional section. F. 
Real-time RT-PCR for mRNA of Casp8 in 2- and 4-week-old retinae. G. TUNEL labeling (green) in 6-
week-old retinae. TUNEL-positive cells (arrows) are mainly localized in the ONL. Nuclei are DAPI-stained 
(blue). Data are expressed as mean ± SEM. n = 5 (B); n = 3 (C and E); n = 7 (F, control at 2 weeks); n = 
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10 (F, Tgfbr2
Δeye
 at 4 weeks); n = 11 (F, Tgfbr2
Δeye
 at 2 weeks and control at 4 weeks). *P ≤ 0.05, **P ≤ 
0.01, ***P ≤ 0.001. AU, arbitrary unit; ERG, electroretinography; GCL, ganglion cell layer; INL, inner 
nuclear layer; ONH, optic nerve head; ONL, outer nuclear layer; OS, ora serrata; TUNEL, terminal 
deoxynucleotidyl transferase-mediated dUTP nick-end labeling. Experiments performed by (A) Anja 
Schlecht and Sarah V. Leimbeck; (B,C) Barbara M. Braunger and Sarah V. Leimbeck; (D) Herbert Jägle; 
(EFG) Barbara M. Braunger.  
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3.5 Discussion 
We conclude that lack of TGF-β signaling in the retinal microenvironment of the mouse eye is 
sufficient to induce all the major structural and functional changes that are associated with 
diabetic retinopathy in humans. The cellular players that are affected by the lack of retinal TGF-β 
signaling are the microvascular pericytes that largely dedifferentiate, the vascular endothelial 
cells that proliferate and lose their barrier function, and the microglia that changes to a reactive 
phenotype. The combined cellular changes directly result in a phenotype quite similar to that 
seen in non-proliferative retinopathy including leakiness of retinal capillaries, microhemorrhages, 
the formation of multiple microaneurysms, and the degeneration of retinal capillaries. The 
pathogenic process subsequently leads to retinal hypoxia, to the induction of angiogenic 
molecules resulting in retinal and vitreal neovascularization, and in the essential structural and 
functional characteristics of proliferative diabetic retinopathy. Our conclusions rest upon (1) the 
generation of mutant Tgfbr2Δeye animals with a tamoxifen-induced conditional deletion of TβRII in 
ocular tissues, (2) the observation that retinal NG2-positive pericytes are markedly reduced in 
number while α-SMA positive perivascular cells are massively increased, (3) the formation of 
abundant vascular microaneurysms in every vascular plexus in the retina, (4) the finding that 
retinal capillaries are leaky, and associated with extravascular erythrocytes and lipid-laden 
macrophages, (5) the fact that capillaries are surrounded by numerous reactive microglial cells, 
(6) the loss of vascular endothelial cells and the continuing closure of the retinal capillaries, (7) 
the increasing amounts of HIF-1α, and of angiogenic molecules and their mRNA, and (8) the 
observation of retinal detachment, retinal and vitreal hemorrhages, neuronal apoptosis and 
impairment of retinal sensory function. 
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3.5.1 TGF-β signaling determines pericyte differentiation during development of the retinal 
vasculature 
TGF-β signaling appears to play an essential role for vascular morphogenesis during early 
embryonic life (Armulik et al. 2011, Gaengel et al. 2009, Pardali et al. 2010, Jakobsson and van 
Meeteren 2013, Goumans et al. 2009, Patel-Hett and D'amore 2011) since mice that are defect 
in genes coding for various components of the TGF-β signaling pathways such as Tgfb1 
(Dickson et al. 1995), Tgfbr2 (Oshima et al. 1996), Tgfbr1/Alk5 (Larsson et al. 2001), Acvrl1/Alk1 
(Urness et al. 2000), Eng (Li 1999, Dijke et al. 2008, Bourdeau et al. 1999), or Smad5 (Chang et 
al. 1999, Yang et al. 1999) develop vascular abnormalities and die during early embryonic life. 
The approach used in the present study enabled us to conditionally delete TGF-β signaling in 
the eye during early angiogenesis of the mouse retina in the first postnatal week. Our results 
provide evidence that TGF-β signaling critically influences the molecular differentiation of 
pericytes in the retina.  
Pericytes constitute a somewhat diverse cell population and no molecular marker has been 
identified so far, which is expressed by all pericytes (Armulik et al. 2011, Krueger and Bechmann 
2010, Díaz-Flores et al. 2009). NG2 is a transmembrane chondroitin sulfate proteoglycan that is 
widely expressed in microvascular pericytes of newly formed blood vessels (Ozerdem et al. 
2001). In the central nervous system including the retina, the majority of pericytes expresses 
NG2 during vascular development and, after their differentiation, throughout adulthood (Hughes 
and Chan-Ling 2004, Winkler et al. 2010, Bell et al. 2010, Schallek et al. 2013). In addition, NG2 
localizes to the surface of retinal vascular smooth muscle cells (Krueger and Bechmann 2010, 
Díaz-Flores et al. 2009, Ozerdem et al. 2001, Hughes and Chan-Ling 2004, Schallek et al. 2013, 
Trost et al. 2013). In contrast to NG2, labeling for α-SMA in the normal retina is not observed in 
microvascular pericytes that are associated with retinal capillaries, but is restricted to vascular 
smooth muscle cells that surround larger vessels such as arterioles and arteries (Hughes and 
Chan-Ling 2004, Trost et al. 2013, Nehls 1991). Results from studies using neural crest-specific 
reporter genes indicate a common neural crest origin for the vast majority of NG2-positive 
pericytes and α-SMA-positive vascular smooth muscle cells in the mouse retina (Gage et al. 
2005, Trost et al. 2013). In retinal development of the mouse eye, both cell types are first 
observed in the eye at around P0 when retinal angiogenesis begins. During the formation of the 
superficial primordial retinal vascular network in the first postnatal week, pericytes spread along 
retinal capillaries while vascular smooth muscle cells surround arterial vessels (Fruttiger 2002). 
Upon retinal Tgfbr2 deficiency, capillaries become completely surrounded by α-SMA-positive 
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smooth muscle-like cells while NG2-positive pericytes are largely reduced in number. The 
observation strongly indicates that during retinal angiogenesis, TGF-β signaling in the retinal 
microenvironment is important to determine the respective pericyte/vascular smooth muscle 
phenotype of mural cells that surround capillaries. Lack of TGF-β signaling during vascular 
development of the retina favors the differentiation of mural cells towards a vascular smooth 
muscle cell-like fate at the expense of the formation of differentiated pericytes.  
It is well established that PDGF-B released from angiogenic endothelial cells binds to PDGFRβ 
to induce a mural cell fate in undifferentiated mesenchymal cells and stimulates their co-
migration. Accordingly, the deletion of Pdgfb or Pdgfrb in mice causes an almost complete 
pericyte deficiency throughout the body and leads to perinatal lethality (Hellström et al. 1999, 
Lindahl et al. 1997). Since TGF-β signaling induces the expression of α-SMA and other 
molecules characteristic for vascular smooth muscle cells in mesenchymal cells both in vitro and 
in vivo (Chambers et al. 2003, Chen 2003, Sieczkiewicz and Herman 2003, Kumar and Owens 
2003, Darland and D'Amore 2001, Hirschi et al. 1998), a contributing role of this signaling 
pathway for mural cell differentiation towards a vascular smooth muscle phenotype has been 
suggested. While our results clearly support the concept that TGF-β signaling is required to 
induce or maintain the differentiated phenotype of pericytes, they also indicate though that the 
lack of TGF-β signaling does not lead to an obvious reduction of vascular smooth muscle cells. 
 
3.5.2 Lack of retinal TGF-β signaling leads to vascular leakage 
Brain capillaries of mice with null and hypomorphic alleles of Pdgfrb, and defects in pericyte 
generation, are permeable to low-molecular-mass and high-molecular-mass tracers such as 
dextran indicating that pericytes are necessary for the formation of the blood-brain barrier (Bell 
et al. 2010, Armulik et al. 2010, Daneman et al. 2010). The increase in permeability is caused by 
an increase in transcytosis that is associated with a marked increase in the number of 
cytoplasmic vesicles in endothelial cells (Daneman et al. 2010, Armulik et al. 2010, Hellström et 
al. 2001). Quite similarly, an increased vascular permeability to fluorescein and FITC-dextran, 
and an accumulation of cytoplasmic vesicles in endothelial cells were observed in our study 
strongly supporting the concept that the α-SMA-positive mural cells covering retinal capillaries in 
the Tgfbr2 –deficient retinae had not differentiated to functional pericytes. In addition to tracer 
leakage, we observed massive retinal hemorrhages and lipid-laden macrophages, all common 
findings seen in human diabetic retinopathy (Wu et al. 2008, Toussaint et al. 1962, Garner 
1993). Clearly, the lack of capillary integrity is even more pronounced in retinae with deficiency 
in retinal TGF-β signaling than in animals lacking pericytes. Factors other than lack of pericyte 
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differentiation appear to contribute to the severe lack of capillary integrity and Tgfbr2 deficiency 
in capillary endothelial cells is a likely candidate. In support of this assumption are findings in 
mice with deficiency of Smad4, an intracellular mediator of TGF-β signaling, in brain capillary 
endothelial cells, which suffer from perinatal intracerebral hemorrhages and breakdown of the 
blood brain barrier (Li et al. 2011). Quite similarly, the selective deletion of Tgfbr2 in endothelial 
cells result in intracerebral hemorrhages and embryonic lethality (Nguyen et al. 2011). In the 
retina, inhibition of TGF-β1 signaling by systemic expression of soluble endoglin also induces 
breakdown of the blood retinal barrier, an effect that is mediated via a decreased association 
between the tight junction proteins zo-1 and occludin. Again, the effect on capillary integrity 
appears to be less pronounced than in our study since hemorrhages were not reported. 
Endothelial cells express the TβRI receptors ALK1 and ALK5 which are each recruited and 
activated following binding of TGF-β1 dimers to TβRII (Pardali et al. 2010). Soluble endoglin 
interferes only with ALK1-mediated TGF-β1 signaling, while ALK5 is not affected. ALK5 
signaling is intracellularly mediated by Smad2/3 (Pardali et al. 2010), and deletion of ALK5 or 
Smad2/3 in vascular endothelial cells causes hemorrhages and embryonic lethality (Itoh et al. 
2012). Our approach causes retinal deficiency of TβRII thus interrupting both ALK1- and ALK5-
mediated signaling in endothelial cells, a scenario that likely explains the more massive 
disruption of vascular integrity. Overall our results clearly support the concept that TGF-β 
signaling induces pericyte-endothelial cell interactions that are critical for the stability of 
capillaries in the retina, a mechanism that likely fails in diabetic retinopathy.  
It is of interest to note that both endothelial cells and α-SMA-positive mural cells of Tgfbr2 –
deficient retinae are covered by a basal lamina which is thicker and richer in type IV collagen 
than that in control littermates. Similar findings are very characteristic for diabetic retinopathy in 
humans (Roy et al. 1994, Garner 1993). In cell culture, TGF-β signaling induces the expression 
of basal lamina proteins in vascular endothelial cells and pericytes (Neubauer et al. 1999, van 
Geest et al. 2010) and its increased activity has been hypothesized to be causative for the 
increase in basal lamina thickening in diabetic retinopathy (van Geest et al. 2010), a concept 
that is not supported by the phenotype observed in Tgfbr2-deficient retinae. 
 
3.5.3 Lack of retinal TGF-β signaling induces the formation of capillary microaneurysms 
A hallmark of non-proliferative diabetic retinopathy are capillary microaneurysms (Sjølie et al. 
2011) which are formed by proliferating endothelial cells (Aguilar et al. 2003). Cell culture studies 
indicate that TGF-β1 is activated upon contact between endothelial cells, and pericytes or 
smooth muscle cells, an effect that mediates the inhibition of endothelial cell proliferation and 
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migration (Sato 1989, Antonelli-Orlidge et al. 1989, Sato 1990). Accordingly, the hypothesis has 
been put forward that the loss of pericytes in diabetic retinopathy is a causative factor for the 
generation of microaneurysms. Still, the formation of retinal microaneurysms is not a prominent 
finding in mouse mutants that lack pericytes, even in those where more than 50% of pericytes 
are missing (Enge 2002, Feng et al. 2007, Hammes 2005, Hammes et al. 2002, Hammes et al. 
2004). Overall, the effects of TGF- β signaling on endothelial cell proliferation appear to depend 
on the relative levels of ALK1/5 expression, and on the strength and duration of the TGF-β 
signal (Armulik et al. 2011, Pardali et al. 2010). ALK1 promotes endothelial cell proliferation 
whereas ALK5 has the opposite effect, and the balance between TGF-β/ALK1 versus TGF-
β/ALK5 determines the pro- or anti-angiogenic effects of TGF-β. We assume that lack of Tgfbr2 
in retinal endothelial cells shifts the balance to the pro-angiogenic effects, a scenario which 
promotes endothelial proliferation and the formation of microaneurysms. In support of this 
assumption are data from mice with induced conditional inactivation of Tgfbr2 in retinal vascular 
endothelial cells, which develop abnormally thickened vessels (Arnold et al. 2012) or glomerular 
tufts (Allinson et al. 2012) during retinal angiogenesis, findings that indicate an increase in 
endothelial proliferation. Overall, the incomplete pericyte differentiation and the increased 
endothelial proliferative activity both induced by retinal lack of Tgfbr2 appear to be the essential 
factors that drive the formation of microaneurysms in the mice investigated in the present study. 
Other prominent angiogenic factors are very likely not involved since the levels of mRNAs for 
Vegf-a-120, Vegf-a-164, Pdgf-b, Ang2, Igf1 or Fgf2 are not significantly elevated in two-week old 
mice with retinal Tgfbr2 deficiency. 
 
3.5.4 Lack of retinal TGF-β signaling induces capillary closure and reactive microglia 
Our results indicate that with increasing age, mice lacking retinal Tgfbr2 develop nonperfused 
capillary segments that are devoid of endothelial cells, a finding commonly observed in diabetic 
retinopathy (Toussaint et al. 1962, Hammes et al. 2011) where capillaries are reduced to 
endothelial cell-free tubes of basal lamina as the disease progresses (Ashton 1963, Cogan 
1961, Engerman 1989). Pericyte dropout appears to play a causative role in the generation of 
nonperfused capillary segments in diabetes, since comparable changes were observed in mice 
with endothelial deficiency of Pdgfb, which show a 50% reduction in the number of retinal 
pericytes that correlates with substantial capillary regression (Enge 2002). Cell culture 
experiments indicate that activated TGF-β released from pericytes plays a causative role in this 
process and acts as survival factor for vascular endothelial cells (Walshe et al. 2009). Indeed, 
systemic inhibition of TGF-β1 by soluble endoglin results in retinal underperfusion, loss of 
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capillary integrity, and ultrastructural changes of retinal capillaries that are quite similar to those 
observed in the present study (Walshe et al. 2009).  
In the perivascular areas of affected vessels, we consistently observed macrophages and 
microglia with a reactive phenotype. Also the high expression of Tnf-α and of other characteristic 
molecules in retinal extracts indicated that microglia had changed from a ramified, resting 
phenotype to that of reactive microglia. Essentially similar changes are seen in human retinae 
with diabetic retinopathy in which microglial perivasculitis is a common finding (Zeng et al. 2008). 
We expect that our approach also caused Tgfbr2-deficiency in microglia, a scenario, which in 
turn induced the reactive changes. In support of this assumption is the well-documented 
immunosuppressive role of TGF-β signaling in the eye (Nussenblatt and Ferris 2007, Niederkorn 
2006). Mediators released by reactive microglia may contribute to the capillary damage seen 
Tgfbr2-deficient retinae, and TNF-α, which induces apoptosis of vascular endothelial cell in 
culture (Robaye et al. 1991), is a likely candidate. TNF-α is similarly increased in the retina of 
diabetic rodents and its suppression reduces diabetic blood-retinal barrier breakdown (Joussen 
et al. 2001), pericyte and endothelial cell death, and apoptosis (Joussen et al. 2009). Also data 
from other animal studies provided evidence for a causative role of low-grade subclinical 
inflammation in the pathogenesis of the vascular changes in diabetic retinopathy (Joussen et al. 
2009, Joussen et al. 2004).  
Cells of macrophage lineage are also involved during the ontogenetic regression of the other 
major capillary network in the posterior eye, the hyaloid vasculature. Apparently, the cells initiate 
a cell-death program in target cells by activating the canonical Wnt pathway via WNT7b as a 
short-range paracrine signal (Lobov et al. 2005). Since our approach caused recombination in 
the entire eye including the vitreous, our findings strongly indicate that vitreous TGF-β signaling 
plays an equally important role during the ontogenetic regression of the hyaloid vasculature. 
Very likely this role is not directly related to canonical Wnt-signaling, and is required to induce 
capillary regression rather than preventing it as presumably in the adult retina. Apparently, the 
role of TGF-β signaling for vascular maintenance depends on tissue-specific and temporal 
contexts. 
 
3.5.5 Phenotypic changes in retinae progress to proliferative retinopathy 
Non-proliferative diabetic retinopathy eventually progresses to proliferative retinopathy that is 
characterized by retinal edema, retinal and vitreal neovascularization, retinal detachment, and 
vitreal hemorrhages (Frank 2004, Cheung et al. 2010, Antonetti et al. 2012, Garner 1993). 
Consequently neurons die by apoptosis, a scenario that results in impairment of retinal sensory 
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function. Essentially similar changes are seen when mice with ocular Tgfbr2-deficiency become 
older, an observation that underlines the close similarity of their phenotype with that of humans 
suffering from diabetic retinopathy. It is more than likely that the driving factors in both conditions 
are similar such as capillary regression leading to hypoxia and the induction of potent angiogenic 
molecules such as vascular endothelium growth factor-A and FGF2. 
 
3.5.6 Conclusion 
We conclude that the interaction of pericytes, vascular endothelial cells and microglia is required 
for maintenance of retinal capillaries and that TGF-β signaling plays an essential role in this 
process. Lack of TGF-β signaling in the retinal microenvironment disrupts this interaction and 
leads to homeostatic changes. The changes induce all the major aspects of the phenotype of 
diabetic retinopathy and underline the important role of the TGF-β signaling pathway during the 
pathogenesis of this disease. 
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4 Ablation of endothelial TGF-β signaling causes choroidal 
neovascularization  
4.1 Abstract 
The molecular pathogenesis of choroidal neovascularization (CNV), an angiogenic process that 
critically contributes to vision loss in age-related macular degeneration (AMD) is unclear. Here 
we analyzed the role of transforming growth factor (TGF)-β signaling for CNV formation by 
generating a series of mutant mouse models with induced conditional deletion of TGF-β 
signaling in the entire eye, the retinal pigment epithelium (RPE) or the vascular endothelium. 
Ablation of TGF-β signaling in the eye caused CNV, irrespectively if it was ablated in newborn or 
three-week-old mice. Areas of CNV showed photoreceptor degeneration, multilayered RPE, 
basal lamina deposits and accumulations of monocytes/macrophages. The changes progressed, 
leading to marked structural and functional alterations of the retina. While the specific deletion of 
TGF-β signaling in the RPE caused no obvious changes, specific deletion in vascular endothelial 
cells caused CNV and a phenotype quite similar to that observed after the deletion in the entire 
eye. We conclude that impairment of TGF-β signaling in the vascular endothelium of the eye is 
sufficient to trigger CNV formation. Our findings highlight the importance of TGF-β signaling as  
key player in the development of ocular neovascularization and indicate a fundamental role of 
TGF-β signaling in the pathogenesis of AMD.  
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4.2 Introduction 
The therapeutic options to treat age-related macular degeneration (AMD), the leading cause of 
vision loss and blindness in industrialized countries (Friedman et al. 2004, Finger et al. 2011, 
Klaver et al. 1998), are limited (Ambati and Fowler 2012, Lim et al. 2012). AMD is a complex 
disease (Fritsche et al. 2016) whose molecular pathogenesis is not well understood (Ambati and 
Fowler 2012, Lim et al. 2012). Vision loss in AMD is caused by choroidal neovascularization 
(CNV) or geographic atrophy (Ambati and Fowler 2012, Lim et al. 2012). In geographic atrophy 
(“late dry” AMD), the progressive atrophy of the retinal pigment epithelium (RPE) and of the 
choriocapillaris causes photoreceptor degeneration. Angiogenic processes that cause immature 
choroidal vessels to break through the RPE into the subretinal space characterize CNV. The 
resulting blood and plasma leakage causes fibrous scarring of the retina (“wet” AMD). The 
pathogenic mechanisms underlying the onset of CNV in AMD are unclear. Dysfunction of the 
retinal pigment epithelium (RPE) and immunovascular deregulation in region of the 
retinal/choroidal interface are considered as contributing factors (Ambati and Fowler 2012, Miller 
et al. 2013, Miller 2013). 
The choroidal vasculature forms the choriocapillaris, a vascular bed of highly anastomosed 
capillaries that is essential for nutrition and oxygen supply of both photoreceptors and RPE (Kur 
et al. 2012). The capillaries have a fenestrated endothelial layer and are highly permeable (Bill et 
al. 1980), a substantial difference to retinal capillaries. There is evidence from several studies of 
genetically engineered mouse models indicating that RPE-derived vascular endothelial growth 
factor (VEGF) is essential for choriocapillaris maintenance. VEGF is expressed in high amounts 
by RPE cells during embryonic development and in adult life (Ford et al. 2011). If VEGF 
expression is compromised, formation of the choriocapillaris in development or its maintenance 
in adult eyes are severely impaired leading to choriocapillaris ablation (Kurihara et al. 2012, 
Marneros et al. 2005, Le et al. 2010, Saint-Geniez et al. 2009, Ohlmann et al. 2016). Other 
growth factors that are secreted by RPE cells in high amounts are transforming growth factor 
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(TGF)-β1 and –β2 (Strauss 2005) causing a concentration of both factors in the RPE/choroid 
complex that is more than 10-fold higher than in the retina (Pfeffer et al. 1994). In a recent study 
we showed that a conditional ocular deletion of TGF-β signaling results in pronounced structural 
changes of retinal capillaries including the formation of abundant microaneurysms, leaky 
capillaries, and retinal hemorrhages. Overall a phenotype resulted very similar to that of diabetic 
retinopathy in humans (Braunger et al. 2015).  
Since TGF-βs are present at very high concentrations in region of the RPE/choroid interface, we 
wondered if TGF-β signaling might not only be required for stability of retinal capillaries, but also 
for that of the choriocapillaris. To this end, we targeted the TGF-β type II receptor (TβRII), which 
is essential for TGF-β signaling and generated a series of mutant mouse strains with an induced 
conditional deletion in the entire eye, the RPE or in vascular endothelial cells. Here we provide 
evidence that impairment of TGF-β signaling in the vascular endothelium of the eye is sufficient 
for the development of CNV. Our findings highlight the importance of the TGF-β signaling 
pathway as a key player in the development of ocular neovascularization and indicate a 
fundamental role of TGF-β signaling in the pathogenesis of AMD. 
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4.3 Material and Methods 
4.3.1 Mice 
All procedures conformed to the tenets of the NIH’s Guidelines for the Care and Use of 
Laboratory Animals, the EU Directive 2010/63/E, institutional guidelines, and were approved by 
the local authority (Regierung der Oberpfalz, AZ 54-2532.1-44/12 and DMS 2532-2-85). All 
experiments were performed in mice of either sex that were tested negatively for the Rd8 
mutation (Mattapallil et al. 2012).  
Mice with two floxed alleles of Tgfbr2 (Tgfbr2fl/fl) (Chytil et al. 2002) were crossed with CAGG 
Cre-ERTM (Hayashi and McMahon 2002), VMD2rtTA Cre (Le et al. 2008) or VECad Cre-ERT2  
(Monvoisin et al. 2006) mice that were heterozygous for the Cre recombinase. Resulting 
Tgfbr2fl/fl; CAGG Cre-ERTM, Tgfbr2fl/fl; VMD2rtTA Cre or Tgfbr2fl/fl; VECad Cre-ERT2 mice were 
used as experimental mice. For simplicity, Tgfbr2fl/fl; CAGG Cre-ERTM mice will be referred to as 
Tgfbr2Δeye, Tgfbr2fl/fl; VMD2rtTA Cre mice will be referred to as Tgfbr2ΔRPE and Tgfbr2fl/fl; VECad 
Cre-ERT2 mice will be referred to as Tgfbr2ΔEC. Tgfbr2fl/fl littermates with two unrecombined 
Tgfbr2 alleles served and are referred to as controls. Genetic backgrounds were 129SV 
(Tgfbr2fl/fl, VMD2rtTA Cre, VECad Cre-ERT2) and C57/Bl6 (CAGG Cre-ERTM). All mice were reared 
in a light/dark cycle of 12 h (lights on at 7AM). Genotypes were screened by isolating genomic 
DNA from tail biopsies and testing for transgenic Cre sequences and floxed Tgfbr2 sequences 
as described previously (Boneva et al. 2016, Braunger et al. 2015).  
 
4.3.2 Induction of Cre recombinase  
Cre recombinase in CAGG Cre-ERTM and VECad Cre-ERT2 mice is tamoxifen dependent. In 
CAGG Cre-ERTM mice, the Cre-ERTM fusion protein is ubiquitously expressed. Cre recombinase 
is restricted to the cytoplasm and will only access the nucleus after binding to tamoxifen 
(Hayashi and McMahon 2002, Feil et al. 1996). VECad Cre-ERT2 mice carry the Cre-ERT2 
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expression cassette under regulatory control of the mouse VE-cadherin gene promoter region 
that specifically drives gene expression in the vascular endothelium (Monvoisin et al. 2006). To 
activate Cre recombinase in Tgfbr2Δeye andTgfbr2ΔEC mice, the animals and their respective 
control littermates were treated with tamoxifen containing eyedrops from P4 to P8 as described 
previously (Schlecht et al. 2016). A second stock of Tgfbr2Δeye and control mice was treated from 
P21 to P25, a time when the development of the retinal vasculature is complete. For simplicity, 
Tgfbr2Δeye mice that were tamoxifen treated from P4-8 will be referred to as “early-induced” and 
Tgfbr2Δeye mice that were tamoxifen treated from P21-25 will be referred to as “late-induced”. Cre 
recombinase in VMD2rtTA Cre;Tgfbr2fl/fl is doxycycline dependent and under the control of the 
RPE-specific bestrophin promotor (Le et al. 2008). Doxycycline (AppliChem, Darmstadt, 
Germany) was diluted in phosphate-buffered saline (PBS) to a final concentration of 0.1 g/ml 
and doxycycline eye drops (10 µl) were pipetted onto the eyes of Tgfbr2ΔRPE mice and their 
control littermates from P21 to P25 three times per day.  
 
4.3.3 mT/mG reporter mice 
The efficient Cre recombinase activation in VeCad-Cre-ERT2 mice was confirmed using mT/mG 
reporter mice (Muzumdar et al. 2007), which express a membrane-targeted green fluorescent 
protein (mG/GFP) after Cre mediated excision. Heterozygous VeCad Cre-ERT2 mice were 
crossed with homozygous mT/mG mice. The resulting offspring (VeCad-Cre-ERT2(+/-
);mT/mG(+/-) and wildtype;mT/mG(+/-)) was treated with tamoxifen eyedrops from P4 to P8 
according to previously published protocols (Braunger et al. 2015, Schlecht et al. 2016). Mice 
were killed at P10. After enucleation, the eyes were fixed in 4% PFA for 4h, washed extensively 
in phosphate buffer (PB), incubated in 10%, 20%, 30% sucrose over night and shock frozen in 
tissue mounting medium (O.C.T. Compound; DiaTec, Bamberg, Germany). Sections were 
washed three times in phosphate buffer (PB, 5 min each) and cell nuclei were counterstained 
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with DAPI (Vectashield; Vector Laboratories, Burlington, CA) 1:10 diluted in fluorescent 
mounting medium (Serva).  
4.3.4 Tgfbr2 deletion PCR 
Tgfbr2 deletion PCR screens its successful genomic deletion following Cre mediated 
recombination. DNA samples of the sensory retina and the choroid (including cells of the RPE) 
served as templates. Primer pairs and protocol are described in previously published 
manuscripts (Chytil et al. 2002, Braunger et al. 2013b). Actin was used as loading control. 
 
4.3.5 Morphology and microscopy 
The eyes were enucleated, fixed for 24 h in 2% paraformaldehyde (PFA)/2.5% glutaraldehyde 
and embedded in Epon (Serva,Heidelberg, Germany) as described elsewhere (Karnovsky 1965, 
Kugler et al. 2015). Semithin meridional sections (1 µm thick) were cut through the eyes and 
stained after Richardson (Richardson et al. 2009). The sections were analyzed using an Axio 
Imager Z1 microscope (Carl Zeiss, Jena, Germany) and appropriate Axiovision version 4.8 
software (Carl Zeiss). Ultrathin sections were processed according to protocols published 
previously (Braunger et al. 2014, Braunger et al. 2013a), stained with uranyl acetate and lead 
citrate, and analyzed on a transmission electron microscope (Libra, Zeiss). 
4.3.6 Immunohistochemistry 
Prior to TβRII, collagen IV and VEGF-A staining, eyes were fixed for 4 h in 4% 
paraformaldehyde (PFA), washed extensively in PB (0.1 M, pH 7.4) and embedded in paraffin 
according to standard protocols. Paraffin sections (6 µm) were deparaffinized and washed in 
H2O. For detection of TβRII, sections were treated with boiling citrate buffer (1 x 10 min, ph 6), 
washed again in H2O and incubated in 0.1 M PB. For detection of collagen IV and VEGF-A, 
sections were pretreated with 0.05 M Tris-HCl (5 min) and covered with Proteinase K (100 µl of 
Proteinase K in 57 ml of Tris-HCl (0.05 M), 5 min), washed in H2O, incubated in 2 N HCl (20 
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min), and washed again in H2O. Sections were incubated in PB for 5 min and then blocked with 
2% BSA, 0.2% CWFG, 0.1% Triton X (TβRII), ) 2% BSA, 0.1% Triton X (Collagen IV) or 5% non-
fat dry milk (VEGF-A) at room temperature for 60 min. Primary antibodies (Table 4) were diluted 
in a 1:10 dilution of blocking solution in PB.  
Prior to F4/80 and PLVAP staining, eyes were fixed for 4 h in 4% paraformaldehyde (PFA), 
washed extensively in phosphate buffer (PB, 0.1 M), incubated in 10%, 20%, 30% sucrose/PBS 
overnight at 4 °C and shock frozen in tissue mounting medium (DiaTec). For 
immunohistochemistry, frozen sections were washed three times in PB or PBS (F4/80) for 5 min 
each and blocked at room temperature with 2% BSA in PB for 45 min (F4/80: 1% non-fat dry 
milk, 0.01% Tween in PB). Primary antibodies (Table 4) were diluted in a 1:10 dilution of 
blocking solution in PB (F4/80: 2% BSA, 0.02% NaN3, 0.01% Triton-X in PBS) and incubated at 
4 °C overnight. After three washes in PB/PBS (5 min each), biotinylated antibodies were applied 
for 1 h, diluted in a 1:10 dilution of the blocking solution, then appropriate secondary antibodies 
(Table 4), diluted in a 1:10 dilution of the blocking solution, were applied for 1 h. Sections were 
washed again three times in PB/PBS and nuclei were counterstained with DAPI (Vectashield, 
Vector Laboratories) diluted 1:10 in fluorescent mounting medium (Serva). Sections were 
investigated on an Axio Imager Z1 fluorescent microscope (Carl Zeiss, Jena, Germany) and 
appropriate Axiovision version 4.8 software (Carl Zeiss). 
 
Table 4. Antibodies used for immunohistochemistry 
Primary antibody Fixation Secondary antibody 
TβRII- L21 (Santa Cruz) 
1:20 
4% paraformaldehyde 
(PFA) 
anti-rabbit, biotinylated (Vector) 1:500, 
Streptavidin Alexa 488 (Invitrogen) 1:1000 
Collagen IV (Rockland) 
1:100 
4% PFA anti-rabbit Cy
TM
-3 conjugated (Jackson 
Immuno Research Lab) 1:2000 
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4.3.7 Dextran Perfusion  
Prior to dextran perfusion, mice were deeply anesthetized with ketamine (120 mg/kg body 
weight) and xylazine (8 mg/kg body weight). Afterwards mice were perfused through the left 
ventricle with 1 ml of PBS containing 50 mg FITC-dextran (MW = 2000 kDa, TdB Consultancy, 
Uppsala, Sweden). The eyes were enucleated and fixed in 4% PFA for 2 h (flatmounts)/ 4 h 
(sections) and washed in PB. Eyes were sectioned, placed on glass slides and counterstained 
with DAPI (Vectashield, Vector Laboratories) 1:10 diluted in fluorescent mounting medium. For 
quantification of CNV, retinal/choroidal tissue were dissected and flat mounted on glass slides 
using fluorescent mounting medium. FITC-dextran perfused sections and flatmounts were 
investigated on an Axio Imager Z1 fluorescent microscope. 
4.3.8 Electroretinography (ERG) 
Mice were dark adapted for at least 12 hours before the experiments and anesthetized by s.c. 
injection of ketamine (65 mg/kg) and xylazine (13 mg/kg). Pupils were dilated with tropicamide 
eye drops (Mydriaticum Stulln; Pharma Stulln GmbH, Stulln, Germany). Silver needle electrodes 
served as reference (forehead) and ground (tail), and gold wire ring electrodes served as active 
electrodes. ERGs were recorded with a Ganzfeld bowl (Ganzfeld QC450 SCX) and an 
amplifier/recording unit (RETI-Port; both Roland Consult, Brandenburg, Germany), band-pass 
filtered (1 to 300 Hz), and averaged. Single-flash scotopic (dark adapted) responses to a series 
of 10 LED-flash intensities (range: -3.5 to 1.0 log cd.s/m2) were recorded. After 10 minutes of 
VEGF-a 1:50 (R&D 
systems) 
4% PFA anti-goat, biotinylated (Vector) 1:500, 
Streptavidin Alexa 546 (Invitrogen) 1:1000 
F4/80 (Acris Antibodies) 
1:600 
4% PFA anti-rat Cy
TM
-3 conjugated (Jackson 
Immuno Research Lab) 1:2000 in PBS 
PLVAP (Santa Cruz) 1:50 4%PFA anti-rat Cy
TM
-3 conjugated (Jackson 
Immuno Research Lab) 1:2000 
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adaption to a white background illumination (20 cd/m2) single flash photopic (light adapted) 
responses to three Xenon-flash intensities (1, 1.5 and 2 log cds/m2) were recorded. All analysis 
and plotting were performed with R version 3.2.1 (The R Foundation for Statistical Computing, 
Vienna, Austria) and ggplot2 version 2.1.0 (Wickham 2009).  
 
4.3.9 Fundus Imaging and Angiography 
Imaging of the retinal vasculature was performed with a commercially available imaging system 
(Micron III; Phoenix Research Laboratories, Pleasanton, CA). Light source and imaging path 
filters (low pass and high pass at 500 nm) were used for fluorescein angiography (FLA). Mice 
were anesthetized by s.c. injection of ketamine (65 mg/kg) and xylazine (13 mg/kg), and their 
pupils were dilated with tropicamide eye drops before image acquisition. FLA was performed 
with s.c. injection of 75 mg/kg body weight fluorescein-Na (Alcon, Hünenberg, Switzerland).  
 
4.3.10 RNA Analysis 
Total RNA from retinae was extracted with TriFast, and first-strand cDNA synthesis was 
performed with iScript cDNA Synthesis Kit (Bio-Rad Laboratories, Inc., Hercules, CA) according 
to the manufacturer’s guidelines. Quantitative real time RT-PCR analyses were performed with 
the iQ5 Realtime PCR Detection System (Bio-Rad Laboratories, Inc.). The temperature profile 
was denaturation at 95°C for 10 s and annealing and extension at 60°C for 40 s for 40 cycles. All 
primer pairs were purchased from Invitrogen and extended over exon-intron boundaries, except 
for Gapdh. Sequences of primer pairs are shown in Table 5. RNA that was not reverse 
transcribed served as a negative control for real time RT-PCR. Before relative quantification, 
mRNAs from three different potential housekeeping genes were tested: glyceraldehyde 3-
phosphate dehydrogenase (Gapdh), guanine nucleotide binding protein (Gnb2l) and ribosomal 
protein L32 (Rpl32). We performed statistical analyses to confirm that none of the housekeeper 
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was regulated and then used the geometric mean of the crossing thresholds of all three 
housekeepers for relative quantification. Quantification was performed using BioRad iQ5 
Standard-Edition (Version 2.1) software (Bio-Rad Laboratories GmbH, Munich, Germany) and 
the ΔΔCt method in Excel (Microsoft Corporation, Redmond, WA, USA) (Livak and Schmittgen 
2001). 
Table 5. Primers used for real time PCR amplification 
 Gene Sequence forward Sequence reverse  
GAPDH 5’-TGTCCGTCGTGGATCTGAC-3’ 
 
5’-CCTGCTTCACCACCTTCTTG-3’ 
GNB2L 5’-TCTGCAAGTACACGGTCCAG-3’ 
 
5’-ACGATGATAGGGTTGCTGCT-3’ 
RPL32 5’-GCTGCCATCTGTTTTACGG-3’ 
 
5’-TGACTGGTGCCTGATGAACT-3’ 
Tgfbr2 5’-AGAAGCCGCATGAAGTCTG-3’ 
 
5’-GGCAAACCGTCTCCAGAGTA-3’ 
Ccl2 5’-CATCCACGTGTTGGCTCA-3’ 
 
5’-GATCATCTTGCTGGTGAATGAGT-3’ 
Cd68 5’-CTCTCTAAGGCTACAGGCTGCT-3’ 
 
5’-TCACGGTTGCAAGAGAAACA-3’ 
Gfap 5`-TCGAGATCGCCACCTACAG.3´ 5`-GTCTGTACAGGAATGGTGATGC-3` 
 
Il6 5’-GCTACCAAACTGGATATAATCAGGA-3’ 
 
5’-CCAGGTAGCTATGGTACTCCAGAA-3’ 
iNos 5’-GGGCTGTCACGGAGATCA-3’ 
 
5’-CCATGATGGTCACATTCTGC-3’ 
Tnf-α 5’-TCTTCTCATTCCTGCTTGTGG-3’ 
 
5’-GGTCTGGGCCATAGAACTGA-3’ 
Vegf-a-120 5’-AAAGCCAGCACATAGGAGAG-3’ 
 
5’-GGCTTGTCACATTTTTCTGG-3’ 
Vegf-a-164 5’-GAACAAAGCCAGAAAATCACTGTG-3’ 
 
5’-CGAGTCTGTGTTTTTGCAGGAAC-3’ 
Fgf2 5’-CGGCTCTACTGCAAGAACG-3’ 
 
5’-TGCTTGGAGTTGTAGTTTGACG-3’ 
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4.3.11 Deep tissue imaging by 3D light-sheet fluorescence microscopy  
Mice were deeply anesthetized with ketamine (120 mg/kg body weight) and xylazine (8 mg/kg 
body weight) and 130 µl of Tomato lectin (Perkin Elmer, Inc., Waltham, MA) were injected slowly 
intravenous. Mice were killed 15 min after injection by cervical dislocation. The eyes were 
enucleated and fixed using Paxgene Tissue Containers (Qiagen, Hilden, Germany) according to 
the manufacturer’s recommendations and thereafter underwent a chemical procedure of optical 
clearing as previously described (Erturk et al. 2012). Cleared transparent whole mouse eyes 
were imaged on a light-sheet fluorescence microscope (UltraMicroscope II, LaVision BioTec, 
Bielefeld, Germany), equipped with a sCMOS camera (Andor Neo, Concord, USA) and a 2x/0.5 
NA objective lens (MVPLAPO 2x, Olympus, Hamburg, Germany). The specimens were two-
sided illuminated by a planar light-sheet using a white light laser (SuperK EXTREME EXW-9, 
NKT Photonics, Birkeröd, Denmark). To visualize the specific TLectinSense680 signals for 
vascularization, a bandpass filter set with an excitation range of 640/30 and emission range of 
690/50 was used in combination with an additional filter set (excitation: 531/40; emission: 
593/40) for detection of autofluorecence (morphology). By moving the specimen chamber 
vertically stepwise (step-size = 4µm) through the laser light-sheet, optical sections were 
obtained. In order to ensure standardized imaging regions for each eye the scan always covered 
600 µm above to 600 µm below the optical nerve. Maximum intensity projections were 
performed by ImspectorPro Software (LaVision BioTec, Bielefeld, Germany). 
 
4.3.12 Statistical Analysis 
All results are expressed as means ± SEM. Comparisons between the mean variables of two 
groups were made by a two-tailed Student’s t-test. Significance of the ERG analyses was 
evaluated using a one-way ANOVA test, followed by Tukey HSD post hoc test P ≤ 0.05 was 
considered to be statistically significant.   
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4.4 Results 
4.4.1 Deletion of ocular TGF-β signaling in mouse pups leads to choroidal neovascularization 
To investigate the role of the TGF-β signaling pathway for the structure of retinal and choroidal 
vessels, we deleted the essential TβRII receptor in the eyes via tamoxifen-induced conditional 
deletion. To this end, Tgfbr2fl/fl;CAGG Cre-ERTM mice were generated and treated from 
postnatal day (P) 4 to P8 with tamoxifen eye drops. For simplicity we will refer to Tgfbr2fl/fl; 
CAGG Cre-ERTM mice that received tamoxifen by this protocol as early-induced Tgfbr2Δeye mice 
and littermates with two unrecombined Tgfbr2fl/fl alleles are referred to as controls. As shown 
previously, the treatment results in a significant reduction of TβRII and its mRNA in the eyes of 
early-induced Tgfbr2Δeye mice compared to controls (Braunger et al. 2015). We also observed in 
the previous study that the deletion of ocular TGF-β signaling leads to the formation of abundant 
microaneurysms in retinal vessels and to a phenotype that largely mimics that of nonproliferative 
and proliferative diabetic retinopathy in humans (Braunger et al. 2015). Consequently we 
observed in the retina of two and three month old early-induced Tgfbr2Δeye mice vascular 
microaneurysms in the inner nuclear layer, which were characterized by thick layers of 
perivascular cells (Fig. 19A, B, C) (Braunger et al. 2015). In contrast, no changes were seen in 
control mice (Fig. 19A and B). We now turned our attention to the choroidal/retinal interface that 
we had not analyzed previously. Here we frequently observed focal areas in which the outer 
segments of photoreceptors were completely missing and the thickness of the outer nuclear 
layer was substantially reduced (Fig. 19B and C). Accumulations of cells were present between 
photoreceptors and RPE. The cells frequently surrounded vascular openings filled with 
erythrocytes strongly indicating their endothelial origin and an ongoing neoangiogenetic process. 
The RPE was multilayered in those areas, and contained cystic and amorphous inclusions (Fig. 
19C).  
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Figure 19. Early-induced deletion of TGF-β signaling in the eye causes structural changes in the 
subretinal space. Richardson`s stained semi-thin sections (1 µm thick) of an early-induced Tgfbr2
Δeye 
mouse and its control littermate. A. Retinal hemispheres of two-month-old control and Tgfbr2
Δeye
 animals. 
B. Detailed magnification of the retina. The control mouse shows regular structure. In the retina of the 
Tgfbr2
Δeye
 mouse a vessel (asterisk) filled with erythrocytes is seen, which disrupts the inner (INL) and 
outer nuclear layer (ONL) and is surrounded by an accumulation of cells that continue into the subretinal 
space (arrows). In the subretinal space mononuclear cells (arrowhead) are present while photoreceptor 
outer segments are degenerated and the choroid is thickened. C. Left-handed panel. In the inner retina of 
two-month-old Tgfbr2
Δeye
 mice accumulations of endothelial cells are seen in both the outer 
nuclear/plexiform layer (ONL/OPL) and in the inner nuclear/plexiform layer (INL/IPL). Right-handed panel. 
At the retinal/choroidal interface of two- and three-month-old Tgfbr2
Δeye
 mice the RPE is multilayered 
(black arrows in upper panel) and contains cystic and amorphous inclusions (upper panel, black 
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arrowhead). At the age of three months erythrocyte-containing vessels fill the subretinal space (middle 
and lower panel, black arrowheads). IPL, inner plexiform layer; OS, outer segments; IS, inner segments; 
INL, inner nuclear layer; RPE, retinal pigment epithelium. Experiments performed by Sarah V. Leimbeck 
and Barbara M. Braunger.  
 
To characterize the origin of the newly formed vessels in the subretinal space (between the 
sensory retina and the RPE) of early-induced Tgfbr2Δeye mice, we now perfused the mice with 
high molecular weight FITC-dextran for vascular labeling. While the retinal and choroidal 
vasculature of control animals was essentially normal, distinct changes were observed in the 
subretinal space of early-induced Tgfbr2Δeye mice. Here we observed vessels breaking from the 
choroid through Bruch’s membrane (BM) across the RPE into the subretinal space (Figure 20A). 
We quantified the number of CNV using FITC dextrane perfused wholemounts of the retina and 
choroid of four to six week old animals and observed 2.86 ± 0.59 CNV per wholemount (n = 
7).To confirm this observation by an independent method, we next performed 3D imaging of 
lectin perfused, optical cleared whole eyes (Figure 20B). The choriocapillaris did not resolve into 
single capillaries but rather appeared as an intense fluorescent line covering the outer surface of 
the retina, a fact that we attributed to the immense density and blood flow of this capillary bed 
(Kaufman et al. 2003). In control eyes, the three plexus of the retinal vasculature could be 
completely visualized and were essentially normal.  In contrast, in early-induced Tgfbr2Δeye mice, 
vessels that originated from the choriocapillaris entered the retina and continued into the retinal 
vascular bed forming obvious anastomoses with retinal vessels (Figure 20B). We now 
characterized the vascular wall of the newly formed vessels by transmission electron 
microscopy. As expected, in control mice the endothelium surrounding retinal vessels was 
continuous (Figure 20C) while that around the choriocapillaris was fenestrated. When we 
analyzed the newly formed vessels in the subretinal space of early-induced Tgfbr2Δeye mice, 
distinct fenestrations covered by a typical diaphragm were regularly observed (Figure 20C). To 
further support this finding, we performed immunohistochemical staining for plasmalemma 
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vesicle-associated protein (PLVAP), a vascular protein, intrinsic component of the diaphragm of 
vascular fenestrae, and marker for fenestrated endothelia (Stan et al. 2001, Stan et al. 1999, 
Stan et al. 2012, Herrnberger et al. 2012). As expected, in control and early-induced Tgfbr2Δeye 
animals the continuous endothelium of the retinal vasculature did not show any PLVAP 
immunoreactivity while the fenestrated endothelium of the choriocapillaris showed an intense 
PLVAP signal (Figure 20D). Furthermore, in early-induced Tgfbr2Δeye mice, intense PLVAP 
immunoreactivity was observed in the areas of neovascularization in the subretinal space 
(Figure 20D). Overall our results strongly indicated that loss of TGF-β signaling in early-induced 
Tgfbr2Δeye mice caused choroidal neovascularization (CNV). 
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Figure 20. Subretinal neovascularization with fenestrated endothelium following deletion of TGF-β 
signaling in the eyes of early-induced Tgfbr2
Δeye
 mice.  A. FITC-dextran (green)-perfused retinal 
meridional section of a control and Tgfbr2
Δeye
 mouse at 6 weeks of age. White arrows point towards 
choroidal vessels breaking through Bruch’s membrane and RPE into the subretinal space. Nuclei are 
DAPI-stained (blue). B. Light-sheet fluorescence microscopy of transparent eyes of six-week-old lectin-
injected Tgfbr2
Δeye
 mice and a control littermate. The control mouse shows an essentially regular 
arborized retinal vasculature. The Tgfbr2
Δeye
 mice have an irregular arrangement of the retinal plexus and 
form anastomoses between retinal and choroidal vessels (arrows). C. Transmission electron microscopy 
of an intraretinal vessel outlined with a continuous endothelium (cE) in a 2.5-month-old control animal. In 
contrast, the subretinal neovasculature in the Tgfbr2
Δeye
 littermate has a fenestrated endothelium (fE, 
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black arrows). D. Immunoreactivity for PLVAP (red) in the retina at 4 weeks of age. The control and the 
Tgfbr2
Δeye
 animal show a thin, one-layered PLVAP signal in the choriocapillaris (white arrowheads). In 
addition, the Tgfbr2
Δeye
 mouse displays PLVAP-positive signals (white arrows) in RPE and subretinal 
space. Nuclei are DAPI-stained (blue). RGC, retinal ganglion cells; INL, inner nuclear layer; ONL, outer 
nuclear layer; RPE, retinal pigment epithelium; C, choroid; BM, Bruch’s membrane; RPE retinal pigment 
epithelium; fE, fenestrated endothelium; cE, continuous endothelium; E, endothelium; CC, choriocapillaris. 
Experiments performed by (A) Sarah V. Leimbeck; (B) Anja Schlecht and Annette Feuchtinger; (C,D) 
Sarah V. Leimbeck.  
 
4.4.2 TGF-β signaling is required to prevent choroidal neovascularization in late-induced 
Tgfbr2Δeyemice 
Next we wondered whether the formation of CNV after TβRII deletion might be supported by the 
fact that retinal vascular development is not completed in mouse pubs and signaling processes 
are continuously ongoing that promote angiogenesis. To learn if TGFβ-signaling is also 
important for maintenance of the adult choriocapillaris when retinal vascular development is 
completed, we deleted TGFβ-signaling by an essentially comparable approach in three week old 
mice after the retinal vasculature had been developed. Mice were treated with tamoxifen eye 
drops from P21 – P25 and are further referred to as late-induced Tgfbr2Δeye mice. The significant 
deletion of retinal Tgfbr2 was confirmed by real time RT-PCR analyses (supplementary data 
Figure 29A). Next, we analyzed the ocular morphology of late-induced Tgfbr2Δeye mice and 
controls at the age of three (Figure 21A and B) and six months (Figure 22A and B). Retinal 
structure was essentially normal in control animals (Figure 21A, B and Figure 22A, B) and no 
obvious changes were observed in the inner retina of three month old late-induced Tgfbr2Δeye 
animals (Figure 21B). However, similar to our observations in early-induced Tgfbr2Δeye animals, 
all of the late-induced Tgfbr2Δeye mice showed structural changes in the subretinal space that 
were essentially comparable to that observed in early-induced Tgfbr2Δeye mice (Figure 21A, E 
and Figure 22A, B and D).  
 
Chapter 4 
81 
 
 
Figure 21. Subretinal neovascularization following deletion of TGF-β signaling in the eyes of three 
month old late-induced Tgfbr2
Δeye
 mice.  A. Richardson`s stained semi-thin sections (1 µm thick) of the 
retinal hemispheres of a three-month-old, late-induced Tgfbr2
Δeye 
mouse and its control littermate. B. 
Higher magnification of the retinal sections. C. In vivo funduscopy and fluorescein angiography of a three-
month-old, late-induced Tgfbr2
Δeye 
mouse and its control littermate. The retinal vasculature and the fundus 
appear essentially normal. D. FITC-dextran (green) perfused retinal meridional section of a 2-month-old 
Tgfbr2
Δeye
 mouse. The three retinal vascular plexus are present in their correct localization. Nuclei are 
DAPI-stained (blue). E. Detailed magnification of Richardson`s stained semithin sections of the 
retinal/choroidal interface in three-month-old Tgfbr2
Δeye
 mice and a control littermate. The control mouse 
does not show abnormalities (upper panel). In focal areas of Tgfbr2
Δeye
 mice, in which photoreceptor outer 
segments are shortened or completely missing, vessels are observed in the subretinal space. The RPE in 
those areas is multilayered (white arrowheads, lower panel) and frequently contains cystic and amorphous 
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inclusions (white arrow, middle panel). Mononuclear cells (arrowhead, middle panel) are visible in the 
subretinal space. INL, inner nuclear layer; ONL, outer nuclear layer; RPE, retinal pigment epithelium; C, 
choroid. Experiments performed by (A,B,D) Anja Schlecht and Sarah V. Leimbeck; (C) Anja Schlecht and 
Herbert Jägle.  
In focal areas in which photoreceptor outer segments were shortened or completely missing, 
vessels were observed in the subretinal space. The RPE in those areas was multilayered and 
frequently contained cystic and amorphous inclusions. In six month old late-induced Tgfbr2Δeye 
mice, the choroid was thickened and photoreceptor outer segments completely missing (Figure 
22A, B and D). The RPE was reduced to a flat layer or formed focal accumulations in those 
areas in which subretinal vessels were present. In vivo imaging and fluorescein in vivo 
angiography of three-month-old animals showed a regular fundus and retinal vasculature in both 
control and late-induced Tgfbr2Δeye mice (Figure 21C). To investigate the retinal vasculature in 
more detail, we additionally perfused two-month-old, late-induced Tgfbr2Δeye mice with high 
molecular weight FITC-dextran and analyzed the vasculature on meridional sections. The retinal 
vasculature had a regular appearance and the vessels were in their anatomically correct 
localization. Furthermore, we did not observe FITC-dextran or fluorescein leaking into the 
vitreous, the subretinal space or the surrounding tissue (Figure 21C and D). When we analyzed 
the eyes at the age of six months by in vivo fundus imaging and fluorescein angiography, control 
mice showed again no pathological changes, neither in the fundus, nor in the retinal vasculature 
(Figure 22C). In contrast, in late-induced Tgfbr2Δeye mice the fundus was hyperpigmented 
indicating RPE proliferation or dedifferentiation, and in some animals the retina had detached 
(Figure 22C). In parallel with the observed structural changes we detected marked functional 
changes by ERG that reflected the observed gradual degeneration of the retina in three month 
old to the six month old late-induced Tgfbr2Δeye mice (Figure 23A-G). While in three month old 
Tgfbr2Δeye mice the scotopic responses showed similar waveform but slightly lower amplitudes 
compared to control mice, the photopic waveform was unchanged in amplitude and implicit time. 
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However, the difference was not statistically significant. In six month old Tgfbr2Δeye mice both, 
the scotopic and photopic response could not be distinguished from noise in almost all eyes.  
 
Figure 22. Subretinal neovascularization and retinal degeneration following deletion of TGF-β 
signaling in the eyes of six month old late-induced Tgfbr2
Δeye
 mice.  A. Richardson`s stained semithin 
sections (1µm) of the retinal hemispheres of six-month-old animals. The control animal shows regular 
retinal morphology. In contrast, in the Tgfbr2
Δeye
 littermate photoreceptor outer segments are completely 
degenerated. B. Detailed magnification of the retina. In the Tgfbr2
Δeye
 mouse the retina is degenerated 
with a complete loss of photoreceptors. The RPE is disorganized, pigmented cells accumulate in the retina 
and the choroid is thickened. C. In vivo funduscopy and fluorescein angiography of the control animal are 
normal. Tgfbr2
Δeye
 mice show a hyperpigmented fundus (middle panel) or retinal detachment (right-
handed panel). D. Detailed magnification of Richardson’s stained semithin sections of the outer retina and 
the choroid of six-month-old Tgfbr2
Δeye
 mice and a control littermate. The morphology of the control mouse 
is normal. In contrast, the Tgfbr2
Δeye
 mouse has erythrocyte-filled vessels at the inner side of the RPE 
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(upper Tgfbr2
Δeye
 panel, arrowheads), thickened (middle Tgfbr2
Δeye
 panel) or thinned (lower Tgfbr2
Δeye
 
panel) RPE and an accumulation of pigmented cells in the sensory retina (upper, middle and lower 
Tgfbr2
Δeye
 panel, arrows). RGC, retinal ganglion cells; INL, inner nuclear layer; IPL, inner plexiform layer; 
PS, photoreceptor segments; RPE, retinal pigment epithelium. C, choroid. Experiments performed by 
(A,B,D) Anja Schlecht; (C) Anja Schlecht and Herbert Jägle.  
 
 
Figure 23. Functional changes following deletion of TGF-β signaling in the eyes of three- and six-
month ´-old late-induced Tgfbr2
Δeye
 mice.  A. Dark adapted scotopic ERGs of three-month-old late-
induced Tgfbr2
Δeye
 mice and controls show similar waveforms. The waveforms of six-month-old Tgfbr2
Δeye
 
mice are not distinguishable from noise in almost all eyes. Compared to controls, the a- and b-wave 
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amplitudes of scotopic responses are reduced B. and implicit times are prolonged C. in three-month-old or 
at noise level in six-month-old late-induced Tgfbr2
Δeye
 mice. D. In addition, a lower (three-month-old) or 
reduced (six-month-old) b/a-wave amplitude ratio points towards an initially predominant inner retinal 
function loss. E. Photopic ERGs show similar waveforms for three-month-old Tgfbr2
Δeye
 mice and controls, 
but again in six-month-old Tgfbr2
Δeye
 mice responses are at noise level. The b-wave amplitudes F. or 
implicit times G. are comparable for the three-month-old animals. Three-month-old mice: Control, n = 4, 
Tgfbr2
Δeye
, n = 4. Six-month-old mice: Control, n = 5, Tgfbr2
Δeye
, n = 5, *P ≤ 0.05, one way ANOVA. 
Experiments performed by Anja Schlecht and Herbert Jägle.  
 
4.4.3 Expression of angiogenic factors and immune modulating cytokines in Tgfbr2Δeye mice  
The ‘‘immunovascular axis’’, a crosstalk of the RPE with immune and vascular cells is 
considered a potent driver of CNV formation (Ambati and Fowler 2012). To clarify the 
mechanisms behind CNV induced by TβRII deletion we consequently analyzed the mRNA 
expression levels of immune modulating cytokines and markers for the reactivity of Müller glia 
and microglia cells, respectively. Early-induced Tgfbr2Δeye mice showed a significant increase in 
retinal mRNA expression levels of glial fibrillary acidic protein (Gfap), cluster of differentiation 
(Cd) 68, inducible nitric oxide synthase (iNos), interleukin (Il) -6, tumor necrosis factor (Tnf) -α 
and monocyte chemoattractant protein-1 (MCP-1/Ccl2) at the age of six weeks compared to 
control littermates (Figure 24A). However, in three-month-old late-induced Tgfbr2Δeye mice, the 
retinal mRNA expression levels were not significantly enhanced compared to controls; in fact 
Gfap was even significantly downregulated (Figure 24B). Next, we used an antibody against 
F4/80 to label macrophages and microglia cells (Hume et al. 1984, Hume et al. 1983, Langmann 
2007). The number of F4/80 positive cells was increased in the choroid of early-induced 
Tgfbr2Δeye animals when compared with controls (Figure 24C). Furthermore, in early-induced 
Tgfbr2Δeye animals, numerous F4/80 positive cells were seen in the subretinal space in close 
association with the CNV (Figure 24C). Quite similarly three-month-old late-induced Tgfbr2Δeye 
animals also presented a distinct accumulation of F4/80 positive cells in the choroid when 
compared to controls (Figure 24D). Subsequently, we focused on molecular factors that 
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influence vascular proliferation. In our previously published study, we already showed that early-
induced four-week-old Tgfbr2Δeye mice had significantly elevated mRNA expression levels for the 
angiogenic factors Vegf-a 120, Vegf-a 164, fibroblast growth factor (Fgf) -2, insulin growth factor 
(Igf)-1, angiopoetin 2 and platelet derived growth factor (Pdgf)–b compared to control littermates 
(Braunger et al. 2015). We now performed immunohistochemistry for VEGF-A to localize the 
increased levels in the retina of early-induced Tgfbr2Δeye mice (Figure 24E). While VEGF-A 
immunoreactivity was not detectable in control eyes, there was distinct and intense staining of 
the ganglion cell layer of early-induced Tgfbr2Δeye mice. When we screened the retinae of late-
induced Tgfbr2Δeye mice and their control littermates for the expression levels of the Vegf-a 
isoforms 120 and 164, the expression of Vegf-a 120 was not altered whereas expression of 
Vegf-a 164 was significantly reduced in five-week-old late-induced Tgfbr2Δeye mice compared to 
controls (Figure 24F). However, at the age of six months, the retinal expression levels of both 
Vegf-a 120 and 164 were significantly higher in late-induced Tgfbr2Δeye mice compared to 
controls. Overall, angiogenic and immune reactivities were much higher in early than in late-
induced Tgfbr2Δeye mice. 
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Figure 24. Early- and late-induced inhibition of TGF-β signaling in the eye: the expression of 
angiogenic factors and immune modulating cytokines.  A./B. Real-time RT-PCR for mRNA of Gfap, 
CD68, iNOS, Ccl2, IL6, Tnf-α in six week old early-induced Tgfbr2
Δeye
 mice and controls (A.) and five 
week old late-induced Tgfbr2
Δeye
 mice (B.) and controls. C. FITC-dextran (green) perfused and F4/80 (red) 
immunostained sections of a six week old early-induced Tgfbr2
Δeye
 mouse and control. The control mouse 
shows a weak immunoreactivity for F4/80 (red) positive cells in the choroid. In Tgfbr2
Δeye
 mice, the 
choroidal immunoreactivity for F4/80 (red) is more pronounced and F4/80 positive cells accumulate in the 
subretinal space and in close association to choroidal vessels penetrating the RPE (arrowhead). Nuclei 
are DAPI-stained (blue). D. F4/80 (red) immunostained sections of a three month old, late-induced 
Tgfbr2
Δeye
 mouse and control. A weak signal for F4/80 is visible in the choroid of the control mouse. In 
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contrast, the Tgfbr2
Δeye
 mouse shows numerous F4/80 positive cells in the choroid. Nuclei are DAPI-
stained (blue). E. Immunoreactivity for VEGF-A (red) in early-induced four week old mice. The control 
mouse has a faint immunoreactivity for VEGF-A. In contrast, in the Tgfbr2
Δeye
 mouse it is markedly 
increased. Nuclei are DAPI-stained (blue). F. Real-time RT-PCR for mRNA of Vegf-a 120, Vegf-a 164 in 
five week (left panel) and six month old mice (right panel). Data are expressed as mean ± SEM. Early-
induced mice: Control: n ≥ 7, Tgfbr2
Δeye
: n ≥ 7. Late-induced mice (5 weeks old): Control: n ≥ 6, Tgfbr2
Δeye
: 
n ≥ 2. Late-induced mice (six months old): Control: n= 9, Tgfbr2
Δeye
: n = 7. *P ≤ 0.05, **P ≤ 0.01. 
Experiments performed by (A) Barbara M. Braunger; (B,D,E,F) Anja Schlecht; (C) Anja Schlecht and 
Barbara M. Braunger.  
 
4.4.4 Formation of basal lamina deposits in Tgfbr2Δeye mice  
Since CNVs need to find their way across Bruch’s membrane (BM) and through the RPE barrier, 
we used TEM to analyze the structure of both. Control mice showed the regular, five-layered 
architecture of the BM (Figure 25A and D). In early- and late-induced Tgfbr2Δeye mice though the 
BM had thickened as result of an accumulation of collagen fibers and fine fibrillar extracellular 
material between the basal lamina of the choriocapillaris and the elastic layer of BM (Figure 25A-
E). Moreover, in some areas, the RPE basal lamina had been replaced by polymorphous 
electron dense material that was localized between the elastic layer of BM and the RPE basal 
infoldings (Figure 25A). In other areas of the same eye, irregular nodules arising from the RPE 
basal lamina and with comparable electron density were found between the basal infoldings of 
the RPE (Figure 25B-C). In addition, the basal lamina was frequently found to be interrupted 
where nodules arised (Figure 25B, C, D). Nodules and RPE basal lamina interruptions were 
found very frequent in early-induced mice and more rarely in late-induced mice. The changes 
were essentially similar in structure to basal lamina deposits typically found in CNV in humans 
patients with AMD. Additionally, we found interruptions of the RPE basal lamina with an 
associated accumulation of electron-dense material in the adjacent RPE infoldings(Figure 25B 
and C). Next, we labeled the basal laminae of RPE and choriocapillaris by collagen type IV 
immunohistochemistry. In control mice, the basal laminae of both RPE and choriocapillaris 
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endothelium were continuously labeled (Figure 25F, G). In early-induced Tgfbr2Δeye mice 
continuous staining was only seen in the basal lamina of the choriocapillaris. Staining was 
irregular and patchy though in region of the RPE (Figure 25F). In late-induced Tgfbr2Δeye mice 
continuous labeling was seen in the basal lamina surrounding choriocapillaris vessels, but was 
incomplete underneath the RP (Figure 25G). In places, the vascular basal lamina reached 
between RPE cells indicating areas of CNV formation.  
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Figure 25. Structural changes of the Bruch’s membrane (BM) in early and late-inducedTgfbr2
Δeye
 
mice.  A. Transmission electron microscopy (TEM) of RPE/BM in early-induced 2.5-month-old mice. The 
BM of the control is of regular structure, but thickened in Tgfbr2
Δeye
 mice as result of an accumulation of 
collagen fibers and fine fibrillar extracellular material between the basal lamina of the choriocapillaris and 
the elastic layer of BM. In some areas (right-handed panel) the RPE basal lamina is replaced by 
polymorphous electron dense material that reaches from the elastic layer of BM to the RPE basal 
infoldings. B. In other RPE/BM areas of early-induced Tgfbr2
Δeye
 mice irregular nodules arise from the 
RPE basal lamina (arrows) and extend between the basal infoldings of the RPE. In places (arrowhead in 
box 3) the RPE basal lamina is interrupted where nodules arise. C. Higher magnification of boxed areas 
(1, 2, 3) in B. D. TEM of RPE/BM in three-month-old late-induced Tgfbr2
Δeye
 mice. RPE/BM are of regular 
structure in control mice, but thickened in Tgfbr2
Δeye
 mice. Erythrocyte (Er)-filled vessels with fenestrated 
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endothelium are seen between RPE and photoreceptor outer segments (upper row, right-hand panel, 
inset). In places, the RPE basal lamina is interrupted and electron dense nodules arise to extend between 
the basolateral RPE infoldings (Lower row, middle panel. Higher magnification, right-handed panel). E. 
TEM of retinal/choroidal interface in six-month-old late-induced mice. While the control is of regular 
structure, photoreceptor outer segments are missing and the RPE forms multilayers in which vessels are 
seen (upper row). BM is thickened (lower row). F. Immunoreactivity for collagen IV (red) of the 
retinal/choroidal interface in early-induced, four-week-old Tgfbr2
Δeye
 mice. In the control, the basal laminae 
of RPE and choriocapillaris endothelium are labeled. In Tgfbr2
Δeye
 mice staining is seen in the basal 
lamina of the choriocapillaris. Staining is irregular and patchy in region of the RPE. Nuclei are DAPI-
stained (blue). RPE nuclei are marked by arrowheads. G. Immunoreactivity for collagen IV (red) in the 
retinal/choroidal interface in late-induced, three-month-old Tgfbr2
Δeye
 mice. In the control, the basal 
laminae of RPE and choriocapillaris endothelium are continuously labeled. In Tgfbr2
Δeye
 mice labeling is 
seen in the basal lamina surrounding choriocapillaris vessels, but is incomplete underneath the RPE. In 
places, the vascular basal lamina continues between RPE cells (arrows) indicating areas of CNV. Nuclei 
are DAPI-stained (blue), RPE nuclei are marked by arrowheads. RPE, retinal pigment epithelium; BM, 
Bruch’s membrane; CC, choriocapillaris, ONL, outer nuclear layer; Er. Erythrocyte. Experiments 
performed by (A,B,C,F) Sarah V. Leimbeck; (D,E,G) Anja Schlecht.  
 
4.4.5 Cell-specific conditional deletion of Tgfbr2 in RPE and vascular endothelium 
Next we aimed at identifying the specific cell type that is responsible for CNV in Tgfbr2Δeye mice. 
We focused on the RPE and the vascular endothelium, as endothelial proliferation and 
breakdown of the RPE barrier are essential requirements for CNV formation. To this end, we 
generated Tgfbr2ΔRPE mice with Tgfbr2 deletion specifically in the RPE via doxycycline-driven 
RPE-specific expression of Cre recombinase. Successful RPE-specific TβRII deletion was 
confirmed by immunohistochemistry that showed its presence in photoreceptor outer segments, 
RPE and choroid of control animals. In contrast, RPE immunoreactivity was not detectable in the 
RPE of Tgfbr2ΔRPE mice (Supplementary data Figure 29B). In addition, we confirmed 
recombination by PCR (Supplementary data Figure 29D). We analyzed the ocular morphology of 
Tgfbr2ΔRPE mice animals in detail by using essentially similar methods as used for Tgfbr2Δeye 
mice, but did neither detect choroidal CNV nor other obvious structural changes (Supplementary 
data Figure 30). For generation of Tgfbr2ΔEC mice with specific deletion of TβRII in vascular 
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endothelial cells VeCad-Cre-ERT2 mice were used with endothelial-specific tamoxifen-inducible 
Cre expression. Specific recombination in retinal and choroidal vessels was confirmed by GFP 
immunoreactivity in VeCad-Cre-ERT2 crossed with mT/mG reporter mice (Supplementary data 
Figure 29D). When analyzing the structure of six-week-old Tgfbr2ΔEC mice the pronounced 
structural changes that we had reported (Braunger et al. 2015) for early-induced Tgfbr2Δeye mice 
such as retinal and vitreal neovascularization, retinal detachment or vitreal hemorrhages were 
completely absent (Figure 26A, B). Still, similar to our results seen in early-induced Tgfbr2Δeye 
mice (Braunger et al. 2015), dilated vessels were frequently observed in the inner nuclear layer 
(Figure 26C). Quite intriguingly, at the retinal/choroidal interface, focal areas where frequently 
observed in which photoreceptor outer segments were degenerated or absent, the RPE 
multilayered and vascular endothelial cells together with extravasated erythrocytes had 
accumulated in the subretinal space (Figure 26D). FITC-dextran perfused ocular sections of 
Tgfbr2ΔEC mice showed tracer leakage from the choriocapillaris towards the RPE and choroidal 
vessels penetrating the RPE, indicating a breakdown of the outer blood retinal barrier and the 
formation of CNV (Figure 27A). In contrast to our data from Tgfbr2Δeye mice though, we did not 
observe an accumulation of F4/80 positive cells in the choroid of Tgfbr2ΔEC mice (Figure 27B). In 
addition, immunoreactivity for collagen IV in the RPE/BM region was seen in basal laminae of 
choriocapillaris and RPE and did not markedly differ between Tgfbr2ΔEC mice and controls 
(Figure 27C). TEM confirmed the findings seen by light microscopy and the presence of 
degenerated photoreceptor outer segments, multilayered RPE and extravasated erythrocytes 
(Figure 27D). Moreover, plasma-derived electron-dense material did not pass the RPE tight 
junctions in controls but accumulated between RPE and photoreceptor outer segments of 
Tgfbr2ΔEC mice indicating breakdown of the RPE barrier (Figure 27E). Overall our data obtained 
in Tgfbr2ΔEC mice strongly support the conclusion that deletion of TβRII in vascular endothelial 
cells alone is sufficient to promote the formation of CNV.  
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Figure 26. Structural changes of the retina in Tgfbr2
ΔEC
 mice.  Richardson stained semi-thin sections 
of a six-week-old Tgfbr2
ΔEC
 mouse and its control littermate. A. Retinal hemispheres of the control mouse 
and the Tgfbr2
ΔEC
 littermate. B. Detailed magnification of the retina and choroid. C. Dilated retinal vessels 
are seen in the INL of Tgfbr2
ΔEC
 mice. D. In the retinal/choroidal interface, endothelial cells (arrow), 
erythrocytes (white arrowheads) and mononuclear cells (black arrowhead) are seen between 
degenerating photoreceptor outer segments. RGC, retinal ganglion cells; IPL, inner plexiform layer; INL, 
inner nuclear layer; ONL, outer nuclear layer; RPE, retinal pigment epithelium. Experiments performed by 
Anja Schlecht 
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Figure 27. Structural changes of the retinal/choroidal interface in Tgfbr2
ΔEC
 mice.  A. FITC-dextran 
perfused retinal meridional sections of a six-week-old Tgfbr2
ΔEC
 mouse and its control littermate. White 
arrows point towards tracer leakage in the RPE (middle panel) and choroidal vessels (right panel) invading 
the RPE. Nuclei are DAPI-stained (blue). B. FITC-dextran (green) perfused and F4/80 (red) 
immunostained sections. The control and the Tgfbr2
ΔEC
 littermate show immunoreactivity for F4/80 (red) 
positive cells in the choroid, which are not of higher number in the mutant. Nuclei are DAPI-stained (blue). 
C. Immunoreactivity for collagen IV (red) in the RPE/BM region of six-week-old mice. Basal laminae of 
choriocapillaris and RPE are regularly labeled in control and mutant. Nuclei are DAPI-stained (blue), RPE 
nuclei are marked by arrowheads. D, E. TEM of RPE/BM in four to six-week-old mice. D. In the control, 
photoreceptor outer segments, RPE and BM are of normal structure. In the Tgfbr2
ΔEC
 mouse, areas of 
degenerated photoreceptor outer segments, multilayered RPE and extravasated erythrocytes are present 
E. Plasma-derived electron-dense material does not pass the RPE tight junctions in controls 
(arrowheads). In contrast, in the mutant it accumulates between RPE and photoreceptor outer segments 
(arrowheads).  Er, erythrocytes; RPE, retinal pigment epithelium; BM, Bruch`s membrane; ONL, outer 
nuclear layer. Experiments performed by Anja Schlecht.  
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Figure 28. Schematic of signaling events at the retinal–choroidal interface. Normally the RPE 
secretes high amounts of both TGF-β and VEGF that both ensure an appropriate physiological 
microenvironment for the choriocapillaris including its maintenance and inhibition of proliferation (right). 
The ablation of Tgfbr2 in endothelial cells results in the specific disability of TGF-β to act on endothelial 
cells. This results in an imbalance of the effects of VEGF/TGF-β, a scenario that promotes the proliferation 
of the vascular endothelium of the choriocapillaris in direction of the RPE and finally results in CNV. RPE, 
retinal pigment epithelium; TGF-β, transforming growth factor-β; VEGF, vascular endothelial growth factor; 
CNV, choroidal neovascularization. 
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4.5 Discussion 
We conclude that the ablation of TGF-β signaling in the ocular microenvironment is sufficient to 
induce CNV and other phenotypic characteristics of AMD in humans. Lack of endothelial TGF-β 
signaling is sufficient to trigger the onset of CNV, while its lack in the RPE is not relevant in this 
context. This conclusion is based on (1) the generation of mice with TβRII deficiency in the 
entire microenvironment of the eye, in vascular endothelial cells, or the RPE; (2) the frequent 
detection of capillaries with fenestrated, PLVAP-positive endothelium that originate from the 
choriocapillaris and traverse the RPE to anastomose with retinal capillaries; (3) the presence of 
basal lamina-like deposits around the RPE basal infoldings and of areas with multilayered RPE; 
(4) the degeneration of photoreceptor outer segments; and (5) the finding of distinct 
accumulations of F4/80 positive macrophages in the choroid.  
 
4.5.1 TGF-β functions at the retinal/choroidal interface to prevent CNV 
The results of our study clearly support the concept that a major function of TGF-β signaling in 
choroid and retina is the stabilization of the choroidal and retinal vascular beds that are each 
essential for neuronal integrity in the sensory retina. This function includes the prevention of 
neoangiogenic processes in the two capillary beds that would otherwise cause neuronal 
dysfunction and death in the retina. It is of interest though that the sensitivity to the induced lack 
of TGF-β signaling differs between the two vascular beds, as the formation of microaneurysms, 
leaky capillaries, and hemorrhages of the retinal vasculature is only seen when TGF-β signaling 
is deleted in the ocular microenvironment shortly after birth (Braunger et al. 2015). In contrast, 
the formation of CNV is seen regardless if TGF-β signaling is interfered with in newborn or three- 
to four-week-old animals. A likely explanation is the fact that the retinal vasculature of the mouse 
eye forms and differentiates in the first two weeks after birth (Fruttiger 2002) and may be more 
vulnerable to lack of TGF-β signaling during that period. A critical contributing factor may be the 
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failure of pericyte differentiation around retinal capillaries that results from deficiency of TGF-β 
signaling during that period (Braunger et al. 2015). Formation of the choroidal vasculature is 
completed in late embryonic life and the choriocapillaris is mature at birth (Rousseau 2003). Its 
higher sensitivity to lack of TGF-β signaling, as opposed to the mature retinal vasculature, is 
likely caused by the presence of the high amounts of VEGF at the retinal/choroidal interface that 
are continuously secreted by the RPE, the only source of VEGF in the back of the adult eye 
(Saint-Geniez et al. 2006). Secretion of VEGF occurs in a polarized fashion to the RPE 
basolateral side facing the choriocapillaris (Blaauwgeers et al. 1999, Kannan et al. 2006) and is 
expected to convey a proliferative signal to endothelial cells of the choriocapillaris that are no 
more under the influence of constitutive TGF-β signaling in animals with an ablation of TβRII. 
 
4.5.2 TGF-β and VEGF as part of a homeostatic system to maintain integrity of the 
choriocapillaris 
It is of interest to note that not only VEGF, but also TGF-β1 and -2 are present at high amounts 
at the retinal/choroidal interface (Pfeffer et al. 1994). It is very tempting to speculate that both 
factors are critical parts of a homeostatic system designed to maintain structure and function of 
the choriocapillaris. In this system, VEGF would be required to maintain the extreme high 
density of the choriocapillaris and their fenestrations (Esser et al. 1998, Kamba et al. 2006), 
while TGF-βs antagonize any proliferative properties of VEGF signaling on the vascular 
endothelium. Failure in the balance of this homeostatic system would cause ablation of the 
choriocapillaris or induce its proliferation finally leading to CNV (Figure 28). There is direct 
evidence for such a homeostatic system from studies in genetically engineered mice in which 
lack of VEGF and/or increase in TGF-β activity leads to ablation of the choriocapillaris (Kurihara 
et al. 2012, Marneros et al. 2005, Le et al. 2010, Saint-Geniez et al. 2009, Ohlmann et al. 2016), 
while increase in VEGF (Oshima et al. 2004, Schwesinger et al. 2001) and/or lack of TGF-β 
activity (results of our present study) have direct opposite and proliferative effects. For the 
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initiation of CNV though, lack of TGF-β activity appears to be more relevant than sole increase 
of VEGF activity, as mice with overexpression of VEGF in the RPE develop an intrachoroidal 
neovascularization, but no CNV (Oshima et al. 2004, Schwesinger et al. 2001). VEGF and TGF-
βs induce the transcription of one another in multiple cell types (Shi et al. 2014, Jeon et al. 2007, 
Nam et al. 2010, Park et al. 2013, Li et al. 2005, Lee et al. 2008) and may well do so in the RPE 
establishing an autoregulatory feedback system designed to maintain structure and function of 
the choriocapillaris. 
 
4.5.3 Potential neuroprotective effects of TGF-β 
Late-induced Tgfbr2Δeye mice showed a dramatic deterioration of the retina. The prolonged 
presence and formation of CNV, and its detrimental effects on structure and function of the 
retina may explain this finding. It may also indicate though a participation of TGF-β signaling in a 
neuroprotective pathway independent of the formation of CNV. We recently showed that TGF-β 
signaling protects retinal neurons from developmental programmed cell death (Braunger et al. 
2013b). It is well possible that it also contributes to maintenance of adult neurons by protecting 
them from apoptosis. In support of such a scenario are findings reported by Walshe and 
colleagues who neutralized TGF-β in the adult mouse eye via expression of soluble endoglin, a 
TGF-β inhibitor (Walshe et al. 2009). Apoptosis of retinal ganglion cells was observed as were 
functional deficits detected by ERG. Neuroprotective activities of TGF-βs were reported for 
multiple types of neurons throughout the central nervous system such as in the striatum (Ma et 
al. 2008), spinal cord (Park et al. 2008), substantia nigra (Roussa et al. 2009) or hippocampus 
(Zhu et al. 2004). Quite similarly, there is increasing evidence that also VEGF signaling is 
important for the trophic maintenance of neurons and their survival after injury, effects that 
appear to be mediated via the VEGF receptor-2 (VEGFR-2) (Carmeliet and Ruiz de Almodovar 
2013, Cvetanovic et al. 2011, Robinson et al. 2001, Jin et al. 2002, Ma et al. 2009b). Mice with a 
Chapter 4 
99 
 
constitutive high expression of VEGF in retinal ganglion cells are protected from RGC 
degeneration after axotomy via VEGFR-2 and downstream activation of ERK1/2 and Akt 
pathways (Kilic et al. 2006). While TGF-β/VEGF are antagonists in their actions at the 
retinal/choroidal interface and the choriocapillaris, they may cooperate in their neuroprotective 
activities. Both functions would serve the ultimate goal to maintain structure and function of the 
retina. 
 
4.5.4 The formation of BlamD-like material is not required for CNV 
While CNV was consistently observed in the eyes of both early and late-induced Tgfbr2Δeye mice, 
and in that of Tgfbr2ΔEC mice, other findings were predominant only in the eyes of early-induced 
Tgfbr2Δeye mice. This includes the formation of homogenous extracellular material between the 
basal infoldings of the RPE and internal to the RPE basal lamina. The material was quite similar 
in electron density and structure to that of basal lamina deposits (BlamD), a characteristic finding 
in patients with early age-related macular degeneration (van der Schaft, T L et al. 1994, Curcio 
et al. 2005, Loeffler and Lee 1992). BlamD-like changes were commonly observed in early-
induced Tgfbr2Δeye mice, only rarely in late-induced Tgfbr2Δeye mice and not in Tgfbr2ΔEC mice 
suggesting that they are not a requirement for CNV and breakdown of the RPE barrier. Our 
immunohistochemical data indicate that the homogenous extracellular BlamD-like material 
contains collagen type IV, an observation that correlates with the observation that basal lamina 
proteins such as collagen IV and laminin are present in BlamD in human patients with AMD (van 
der Schaft, T L et al. 1994, Marshall et al. 1992). BlamD formation in AMD is likely caused by 
RPE dysfunction (Curcio et al. 2005). A comparable dysfunction might more easily happen in 
early-induced Tgfbr2Δeye mice, in which the RPE is not yet fully differentiated. Direct ablation of 
TGF-β signaling in RPE cells appears not to be relevant for formation of BlamD-like material, as 
it was not observed in Tgfbr2ΔRPE mice.  
Chapter 4 
100 
 
4.5.5 Neovascularization is associated with macrophage accumulation 
A common finding Tgfbr2Δeye mice with CNV was the marked accumulation of F4/80 positive 
macrophages in region of the retinal/choroidal interface. Comparable findings have been 
described for patients suffering from AMD (Xu et al. 2009). It is reasonable to assume that 
signaling molecules released from proliferative capillary endothelial cells attracted the cells. 
Reactive macrophages might contribute to the loss of the RPE barrier in our mice and its 
transition from an epithelial layer to a multilayer in areas of CNV. Our findings in Tgfbr2ΔRPE mice 
indicate that lack TGF-β signaling in RPE cells is not required for this process. Currently we do 
not know how proliferating choroidal endothelial cells manage to break down the RPE barrier, 
but we trust that our mouse models are appropriate tools to study this in the future. The 
expression of signaling molecules characteristic for reactive macrophages/microglia such iNos, 
Il-6, Tnf-α and MCP-1/Ccl was elevated in the retinal mRNA of early-induced Tgfbr2Δeye mice, 
but not in late-induced, an observation that we attribute to the marked changes in the inner 
retina of early-induced mice that are absent in late-induced. Still, those molecules might well be 
elevated in the microenvironment of the choroidal/retinal interface where macrophages 
accumulate in mice with CNV. 
 
4.5.6 TGF-β signaling and endothelial proliferation 
Retinal endothelial cells express two types of TβRI receptors, the activin receptor-like kinase 1 
(ALK1) and ALK5, which are each recruited and activated after binding of TGF-β dimers to the 
TβRII (van Geest et al. 2010, Goumans et al. 2002). Depending on which TβRI is recruited, 
different SMAD signaling cascades are activated resulting either in an ALK5/SMAD2/3 mediated 
inhibition of endothelial cell migration and proliferation or an ALK1/SMAD1/5/8 induced 
proangiogenic stimulation of both processes (Goumans et al. 2002, van Geest et al. 2010, 
Massague 2000) In our Tgfbr2ΔEC and Tgfbr2Δeye animal models, the deletion of TβRII interrupts 
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both ALK1- and ALK5-mediated signaling cascades. We therefore hypothesize that the 
deficiency of TβRII in endothelial cells shifts the ALK1/ALK5 balance towards the proangiogenic 
side, a scenario that finally results in the proliferation of endothelial cells promoting the 
development of CNV. Data obtained in mice with an inducible conditional deletion of TβRII in 
retinal endothelial cells further support the concept of an increased endothelial proliferation 
following an interruption of the TGF-β signaling pathway. The mice demonstrated a significant 
increase in vascular branch point density, the area of retina covered by vascular endothelial 
cells, the number of proliferating endothelial cells and glomerular tuft formation during retinal 
angiogenesis (Arnold et al. 2012, Allinson et al. 2012). The fact that we observed a leakage of 
high molecular weight FITC-dextran and erythrocytes in the retina and in the sub-retinal space in 
both animal models, e.g. mice with an early-induced deletion of the TGF-β signaling pathway in 
the entire eye (Braunger et al. 2015) and with a deletion of the TGF-β signaling pathway 
specifically in endothelial cells (present study), implicates a disruption of the inner and outer 
blood retinal barriers. Deficiency of the TGF-β signaling pathway in endothelial cells is likely the 
major contributor in this scenario. Data obtained in mice with an endothelial specific deficiency of 
SMAD4, an intracellular downstream mediator of TGF-β signaling, or data from mice with a 
deletion of TβRII specifically in endothelial cells in the brain (Li et al. 2011, Nguyen et al. 2011) 
are in agreement with our results as both conditions caused perinatal intracerebral hemorrhages 
and a breakdown of the blood brain barrier. Furthermore, the virus-driven expression of soluble 
endoglin resulted in an inhibition of TGF-β1 signaling in the murine retina, a situation that also 
caused a breakdown of the blood retinal barrier, most likely mediated through a decreased 
association of the tight junction proteins occludin and zona occludens (ZO)-1 (Walshe et al. 
2009). 
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4.5.7 TGF-β signaling in human patients with AMD  
Several independent case-control genome-wide association studies detected an association of 
two synonymous polymorphisms in exon 1 of the high-temperature requirement A1 (HTRA1) 
gene with a high risk to develop AMD (Fritsche et al. 2013, Yang et al. 2006, Dewan et al. 2006). 
The gene product HTRA1 appears to play a causative role in CNV (Vierkotten et al. 2011, Zhang 
et al. 2012, Nakayama et al. 2014). Quite intriguingly a recent study provided evidence that the 
two synonymous HTRA1 variants influence their protein interaction with TGF-β1 leading to an 
impairment of TGF-β signaling (Friedrich et al. 2015). Moreover, a collaborative genome-wide 
association study identified TGFBR1 the gene encoding for the TGF-β1 type I receptor, as a 
new susceptibility gene for AMD further highlighting the importance of the TGF-β signaling 
pathway in the context of AMD (Fritsche et al. 2013).  
 
4.5.8 Conclusion 
Our findings emphasize the importance of TGF-β signaling as a key player in the development 
of ocular neovascularization and implicate a fundamental role of TGF-β signaling in the 
pathogenesis of AMD. A more thorough understanding of this role at the retinal/choroidal 
interface has the distinct potential to lead to the development of novel treatments strategies 
preventing CNV in patients suffering from AMD. 
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4.6 Supplementary Data 
 
Figure 29. Deletion of TβRII in late-induced Tgfbr2
Δeye
, Tgfbr2
ΔRPE
 and Tgfbr2
ΔEC
 mice.  A. Real time 
RT-PCR for mRNA of Tgfbr2 in four-week-old control and late-induced Tgfbr2
Δeye
 mice. Data are 
expressed as mean±SEM; control: n= 9, Tgfbr2
Δeye
: n = 4; ***P ≤ 0.001. B. Immunoreactivity for TβRII 
(green) in the RPE in four week old Tgfbr2
ΔRPE
 and control littermates. The control shows a distinct 
immunoreactivity for TβRII in the RPE which is essentially absent in the Tgfbr2
ΔRPE
 animal. Nuclei are 
DAPI-stained (blue). C. Tgfbr2 deletion PCR of a four week old Tgfbr2
ΔRPE
 mouse and its control littermate 
using the sensory retina and RPE/choroid as genomic DNA samples. Due to their different product sizes 
(product size control: 3974bp, product size after Tgfbr2 deletion: 636bp) and the PCR elongation time of 1 
min, the Tgfbr2 PCR product was only amplified after Cre mediated recombination. As expected, in the 
Tgfbr2
ΔRPE
 mouse the recombination occurred only in RPE/choroidal sample but not in the retina. D. A 
distinct GFP signal in 10 day old VeCad Cre-ER
T2
;mT/mG mice indicates a successful activation of the 
Cre recombinase in retinal and choroidal endothelial cells following tamoxifen treatment. RGC, retinal 
ganglion cells; INL, inner nuclear layer; ONL, outer nuclear layer; TβRII, TGF-β type II receptor; CC, 
choriocapillaris; RPE, retinal pigment epithelium. Experiments performed by Anja Schlecht.  
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Figure 30. Inhibition of TGFβ-signaling in the RPE: the morphology of the eye.  Richardson`s stained 
semithin sections. A. Retinal hemispheres of six month old animals. The control mouse and the Tgfbr2
ΔRPE
 
mouse do not obviously differ in structure. B. Detailed magnification of the retina/choroid of a Tgfbr2
ΔRPE
 
mouse and its control littermate showing an essentially normal morphology. C. In vivo funduscopy and 
fluorescein angiography show no obvious alterations in the Tgfbr2
ΔRPE
 mouse compared to the control. D. 
Detailed magnifications of the interface of the outer retina, RPE and choroid, again showing a regular 
morphology in theTgfbr2
ΔRPE
 mice and controls. RGC, retinal ganglion cells; INL, inner nuclear layer; ONL, 
outer nuclear layer; RPE, retinal pigment epithelium. Experiments performed by (A,B,D) Anja Schlecht; (C) 
Anja Schlecht and Herbert Jägle.  
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5 General discussion 
TGF-β signaling plays an important role in many cellular processes including cell growth, 
differentiation and apoptosis (Heldin et al. 1997, Massagué 2012, Braunger et al. 2015, 
Braunger et al. 2013b). Throughout the past years, great research efforts have been made to 
further investigate the effects and functions of TGF-β signaling in vivo. Since the systemic 
constitutive deletion of the TGF-β signaling pathway is embryonic lethal (Dickson et al. 1995), 
the development of the Cre-loxP system greatly enhanced the possibilities to study TGF-β in 
vivo as different time- and/or cell type-specific Cre recombinases are available.  
In our group, we aimed to investigate the role of TGF-β signaling during development and 
maintenance of the ocular vasculature. Therefore, we deleted the TGF-β signaling pathway in 
the entire eye. To circumvent the embryonic lethality, we decided to use an inducible, tamoxifen 
dependent Cre recombinase expressing mouse line (CAGG Cre-ERTM). CAGG Cre-ERTM mice 
carry a Cre recombinase which is fused to a mutant form of an estrogen receptor binding domain 
(ERTM) (Hayashi and McMahon, 2002). The fusion leads to a sequestration of the Cre in the 
cytoplasm and Cre-ERTM will only translocate to the nucleus after binding to tamoxifen (Feil et al. 
1997, Hayashi and McMahon 2002). 
In this study, we provide evidence that the topical administration of tamoxifen eye drops in 
CAGG-Cre ERTM mice leads to a successful activation of the Cre recombinase in the entire eye 
(Schlecht et al. 2016). Furthermore, we were able to show that an early-induced deletion of 
Tgfbr2 (tamoxifen treatment starting at P4) in the eye resulted in a phenotype mimicking 
essential characteristics of diabetic retinopathy (Braunger et al. 2015).In addition, we observed 
that a late-induced deletion of Tgfbr2, after development of the retinal vasculature (tamoxifen 
treatment starting on P21), resulted in the formation of choroidal neovascularization, a hallmark 
of age-related macular degeneration.  
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5.1 Tamoxifen eye drops: A new delivery method without side effects? 
A frequently used standard protocol to activate tamoxifen-dependent Cre recombinases 
describes the administration of up to 1mg tamoxifen via a single or repeated intraperitoneal 
injections, depending on the used Cre recombinase (Kuhbandner et al. 2000, Leone et al. 2003, 
Kim et al. 2004, Indra et al. 1999). These procedures harbor the risk of infections as a result of 
the intraperitoneal injections (Leenaars et al. 1998, Leenaars and Hendriksen 2005). Intravitreal 
tamoxifen injections still go along with the risk of an ocular infection. Furthermore, studies could 
show that intravitreal injections of the vehicle alone can lead to a reactivity of microglia cells and 
elevated expression levels of neuroprotective molecules (Braunger 2014, Seitz and Tamm 
2014).  
In the current study, we aimed to establish an efficient recombination of the Cre recombinase in 
CAGG Cre-ERTM mice by using tamoxifen containing eye drops. We provide substantial 
evidence that tamoxifen administration via eye drops (duration of treatment was five consecutive 
days, eye drops were given three times per day, either from P4 – P8, or from P21 – P25) results 
in successful activation of the Cre recombinase in ocular tissue of CAGG Cre-ERTM mice.  
It is of interest to mention that our group could show that the mentioned negative side effects of 
an invasive tamoxifen administration can be avoided by the use of tamoxifen eye drops. We 
demonstrated that Cre expression itself, or topical tamoxifen treatment does not result in 
detectible changes in the retinal morphology and function, the expression levels of 
neuroprotective molecules, neuronal vulnerability or glial reactivity (Boneva et al. 2016).  
After verifying the reliability of this newly established method, we also wanted to know if the 
activation of the Cre via tamoxifen containing eye drops is restricted to ocular tissue only or if 
Cre had also been activated in other organs. To answer this question, we crossed heterozygous 
CAGG Cre-ERTM mice with homozygous mT/mG double fluorescent Cre reporter mice 
(Muzumdar et al. 2007). These reporter mice express GFP (green fluorescent protein) in each 
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cell in which the Cre is active. We sampled and sectioned organs from CAGG Cre-ERTM;mT/MG 
and control;mT/mG mice that had been treated with tamoxifen eye drops from p4 – p8. As 
shown in Figure 31 mice carrying the Cre recombinase present an intense GFP signal in all 
investigated organs: the brain, the lung, the liver, the kidney, the heart and the intestine. The 
control littermates did not show a GFP reaction, we only observed DAPI-labeled nuclei. This 
outcome indicates that the application of tamoxifen eye drops does not only result in a 
successful activation of the Cre in ocular tissue, but also in other parts of the body. This effect 
might be the result of the five-day duration of the treatment. Perhaps, a shorter timeframe of e.g. 
three days would be sufficient to result in a successful activation of Cre in ocular tissue, without 
distributing tamoxifen to any other parts of the body. We conclude, that tamoxifen eye drops are 
a save and non-invasive method to activate the Cre recombinase without running the risk of 
infections e.g. due to intraperitoneal injections or inducing the expression of neuroprotective 
factors or the reactivity of micro- and macroglia cells. Furthermore, we are convinced that the 
topical application of tamoxifen via eye drops might be an interesting approach for scientists to 
investigate gene function outside the eye, too. 
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Figure 31. Activation of the Cre recombinase after the administration of tamoxifen eye drops.  The 
10 days old double transgenic CAGG Cre-ER
TM
/mTmG mice show a strong green fluorescence in all 
examined organs. In contrast, in the control littermate (mTmG) only the DAPI-labeled nuclei are visible.  
 
5.2 TGF-β signaling is required for pericyte differentiation 
A general pan-pericyte marker does not exist to date, due to the diverse characteristics, 
functions and locations of pericytes. There are several commonly used markers for defining 
pericytes like alpha-smooth-muscle actin (α-SMA), regulator of G protein signaling 5 (RGS-5), 
neuron-glial 2 (NG2) or platelet-derived growth factor receptor beta (PDGFRβ). However, the 
expression patterns of these markers vary, depending on the tissue or on the developmental or 
angiogenic stage of a blood vessel (Bergers and Song 2005). In the retina, NG2 is mostly 
expressed in pericytes during vascular development and after the pericytes’ differentiation 
(Schallek et al. 2013, Trost et al. 2013). α-SMA expression in the retina is normally restricted to 
vascular smooth muscle cells surrounding larger vessels like arteries and arterioles and mostly 
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absent in retinal capillaries (Hughes and Chan-Ling 2004, Trost et al. 2013, Nehls 1991). RGS-5 
and PDGFR-β were identified as markers for developing pericytes (Bondjers et al. 2003, Lindahl 
et al. 1997). When we used these markers for pericytes in our immunohistochemical analyses, 
Tgfbr2-deficient mice showed only few NG2-positive pericytes covering retinal capillaries. 
However, these capillaries were densely covered with α-SMA-positive smooth muscle-like cells. 
As pericytes and smooth muscle cells originate from the same precursors, our results indicate 
that, during the development of the retinal vasculature, TGF-β signaling is essential for 
determining the cell fate of mural cells surrounding retinal capillaries.  
 
5.3 Early-induced deletion of ocular TGF-β signaling leads to formation of multiple 
microaneurysms 
The loss of pericytes and the formation of capillary microaneurysms are hallmarks of diabetic 
retinopathy (Cogan 1961). Proliferation of endothelial cells is thought to be a trigger for the 
formation of microaneurysms (Aguilar et al. 2003). In vitro studies showed that pericytes can 
control endothelial cell proliferation. This effect is discussed to be mediated by the activation of 
TGF-β1 upon contact between endothelial cells and pericytes (Sato et al. 1990, Antonelli-Orlidge 
et al. 1989, Hirschi et al. 1998). In addition to the proliferation of the endothelium, the early loss 
of pericytes is hypothesized to be a causative factor for the generation of microaneurysms. 
However, the fact that in mouse mutants that lack more than 50% of pericytes, microaneurysms 
are rare, may point towards a synergistic effect between the loss of pericytes and the 
proliferation of endothelial cells (Enge 2002, Hammes et al. 2002, Hammes et al. 2004, Hammes 
2005). Our data show that the inhibition of ocular TGF-β signaling leads to the formation of 
microaneurysms. The observed dedifferentiation of pericytes in Tgfbr2-deficient mice 
concomitant with an increased proliferation of endothelial cells is a very likely explanation for this 
scenario. It is worthwhile to mention that endothelial cells express two different TGF-β type I 
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receptors (TβRI), i.e. ALK1 and ALK5. Recruitment and activation of ALK1 leads to intracellular 
phosphorylation of Smad1/5/8 which results in stimulation of endothelial cell migration and 
proliferation. ALK5 signaling, however, is intracellularly mediated via Smad2/3 and leads to an 
inhibition of these two processes (Goumans et al. 2003, Goumans et al. 2002). The balance 
between these two possibilities determines the pro- or antiangiogenic effects of TGF-β in 
endothelial cells. Our results indicate that the lack of Tgfbr2 in retinal endothelial cells shifts the 
balance towards the proangiogenic side, resulting in endothelial proliferation. To our 
understanding, the proliferation of endothelial cells and the dedifferentiated pericyte population 
promote the formation of microaneurysms.  
 
5.4 Early-induced deletion of ocular TGF-β signaling results in non-perfused capillaries 
and activation of the ocular immune system  
Based on our results we provide evidence that a deletion of ocular TGF-β signaling results in 
non-perfused capillaries that lack endothelial cells. Again, comparable morphological findings 
are described for patients suffering from diabetic retinopathy (Garner 1993, Hammes et al. 
2011). In support to our findings are data obtained in mice that lack 50% of retinal pericytes. 
These animals also developed vascular occlusion and regression, which indicates that capillary 
regression is caused by pericyte dropout (Enge 2002). Furthermore, in vitro experiments showed 
that pericytes release active TGF-β1 which is necessary for survival of vascular endothelial cells 
(Walshe 2010). In Tgfbr2 deficient mice, endothelial cells lack the Tgfbr2, which is essential for 
TGF-β signaling. Thus TGF-β1 cannot promote the survival of endothelial cells in this model.  
It is well-known that TGF-β signaling plays an important immunosuppressive role in the eye 
(Nussenblatt and Ferris 2007, Niederkorn 2006). The deletion of Tgfbr2 via tamoxifen eye drops 
in Tgfbr2 deficient mice affects the whole ocular microenvironment; hence microglia cells are 
also affected by the deletion of Tgfbr2. It is very likely that the observed accumulation of 
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macrophages and reactive microglia in close association with the retinal vessels and a 
significant induction of immune modulating cytokines are a direct effect of the Tgfbr2 deletion on 
micro-and macroglia cells. Similar to our data, studies demonstrated that patients with diabetic 
retinopathy frequently show microglia with a reactive phenotype which clusters around the retinal 
vessels, especially next to dilated veins, microaneurysms and intraretinal hemorrhages (Zeng et 
al. 2008). 
 
5.5 Early-induced deletion of ocular TGF-β signaling causes vitreal neovascularization, 
impaired retinal function and retinal detachment 
The presence of non-perfused capillaries most likely triggered the significant elevation of HIF-1α, 
which is a marker for hypoxia. Subsequently, in Tgfbr2 deficient mice, the expression levels of 
potent angiogenic molecules were significantly elevated, too. This resulted in vitreal 
neovascularization, comparable to patients suffering from proliferative diabetic retinopathy 
(Frank 2004, Antonetti et al. 2012, Cheung et al. 2010). Furthermore, we observed the formation 
of membranes in the vitreous, an increased number of apoptotic cells in the retina, an impaired 
retinal function and finally retinal detachment. Similar changes can be seen in humans with late-
stage proliferative diabetic retinopathy: Patiens show an imparied sensory function and the 
formation of tractional membranes which can lead to retinal detachment (Garner 1993, Frank 
2004).  
 
5.6 Early-induced deletion of ocular TGF-β signaling leads to an AMD-like phenotype 
It is well known, that the Bruch’s membrane plays an essential role in the exchange of diverse 
substances between the retina, the RPE and the choriocapillaris (Hamilton and Leach 2011). 
Animal models in which CNV is induced by laser induced disruption of the Bruch’s membrane 
demonstrate that the loss of the integrity of the Bruch’s membrane can lead to choroidal 
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neovascularization (Dobi et al. 1989, Ryan 1982). Researchers propose that throughout time 
abnormal molecules accumulate within the RPE due to failures in the cells’ digestive 
mechanisms. These molecules hinder the normal metabolism, leading to an aggregation of 
cellular debris within the Bruch’s membran which results in the formation of basal linear deposits 
(BlinD), basal laminar deposits (BlamD) and drusen (Young 1987, Loffler and Lee 1986). This 
may lead in the following to a thickening of the Bruch’s membrane (Young 1987). In general, 
drusen are discussed to correlate with the risk of developing AMD (Ambati et al. 2013). In our 
study, we provide evidence that an early-induced deletion of TGF-β signaling in the retinal 
microenvironment induces substantial changes of the Bruch’s membrane, similar to those of 
patients suffering from AMD. We observed that alterations in the Bruch’s membrane, the 
formation of BlinDs and BlamDs, and finally the development of choroidal neovascularization. 
Another important factor contributing to the pathogenesis of AMD is the ocular immune system. 
Several studies showed that animal models with an impaired immune cell trafficking develop an 
AMD-like phenotype (Ambati et al. 2003, Combadiere et al. 2007, Ross et al. 2008). 
Furthermore, the observed accumulation of microglia in the subretinal space in patients suffering 
from AMD is discussed to be both a symptom of inflammatory damage and a beneficial 
response to injury (Xu et al. 2009). In addition, the recruitment of microglia and/or macrophages 
have been shown to support the growth of neovascular lesions (Espinosa-Heidmann et al. 2003, 
Sakurai et al. 2003, Ma et al. 2009a). In our study, we could also observe an accumulation of 
macrophages in the subretinal region and the choroid of Tgfbr2-deficient mice and an increased 
expression of immune modulating cytokines in the retina.  
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5.7 Late-induced deletion of ocular TGF-β signaling results in CNV and a alterations of the 
Bruch’s membrane 
Next we investigated whether the development of CNV in TβRII deficient mice might be a direct 
effect of the conditional deletion of the TGF-β signaling pathway or if CNV occurs as a 
consequence of developmental vascular pathologies e.g. the persistence of the hyaloid artery 
and the presence of non-perfused capillaries, and the herein resulting retinal hypoxia in the 
early-induced Tgfbr2Δeye mice  
To discriminate between these two possibilities, we decided to inhibit the TGF-β signaling 
pathway after the retinal vasculature had been developed. Thus, we treated the mice with 
tamoxifen eye drops from P21 – P25 and analyzed the phenotype of these mice. The retinal 
vasculature was regular with all three retinal plexus in the correct localization. However, we still 
found alterations of the Bruch’s membrane, CNV, an accumulation of macrophages in the 
choroid, an impairment of the sensory function and retinal degeneration. Therefore, our data 
clearly shows that TGF-β signaling is essential for maintaining the ocular vasculature and 
microenvironment, and that deleting TβRII is sufficient to induce changes similar to those seen 
in human patients with AMD. Still, the question remains whether an impaired TGF-β signaling 
pathway may contribute to the molecular pathogenesis of AMD in humans. 
Genome wide association studies showed that HTRA1 (high temperature requirement factor A1) 
is a risk factor for developing AMD (Deangelis et al. 2008, Fritsche et al. 2013, Dewan et al. 
2006). Interestingly, it has been shown that HTRA1 is an important regulator of the TGF-β 
signaling pathway. The AMD-associated polymorphism in HTRA1 results in a reduced affinity for 
TGF-β1 and a decreased ability to control TGF-β signaling (Friedrich et al. 2015). Another 
genome-wide association study in 2013 identified TGFBR1 as a risk gene for developing AMD 
(Fritsche et al. 2013). This data together with the results obtained in our study clearly point 
towards an involvement of TGF-β signaling in the pathogenesis of AMD.  
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5.8 Deletion of endothelial TGF-β signaling leads to development of CNV and changes in 
the Bruch’s membrane 
Next we aimed to identify the specific cell population which might be responsible for the 
observed choroidal neovascularization in Tgfbr2Δeye mice. Herein, we focused on the RPE and 
the endothelium, as the basement membranes of both directly contribute to the formation of BM 
(Booij et al. 2010). To this end, we used a doxycycline-inducible Cre mouse with a cell specific 
expression of the Cre recombinase in the RPE (Le et al. 2008) and a tamoxifen-dependent Cre 
mouse with the Cre recombinase under the control of the endothelial specific cadherin 5 
promotor element (Monvoisin et al. 2006). We provide evidence that a specific deletion of TβRII 
in the cells of the RPE is not sufficient to trigger the development of CNV. In contrast, mice with 
an endothelial deletion of TβRII, showed an alterated Bruch’s membrane that lost its organized, 
five-layered morphology and the development of CNV. This indicates that a deletion of 
endothelial TGF-β signaling, most likely of the choriocapillaris, leads to a disruption of the 
Bruch’s membrane integrity and in the following to the formation of CNV. Furthermore, the 
accumulation of erythrocytes in the retina and in the subretinal space indicates a breakdown of 
the inner and outer blood retinal barriers. In contrast to our data obtained in mice with an ocular 
deletion of TβRII in the entire eye, we did not observe an accumulation of immune cells in the 
retina and/or the choroid in endothelial specific Tgfbr2 knockouts. Clearly, the endothelial 
deletion of TβRII does not directly affect the microglia cells or macrophages. Therefore,  these 
cells can still respond to the high levels of TGF-β2 that maintain the ocular immune privilege 
(Streilein 1999). Consequently, the observed reactivity and accumulation of microglia cells in 
mice with a deletion of Tgfbr2 in the entire eye pinpoints towards a direct effect of the deletion on 
these cells.   
We hypothesize that the development of CNV in mice with an endothelial specific deletion of the 
TGF-β signaling pathway may be the result of an increased endothelial cell proliferation 
concomitant with a disruption of the BM integrity. This theory is strengthened by data obtained 
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from mice with an endothelial deletion of TβRII. These mice showed an increase in vascular 
branch point density, the number of proliferating endothelial cells and glomerular tuft formation 
(Allinson et al. 2012, Arnold et al. 2012) 
Most likely, the deletion of endothelial TβRII shifts the ALK1/ALK5 balance towards a 
proangiogenic and pro-proliferative effect, quite comparable to the situation in our Tgfbr2Δeye 
mice. In summary, our data obtained in Tgfbr2ΔEC mice strongly support the conclusion that a 
deletion of TβRII in endothelial cells is sufficient to promote an AMD-like phenotype  
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6 Summary 
Two of the leading causes of blindness worldwide are diabetic retinopathy and age-related 
macular degeneration. Both diseases are associated with pathological changes in the ocular 
vasculature. In the pathogenesis of diabetic retinopathy, a proliferation of the retinal vessels can 
be observed whereas in the wet form of age-related macular degeneration the choroidal vessels 
penetrate the retinal pigment epithelium and grow into the retina. The molecular mechanisms 
leading to these changes are mostly unknown, however there is evidence, that TGF-β signaling 
is involved in the pathogenesis of these diseases.  
To study the exact role of TGF-β signaling during development and maintenance of the ocular 
vasculature, we generated mice with an ocular deletion of Tgfbr2, using CAGG Cre-ERTM mice 
with two floxed alleles for Tgfbr2, and activated the Cre recombinase by applying tamoxifen eye 
drops.  
The tamoxifen treatment via eye drops resulted in efficient activation of the Cre recombinase in 
all ocular tissue. When tamoxifen application started on postnatal day P4, the lack of Tgfbr2 in 
the eye caused a phenotype that mimics essential characteristics of diabetic retinopathy. We 
observed the formation of multiple microaneurysms, leaky capillaries and hemorrhages. 
Immunohistochemial staining could show that the retinal capillaries were no longer covered by 
pericytes, but were densely coated by vascular smooth muscle-like cells. The basal lamina 
between endothelial cells and pericytes was markedly thickened. In addition, we found microglia 
with a reactive phenotype in close association with the retinal vessels correlating with the 
induction of immunmodulating cytokines. Furthermore, we found an induction of angiogenic 
molecules and an accumulation of retinal HIF-1α which suggests local hypoxia. In the following, 
we could observe neuronal apoptosis and an impairment of sensory function and vitreal 
neovascularization which lead to the formation of vitreal membranes and finally retinal 
detachment.  
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In addition to the already mentioned structural and functional changes that mimic the phenotype 
of diabetic retinopathy, we found that these mice also show choroidal neovascularization (CNV), 
alterations of the Bruch’s membrane and the formation of basal laminar as well as basal linear 
deposits. All findings are similar to those seen in the wet form of AMD. A later deletion of TGFβ-
signaling (at P21, after development of the retinal vasculature) resulted in a normal retinal 
vasculature but still in the formation of CNV. To investigate which cell type is responsible for the 
choroidal neovascularization, we generated mice with a specific deletion of Tgfbr2 in cells of the 
retinal pigment epithelium and mice with a specific deletion in endothelial cells. The deletion of 
Tgfbr2 in the RPE did not result in structural changes e.g. choroidal neovascularization. 
However, mice with a deletion of TGF-β signaling in endothelial cells developed alterations in 
the Bruch’s membrane, hemorrhages and CNV.  
We conclude that the lack of ocular TGF-β signaling leads to a phenotype that shows 
characteristics of both diabetic retinopathy and age-related macular degeneration. These results 
strongly suggest that TGF-β signaling plays an important role in the molecular pathogenesis of 
these ocular diseases.  
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10 Abbreviations 
ALK  Activin receptor-like kinase 
AMD  Age related macular degeneration 
Ang-2  Angiopoietin-2 
α-SMA  alpha-smooth muscle actin 
AU  Arbitrary unit 
BlamD  Basal laminar deposits 
BlinD  Basal linear deposits 
BM  Bruch’s membrane 
BRB  Blood-retinal barrier 
C  Choroid 
Casp8  Caspase 8 
CB  Ciliary body 
CC  Choriocapillaris 
Ccl2  CC- chemokine ligand 2 
CD31  Cluster of differentiation 31 
CD68  Cluster of differentiation 68 
CO  Cornea 
Col  Collagen 
CNV  Choroidal neovascularization 
CMV  Cytomegalovirus 
Cre  Causes recombination 
DNA  Deoxyribonucleic acid 
DR  Diabetic retinopathy  
EC   Endothelial cell 
Egr-1  Early growth response protein-1 
Er  Erythrocyte 
ERG  Electroretinogram 
Fgf2  Basic fibroblast growth factor-2 
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FITC-dextran Fluorescein isothiocyanate-dextran 
FLA  Fluorescein angiography 
GAPDH Glycerinaldehyde-3-phosphate dehydrogenase 
GCL  Ganglion cell layer 
GDF6  Growth differentiation factor 6 
GFAP  Glial acidic fibrillary protein 
Gnb2l  Guanine nucleotide binding preotein, beta polypeptide 2-like 
HIF-1α  Hypoxia inducible factor-1α 
Hsp90  Heat shock protein 90 
HTRA1 High temperature requirement factor A1 
IBA-1  Ionized calcium-binding adapter molecule-1 
Igf-1  Insulin-like growth factor-1 
Il6  Interleukin 6 
INL  Inner nuclear layer 
iNos  Inducible nitric oxide synthase 
Le  Lens 
NBL  Neuroblast layer 
Ndp  Norrie disease protein 
NG2  Neural/glial antigen 2 
ON  Optic nerve 
ONH  Optic nerve head 
ONL  Outer nuclear layer 
OPL  Outer plexiform layer 
OS  Ora serrata 
PB  Phosphate buffer 
PBS  Phosphate buffered saline 
PC  Pericyte 
PCR  Polymerase chain reaction 
PDGF-β Platelet-derived growth factor-beta 
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PDGFR-β Platelet-derived growth factor receptor-beta 
PLVAP Plasmalemma vesicle associated protein 
PFA  Paraformaldehyde 
PPD  Phenylendiamine 
RGC  Retinal ganglion cell 
Rgs-5  Regulator of G-protein signaling-5 
RNA  Ribonucleic acid 
RPE  Retinal pigment epithelium 
Rpl32  Ribosomal protein l32 
SC  Schlemm`s canal 
SEM  Standard error of the mean 
TBS  Tris buffered saline 
TEM  Transmission electron microscopy 
TGF  Transforming growth factor 
TGF-β  Transforming growth factor-beta 
Tgfbr1  Transforming growth factor-beta receptor type 1 
Tgfbr2  Transforming growth factor-beta receptor type 2 
TβRII  Transforming growth factor-beta receptor type 2 
TM  Trabecular meshwork 
Tnf-α  Tumor necrosis factor-α 
TUNEL Terminal deoxynucleotidyl transferase dUTP nick end labeling 
Tx  Tamoxifen 
VEGF  Vascular endothelial growth factor 
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